Table of Contents


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 10-K
 
ý
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the Fiscal Year Ended December 31, 2017
or
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the Transition Period from              to             
Commission File No. 001-32260
 
Westlake Chemical Corporation
(Exact name of registrant as specified in its charter)
 
 
Delaware
 
76-0346924
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
2801 Post Oak Boulevard, Suite 600
Houston, Texas 77056
(Address of principal executive offices, including zip code)
(713) 960-9111
(Registrant's telephone number, including area code)
 
  Securities registered pursuant to Section 12(b) of the Act:
Title of each class
 
Name of each exchange on which registered
Common Stock, $0.01 par value
 
New York Stock Exchange, Inc.
Securities registered pursuant to Section 12(g) of the Act: None
 
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes   ý     No   ¨
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act.    Yes   ¨     No   ý
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes   ý    No   ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes   ý     No   ¨
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.   ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a smaller reporting company. See definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act:
 Large accelerated filer   x
 
Accelerated filer ¨   
 
Non-accelerated filer ¨   
 
Smaller reporting company ¨
 
  
 
  
(Do not check if a smaller
reporting company)
  
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ¨    
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes   ¨     No   ý
The aggregate market value of the registrant's voting stock held by non-affiliates of the registrant on June 30, 2017 , the end of the registrant's most recently completed second fiscal quarter, based on a closing price on June 30, 2017 of $66.21 on the New York Stock Exchange was approximately $2.4 billion .
There were 129,419,805 shares of the registrant's common stock outstanding as of February 14, 2018 .
DOCUMENTS INCORPORATED BY REFERENCE:
Certain information required by Part II and Part III of this Form 10-K is incorporated by reference from the registrant's definitive Proxy Statement to be filed pursuant to Regulation 14A with respect to the registrant's 2018 Annual Meeting of Stockholders to be held on May 18, 2018 .

Table of Contents


TABLE OF CONTENTS

 
 
 
 
 
 
 
Page
 
 
 
 
 
 
 
Item
 
 
 
1 )
 
 
 
2 )
 
3 )
 
4 )
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5 )
 
6 )
 
7 )
 
 
8 )
 
9 )
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Table of Contents



Explanatory Note
References in this Annual Report on Form 10-K (this "report") to "we," "our," "us" or like terms refer to Westlake Chemical Corporation ("Westlake" or the "Company").
Cautionary Statements about Forward-Looking Statements
The Private Securities Litigation Reform Act of 1995 provides safe harbor provisions for forward-looking information. Certain of the statements contained in this Form 10-K are forward-looking statements. All statements, other than statements of historical facts, included in this Form 10-K that address activities, events or developments that we expect, project, believe or anticipate will or may occur in the future are forward-looking statements. Forward-looking statements can be identified by the use of words such as "believes," "intends," "may," "should," "could," "anticipates," "expected" or comparable terminology, or by discussions of strategies or trends. Although we believe that the expectations reflected in such forward-looking statements are reasonable, we cannot give any assurances that these expectations will prove to be correct. Forward-looking statements relate to matters such as:
•
future operating rates, margins, cash flows and demand for our products;
•
industry market outlook, including the price of crude oil;
•
production capacities;
•
currency devaluation;
•
our ability to borrow additional funds under the Credit Agreement;
•
our ability to meet our liquidity needs;
•
our ability to meet debt obligations under our debt instruments;
•
our intended quarterly dividends;
•
future capacity additions and expansions in the industry;
•
timing, funding and results of capital projects, such as the expansion program at our Calvert City facility and the construction of the LACC plant;
•
pension plan obligations, funding requirements and investment policies;
•
compliance with present and future environmental regulations and costs associated with environmentally related penalties, capital expenditures, remedial actions and proceedings, including any new laws, regulations or treaties that may come into force to limit or control carbon dioxide and other GHG emissions or to address other issues of climate change;
•
effects of pending legal proceedings; and
•
timing of and amount of capital expenditures.
We have based these statements on assumptions and analyses in light of our experience and perception of historical trends, current conditions, expected future developments and other factors we believe were appropriate in the circumstances when the statements were made. Forward-looking statements by their nature involve substantial risks and uncertainties that could significantly impact expected results, and actual future results could differ materially from those described in such statements. While it is not possible to identify all factors, we continue to face many risks and uncertainties. Among the factors that could cause actual future results to differ materially are the risks and uncertainties discussed under "Risk Factors" and those described from time to time in our other filings with the SEC including, but not limited to, the following:
•
general economic and business conditions;
•
the cyclical nature of the chemical industry;
•
the availability, cost and volatility of raw materials and energy;
•
uncertainties associated with the United States, European and worldwide economies, including those due to political tensions and unrest in the Middle East, the Commonwealth of Independent States (including Ukraine) and elsewhere;
•
current and potential governmental regulatory actions in the United States and other countries and political unrest in other areas;
•
industry production capacity and operating rates;
•
the supply/demand balance for our products;

i
Table of Contents


•
competitive products and pricing pressures;
•
instability in the credit and financial markets;
•
access to capital markets;
•
terrorist acts;
•
operating interruptions (including leaks, explosions, fires, weather-related incidents, mechanical failure, unscheduled downtime, labor difficulties, transportation interruptions, spills and releases and other environmental risks);
•
changes in laws or regulations;
•
technological developments;
•
foreign currency exchange risks;
•
our ability to implement our business strategies; and
•
creditworthiness of our customers.
Many of such factors are beyond our ability to control or predict. Any of the factors, or a combination of these factors, could materially affect our future results of operations and the ultimate accuracy of the forward-looking statements. These forward-looking statements are not guarantees of our future performance, and our actual results and future developments may differ materially from those projected in the forward-looking statements. Management cautions against putting undue reliance on forward-looking statements or projecting any future results based on such statements or present or prior earnings levels. Every forward-looking statement speaks only as of the date of the particular statement, and we undertake no obligation to publicly update or revise any forward-looking statements.
Industry and Market Data
Industry and market data used throughout this Form 10-K were obtained through internal company research, surveys and studies conducted by unrelated third parties and publicly available industry and general publications, including information from IHS Markit (formerly IHS Chemical) ("IHS") . We have not independently verified market and industry data from external sources. While we believe internal company estimates are reliable and market definitions are appropriate, neither such estimates nor these definitions have been verified by any independent sources.
Production Capacity
Unless we state otherwise, annual production capacity estimates used throughout this Form 10-K represent rated capacity of the facilities at December 31, 2017 . We calculated rated capacity by estimating the number of days in a typical year that a production unit of a plant is expected to operate, after allowing for downtime for regular maintenance, and multiplying that number by an amount equal to the unit's optimal daily output based on the design feedstock mix. Because the rated capacity of a production unit is an estimated amount, actual production volumes may be more or less than the rated capacity.




i
Table of Contents

PART I

Item 1. Business
General
We are a vertically integrated global manufacturer and marketer of basic chemicals, vinyls, polymers and building products. Our products include some of the most widely used chemicals in the world, which are fundamental to many diverse consumer and industrial markets, including flexible and rigid packaging, automotive products, coatings, water treatment, refrigerants, residential and commercial construction as well as other durable and non-durable goods. We operate in two principal operating segments, Olefins and Vinyls. We are highly integrated along our olefins product chain with significant downstream integration into polyethylene and styrene monomer. We are also an integrated global producer of vinyls with substantial downstream integration into polyvinyl chloride ("PVC") building products.
We began operations in 1986 after our first polyethylene plant, an Olefins segment business, near Lake Charles, Louisiana was acquired from Occidental Petroleum Corporation. We began our vinyls operations in 1990 with the acquisition of a vinyl chloride monomer ("VCM") plant in Calvert City, Kentucky from Goodrich Corporation. In 1992, we commenced our Vinyls segment's building products operations after acquiring three PVC pipe plants. Since 1986, we have grown rapidly into an integrated global producer of petrochemicals, vinyls, polymers and building products. We achieved this growth by acquiring existing plants or constructing new plants and completing numerous capacity or production line expansions. We regularly consider acquisitions and other internal and external growth opportunities that would be consistent with, or complementary to, our overall business strategy.
In 2014, we formed Westlake Chemical Partners LP ("Westlake Partners") to operate, acquire and develop ethylene production facilities and related assets. Also in 2014, Westlake Partners completed an initial public offering of 12,937,500 common units (the "Westlake Partners IPO"). On September 29, 2017, Westlake Partners completed a secondary offering of 5,175,000 common units at a price of $22.00 per unit and purchased an additional 5.0% newly-issued limited partner interest in Westlake Chemical OpCo LP ("OpCo") for approximately $229 million resulting in an aggregate 18.3% limited partner interest in OpCo effective July 1, 2017. As of February 14, 2018 , Westlake Partners' assets consist of an 18.3% limited partner interest in OpCo, as well as the general partner interest in OpCo. Prior to the Westlake Partners IPO, OpCo's assets were wholly-owned by us. OpCo's assets include two ethylene production facilities at our olefins facility at our Lake Charles site, one ethylene production facility at our Calvert City site and a 200 -mile common carrier ethylene pipeline that runs from Mont Belvieu, Texas to the Longview, Texas site, which includes our Longview polyethylene production facility. We retain an 81.7% limited partner interest in OpCo, a 43.8% limited partner interest in Westlake Partners (consisting of 14,122,230 common units), a general partner interest in Westlake Partners and incentive distribution rights. The operations of Westlake Partners are consolidated in our financial statements. We are party to certain agreements with Westlake Partners and OpCo whereby, among other things, OpCo sells us 95% of the ethylene it produces on a cost-plus basis that is expected to generate a fixed margin per pound of $0.10. We use this ethylene in the production processes of both our Olefins and Vinyls segments. For more information, see "—Olefins Business" and "—Vinyls Business" below.
On August 31, 2016, we completed the acquisition of Axiall Corporation ("Axiall") for $33.00 per share in an all-cash transaction (the "Merger"), pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of June 10, 2016, by and among Westlake, Axiall and Lagoon Merger Sub, Inc., a wholly-owned subsidiary of Westlake. Axiall is a manufacturer and international marketer of chemicals and building products, with manufacturing sites in North America. As a result of the combination with Axiall, we are the third-largest global chlor-alkali producer and the third-largest PVC producer in the world.
We benefit from highly integrated production facilities that allow us to process raw materials into higher value-added chemicals and building products. As of February 14, 2018 , we (directly and through OpCo and our 95% and 60% owned Asian joint ventures) had approximately 40.7 billion pounds per year of aggregate production capacity at numerous manufacturing sites in North America, Europe and Asia.
Olefins Business
Products
Olefins are the basic building blocks used to create a wide variety of petrochemical products. We manufacture ethylene (through OpCo), polyethylene, styrene and associated co-products at our manufacturing facility in Lake Charles and polyethylene at our Longview facility. We have two ethylene plants, which are owned by OpCo, two polyethylene plants and one styrene monomer plant at our olefins facility at our Lake Charles site. We have three polyethylene plants and a specialty polyethylene wax plant at our Longview site.

1
Table of Contents

The following table illustrates our production capacities at February 14, 2018 by principal product and the primary end uses of these materials:
    Product
 
Annual Capacity
 
    End Uses
 
 
(Millions of pounds)
 
 
Ethylene (1)
 
2,990

 
Polyethylene, ethylene dichloride ("EDC"), styrene,
   ethylene oxide/ethylene glycol
Low-Density Polyethylene ("LDPE")
 
1,500

 
High clarity packaging, shrink films, laundry and dry
   cleaning bags, ice bags, frozen foods packaging, bakery
   bags, coated paper board, cup stock, paper folding
   cartons, lids, closures and general purpose molding
Linear Low-Density Polyethylene
   ("LLDPE")
 
1,070

 
Heavy-duty films and bags, general purpose liners
Styrene
 
570

 
Consumer disposables, packaging material, appliances,
   paints and coatings, resins and building materials

______________________________
(1)
Production capacity owned by OpCo.
Ethylene. Ethylene is the world's most widely used petrochemical in terms of volume. It is the key building block used to produce a large number of higher value-added chemicals including polyethylene, EDC, VCM and styrene. OpCo has the capacity to produce approximately 3.0 billion pounds of ethylene per year at our olefins facility at our Lake Charles site, and we have the capability to consume all of OpCo's production that we purchase at Lake Charles to produce polyethylene and styrene monomer in our Olefins business and to produce VCM and EDC in our Vinyls business. OpCo also produces ethylene for our Vinyls segment at our Calvert City site, and substantially all of the ethylene we purchase from OpCo at Calvert City is used internally in the production of VCM. For OpCo's annual ethylene production that is purchased by us for our Vinyls business, see "Business—Vinyls Business." In addition, we (through OpCo) produce ethylene co-products including chemical grade propylene, crude butadiene, pyrolysis gasoline and hydrogen. We (through OpCo) sell our entire output of these co-products to external customers. OpCo completed an upgrade and capacity expansion of its Petro 1 ethylene unit at our Lake Charles site in the third quarter of 2016. The Petro 1 expansion project increased OpCo's ethylene capacity by approximately 250 million pounds annually.
Polyethylene. Polyethylene, the world's most widely consumed polymer, is used in the manufacture of a wide variety of film, coatings and molded product applications primarily used in packaging. Polyethylene is generally classified as either LDPE, LLDPE or high-density polyethylene ("HDPE"). The density correlates to the relative stiffness of the end-use products. The difference between LDPE and LLDPE is molecular, and products produced from LLDPE, in general, have higher strength properties than products produced from LDPE. LDPE exhibits better clarity and other physical properties and is used in end products such as bread bags, dry cleaning bags, food wraps, milk carton coatings and snack food packaging. LLDPE is used for higher film strength applications such as stretch film and heavy duty sacks. HDPE is used to manufacture products such as grocery, merchandise and trash bags, rigid plastic containers, plastic closures and pipe.
We are the leading producer of LDPE by capacity in North America and predominantly use the autoclave technology (versus tubular technology), which is capable of producing higher margin specialty polyethylene products. In 2017 , our annual capacity of approximately 1.5 billion pounds was available in numerous formulations to meet the needs of our diverse customer base. We also have the capacity to produce approximately 1.1 billion pounds of LLDPE per year in various formulations. We produce LDPE and LLDPE at both Lake Charles and Longview facilities. Our Lake Charles and Longview facilities also have the capability to produce HDPE. We sell polyethylene to external customers as a final product in pellet form.
Styrene. Styrene is used to produce derivatives such as polystyrene, acrylonitrile butadiene styrene, unsaturated polyester and synthetic rubber. These derivatives are used in a number of applications including consumer disposables, food packaging, housewares, paints and coatings, building materials, tires and toys. We produce styrene at our Lake Charles plant, where we have the capacity to produce approximately 570 million pounds of styrene per year, all of which is sold to external customers.

2
Table of Contents

Feedstocks
We are highly integrated along our olefins product chain. We (through OpCo) produce most of the ethylene required to produce our polyethylene and styrene. Ethylene can be produced from either petroleum liquid feedstocks, such as naphtha, condensates and gas oils, or from natural gas liquid feedstocks, such as ethane, propane and butane. Both of OpCo's Lake Charles ethylene plants use ethane as the primary feedstock. Pursuant to a feedstock supply agreement between us and OpCo, OpCo receives ethane feedstock at our olefins facility at our Lake Charles site through several pipelines from a variety of suppliers in Texas and Louisiana. We own a 50% interest in a 104-mile natural gas liquids pipeline from Mont Belvieu to our Lake Charles site. OpCo owns a 200-mile ethylene pipeline that runs from Mont Belvieu to our Longview site.
In addition to ethylene supplied by OpCo, we also acquire ethylene from third parties in order to supply a portion of our ethylene requirements. We acquire butene and hexene to manufacture polyethylene and benzene to manufacture styrene. We receive butene and hexene at the Lake Charles site and hexene at the Longview site via rail car from several suppliers. We receive benzene via barges, ships and pipeline pursuant to short-term arrangements. We purchase butene and hexene pursuant to multi-year contracts, some of which are renewable for an additional term subject to either party to the contract notifying the other party that it does not wish to renew the contract. We purchase electricity for our Lake Charles facility under long-term industrial contracts.
Marketing, Sales and Distribution
We have an internal sales force that sells our products directly to our customers. Our polyethylene customers are some of the nation's largest producers of film and flexible packaging.
We and OpCo sell ethylene and ethylene co-products to external customers. OpCo's primary ethylene co-products are chemical grade propylene, crude butadiene, pyrolysis gasoline and hydrogen.
We have storage agreements and exchange agreements that allow us and OpCo access to customers who are not directly connected to the pipeline system that we own. OpCo ships crude butadiene and pyrolysis gasoline by rail or truck. Additionally, we transport our polyethylene and styrene by rail or truck. Further, styrene can be transported by barge or ship.
No single customer accounted for 10% or more of net sales for the Olefins segment in 2017 .
Competition
The markets in which our Olefins business operates are highly competitive. We compete on the basis of customer service, product deliverability, quality, consistency, performance and price. Our competitors in the ethylene, polyethylene and styrene markets are some of the world's largest chemical companies, including Chevron Phillips Chemical Company, DowDuPont Inc., ExxonMobil Chemical Company, Formosa Plastics Corporation, LyondellBasell Industries, N.V. and NOVA Chemicals Corporation.
Vinyls Business
Products
Principal products in our integrated Vinyls segment include PVC and PVC compounds, VCM, EDC, chlor-alkali (chlorine and caustic soda) and chlorinated derivative products and, through OpCo, ethylene. We also manufacture and sell building products fabricated from PVC, including siding, pipe, fittings, profiles, trim, mouldings, fence and decking products, window and door components and film and sheet products. We manage our integrated Vinyls production chain, from the basic chemicals to finished building products, to optimize product margins and capacity utilization. Our primary North American chemical manufacturing facilities are located in our Calvert City, Kentucky and Lake Charles, Plaquemine and Geismar, Louisiana sites. Our Calvert City site includes an ethylene plant, which is owned by OpCo, a chlor-alkali plant, a VCM plant and a PVC plant. Our Lake Charles site includes three chlor-alkali plants, two VCM plants, a chlorinated derivative products plant and cogeneration assets. Our Plaquemine site includes a chlor-alkali plant, a VCM plant, a PVC plant and cogeneration assets. Our Geismar site includes a chlor-alkali plant, a VCM plant and a PVC plant. We also produce chlorine, caustic soda, hydrogen and chlorinated derivative products at our Natrium, West Virginia, Longview, Washington and Beauharnois, Quebec facilities and PVC resin and PVC compounds at several facilities in Mississippi. Our European chemical manufacturing facilities are located in Germany and the United Kingdom and include two chlor-alkali plants, two VCM plants and six PVC plants. Our Asian manufacturing facilities are located near Shanghai, in the People's Republic of China, and in Kaohsiung, Taiwan, through our 95% and 60% owned joint ventures, respectively, and include a PVC plant, a PVC film and sheet plant, a chlor-alkali plant and a chlorinated derivative products plant. As of February 14, 2018 , we owned 24 building product facilities.

3
Table of Contents

The following table illustrates our production capacities at February 14, 2018 by principal product and the end uses of these products:
    Product (1)
 
Annual Capacity (2)
 
    End Uses
 
 
(Millions of pounds)
 
 
Specialty PVC
 
1,100

 
Automotive sealants, cable sheathing, medical
   applications and other applications
Commodity PVC
 
6,030

 
Construction materials including pipe, siding, profiles for
   windows and doors, film and sheet for packaging
   and other applications
VCM
 
7,480

 
PVC
Chlorine
 
7,140

 
VCM, organic/inorganic chemicals, bleach
Caustic Soda
 
7,860

 
Pulp and paper, organic/inorganic chemicals,
   neutralization, alumina
Chlorinated Derivative Products
 
2,290

 
Coatings, flavorants, films, refrigerants, water treatment applications, chemicals and pharmaceutical production
Ethylene   (3)
 
730

 
VCM
Building Products
 
1,950

 
Pipe: water and sewer, plumbing, irrigation, conduit;
   fittings; profiles and foundation building products;
   window and door components; fence and deck
   components; siding, trim and mouldings; film and sheet

______________________________
(1)
EDC, a VCM intermediate product, is not included in the table.
(2)
Includes capacity related to our 95% and 60% owned Asian joint ventures.
(3)
Production capacity owned by OpCo.
PVC and PVC Compounds. PVC, the world's third most widely used plastic, is an attractive alternative to traditional materials such as glass, metal, wood, concrete and other plastic materials because of its versatility, durability and cost-competitiveness. PVC is produced from VCM, which is, in turn, made from chlorine and ethylene. PVC compounds are highly customized formulations that offer specific end-use properties based on customer-determined manufacturing specifications. PVC compounds are made by combining PVC resin with various additives in order to make either rigid and impact-resistant or soft and flexible compounds. The various compounds are then fabricated into end-products through extrusion, calendering, injection-molding or blow-molding. Flexible PVC compounds are used for wire and cable insulation, medical films and packaging, flooring, wall coverings, automotive interior and exterior trims and packaging. Rigid extrusion PVC compounds are commonly used in window and door profiles, vertical blinds and construction products, including pipe and siding. Injection-molding PVC compounds are used in specialty products such as computer housings and keyboards, appliance parts and bottles.
We are the third-largest PVC producer in the world. We have the capacity to produce approximately 6.0 billion pounds and 1.1 billion pounds of commodity and specialty PVC per year, respectively, at our various facilities globally. We use some of our North American-produced PVC internally in the production of our building products and PVC compounds. The remainder of our PVC, including the PVC produced at our European and Asian facilities, is sold to downstream fabricators and the international markets.
VCM. VCM is used to produce PVC, solvents and PVC-related products. We use ethylene and chlorine to produce VCM. We have the capacity to produce approximately 6.0 billion pounds and 1.5 billion pounds of VCM per year at our North American and European facilities, respectively. The majority of our VCM is used internally in our PVC operations. VCM not used internally is sold to other vinyl resins producers in domestic and international markets.
Chlorine and Caustic Soda. We combine salt and electricity to produce chlorine and caustic soda, commonly referred to as chlor-alkali, at our Lake Charles, Plaquemine, Natrium, Calvert City, Geismar, Beauharnois, Longview, Gendorf, and Knapsack, Germany and Kaohsiung facilities. We are the third-largest chlor-alkali producer in the world. We use our chlorine production in our VCM and chlorinated derivative products plants. We currently have the capacity to supply all of our chlorine requirements internally. Any remaining chlorine is sold into the North American merchant chlorine market. Our caustic soda is sold to external customers who use it for, among other things, the production of pulp and paper, organic and inorganic chemicals and alumina.

4
Table of Contents

Chlorinated Derivative Products. Our chlorinated derivative products include ethyl chloride, perchloroethylene, trichloroethylene, tri-ethane ® solvents, VersaTRANS ® solvents, calcium hypochlorite, hydrochloric acid ("HCL") and pelletized caustic soda ("PELS"). We have the capacity to produce approximately 2.3 billion pounds of chlorinated derivative products per year, primarily at our Lake Charles, Natrium, Beauharnois and Longview facilities. The majority of our chlorinated derivative products are sold to external customers who use these products for, among other things, refrigerants, water treatment applications, chemicals and pharmaceutical production, food processing, steel pickling, solvent and cleaning chemicals and natural gas and oil production.
Ethylene. We use the ethylene we purchase that is produced by OpCo at Calvert City to produce VCM. OpCo's Calvert City ethylene plant has the capacity to produce approximately 20% of the ethylene required for our total VCM production. We obtain the remainder of the ethylene we need for our Vinyls business from OpCo's Lake Charles plants and from third party purchases. OpCo's Calvert City ethylene plant utilizes ethane feedstock and enables us, through OpCo, to enhance our vinyl chain integration. In January 2016, OpCo announced an expansion project to increase the ethylene capacity of its ethylene plant at our Calvert City facility. The expansion was completed in 2017 and, along with other initiatives, increased ethylene capacity by approximately 100 million pounds annually.
Building Products. Products made from PVC are used in construction materials ranging from water and sewer systems to home and commercial applications for siding, trim, mouldings, fence, deck, window and door systems. Our building products consist of two primary product groups: (i) exterior products, which includes siding, trim, mouldings, window profiles, fence and decking products; and (ii) PVC pipe, specialty PVC pipe and fittings. We manufacture and market exterior products under the Royal Building Products ® , Celect Cellular Exteriors by Royal ® , Zuri Premium Decking by Royal ® , Royal S4S Trim Board ® and Exterior Portfolio ® brand names. We manufacture and market specialty pipe and fittings, water, sewer, irrigation and conduit pipe products under the North American Pipe ® and Royal Building Products ® brand names. We manufacture film and sheet at our Shanghai facility for both Asian and global markets. All of our building products are sold to external customers. The combined capacity of our 24 building products plants is approximately 2.0 billion pounds per year.
Feedstocks
We are highly integrated along our vinyls production chain. We produce most of the ethylene required by our Calvert City and Geismar facilities (through OpCo). Ethylene produced at OpCo's Calvert City facility utilizes ethane feedstock. We purchase the remainder of the ethylene required for our other North American and European facilities from a number of sources under various contracts. We have access to, and partially own, an ethylene pipeline in Germany. We have long-term leases on salt domes, from which we supply our salt brine requirements by pipeline, close to our Lake Charles chlor-alkali plant. The salt requirements for our Plaquemine and Natrium chlor-alkali plants are supplied internally from our salt domes. We purchase the salt required for our other chlor-alkali plants pursuant to long-term contracts. Electricity and steam for one of our Lake Charles facilities are produced by both on-site cogeneration units and through a toll arrangement with RS Cogen, LLC ("RS Cogen"), a joint venture in which we own a 50% interest. RS Cogen operates a process steam, natural gas-fired cogeneration facility adjacent to the site. Electricity and steam for the Plaquemine facility is supplied internally by our on-site cogeneration unit. A portion of our Natrium facility's electricity requirements is produced by our on-site generation unit, and the remainder purchased under an industrial contract. We purchase electricity for our remaining North American and European facilities under long-term industrial contracts. We purchase VCM for our Asian PVC plant on a contract and spot basis.
Our North American and Asian facilities supply predominantly all of the PVC required for our building products plants. We may also purchase PVC at market prices, if needed. The remaining feedstocks for building products include pigments, fillers, stabilizers and other ingredients, which we purchase under short-term contracts based on prevailing market prices.
Marketing, Sales and Distribution
We have a dedicated sales force for our business, organized by product line and region. In addition, we rely on distributors to market products to smaller customers. We use some of our North American-produced PVC internally in the production of our building products and PVC compounds. The remainder of our PVC, including the PVC produced at our European and Asian facilities, is sold to downstream fabricators and the international markets. We have the capacity to use a majority of our chlorine internally to produce VCM and EDC, most of which, in turn, is used to produce PVC. We also use our chlorine internally to produce chlorinated derivative products. We sell the remainder of our chlorine and substantially all of our caustic soda production to external customers. The majority of our products are shipped from production facilities directly to the customer via pipeline, truck, rail, barge and/or ship. The remaining products are shipped from production facilities to third party chemical terminals and warehouses until being sold to customers.

5
Table of Contents

We are the second largest manufacturer of PVC pipe by capacity in the United States. We sell a majority of our siding, trim and mouldings products, PVC pipe, specialty PVC pipe and fittings, and film and sheet products through a combination of our internal sales force and manufacturer's representatives. In Canada, we operate 19 company-owned distribution branches that sell our vinyl siding and accessories and trim and mouldings products, as well as pipe and fittings. We also engage in advertising programs primarily directed at trade professionals that are intended to develop awareness and interest in our products. In addition, we display our building products at trade shows.
No single customer accounted for 10% or more of net sales for the Vinyls segment in 2017 .
Competition
The markets in which our Vinyls business operates are highly competitive. Competition in the vinyls market is based on product availability, product performance, customer service and price. We compete in the vinyls market with other producers including Formosa Plastics Corporation, Oxy Chem, LP, Shintech, Inc., Olin Corporation, Mexichem, S.A.B. de C.V., INOVYN ChlorVinyls Limited, VYNOVA Group and Kem One Group SAS.
Competition in the building products market is based on on-time delivery, product quality, product innovation, customer service, product consistency and price. We compete in the building products market with other producers and fabricators including Diamond Plastics Corporation, JM Eagle, Ply Gem Holdings, Inc., CertainTeed Corporation, IPEX Inc., Associated Materials LLC and CPG International, LLC.
Environmental
As is common in our industry, we are subject to environmental laws and regulations related to the use, storage, handling, generation, transportation, emission, discharge, disposal and remediation of, and exposure to, hazardous and non-hazardous substances and wastes in all of the countries in which we do business. National, state or provincial and local standards regulating air, water and land quality affect substantially all of our manufacturing locations around the world. Compliance with such laws and regulations has required and will continue to require capital expenditures and increase operating costs.
It is our policy to comply with all environmental, health and safety requirements and to provide safe and environmentally sound workplaces for our employees. In some cases, compliance can be achieved only by incurring capital expenditures. In 2017 , we made capital expenditures of $15 million related to environmental compliance. We estimate that we will make capital expenditures of approximately $42 million in 2018 and $42 million in 2019 , respectively, related to environmental compliance. The expected 2018 and 2019 capital expenditures are relatively higher than the amounts we have spent related to environmental compliance in recent years in large part due to capital expenditures related to Environmental Protection Agency (the "EPA") regulations and requirements with respect to the Axiall chlor-alkali sites. The remainder of the 2018 and 2019 estimated expenditures are related to equipment replacement and upgrades. We anticipate that stringent environmental regulations will continue to be imposed on us and the industry in general. Although we cannot predict with certainty future expenditures, management believes that our current spending trends will continue.
From time to time, we receive notices or inquiries from government entities regarding alleged violations of environmental laws and regulations pertaining to, among other things, the disposal, emission and storage of chemical substances, including hazardous wastes. Item 103 of the SEC's Regulation S-K requires disclosure of certain environmental matters when a governmental authority is a party to the proceedings and the proceedings involve potential monetary sanctions, unless we reasonably believe such sanctions would not exceed $100,000 .
•
During September 2010, our vinyls facilities in north Lake Charles and Plaquemine each received a Consolidated Compliance Order and Notice of Potential Penalty, alleging violations of various requirements of those facilities' air permits, based largely on self-reported permit deviations related to record-keeping violations. We have been negotiating a possible global settlement of these and several other matters with Louisiana Department of Environmental Quality. We believe the resolution of these matters may require the payment of a monetary sanction in excess of $100,000 .
•
For several years, the EPA has been conducting an enforcement initiative against petroleum refineries and petrochemical plants with respect to emissions from flares. On April 21, 2014, we received a Clean Air Act Section 114 Information Request from the EPA which sought information regarding flares at the Calvert City, Kentucky facility and certain Lake Charles facilities. The EPA has informed us that the information provided leads the EPA to believe that some of the flares are out of compliance with applicable standards. The EPA has indicated that it is seeking a consent decree that would obligate us to take corrective actions relating to the alleged noncompliance. We believe the resolution of these matters may require the payment of a monetary sanction in excess of $100,000 .

6
Table of Contents

•
Regional offices of the EPA have investigated, and in some cases inspected, our compliance with Risk Management Program requirements under the Clean Air Act at our Calvert City, Kentucky; Natrium, West Virginia and Geismar, Louisiana facilities. We believe the resolution of these matters may require the payment of a monetary sanction in excess of $100,000.
•
In October 2017, the Enforcement Division of Kentucky Department of Environmental Protection ("KDEP") indicated that it intended to proceed with enforcement on two Notices of Violation ("NOVs") received by our Calvert City, Kentucky facility in December 2016 and May 2017. The NOVs allege violations of state and federal air requirements in connection with the operation of the olefins unit at the facility. We have engaged in negotiations with KDEP to resolve these alleged violations. We believe the resolution of these matters may require the payment of a monetary sanction in excess of $100,000.
We do not believe that the resolution of any or all of these matters will have a material adverse effect on our financial condition, results of operations or cash flows.
Also see our discussion of our environmental matters contained in Item 1A, "Risk Factors" below, Item 3, "Legal Proceedings" below and Note 20 to our consolidated financial statements included in Item 8 of this Form 10-K.
Employees
As of December 31, 2017 , we had approximately 8,800 employees in the following areas:
Category
 
Number
Olefins segment
 
820

Vinyls segment
 
7,610

Corporate and other
 
370

Approximately 32% of our employees are represented by labor unions, and all of these union employees are working under collective bargaining agreements that expire at various times through 2022. We have multiple collective bargaining agreements in Europe, Canada and the United States, with varying expiration years, covering different groups of our work force. There were no strikes, lockouts, or work stoppages in 2017 and we believe that our relationship with our employees and unions is open and positive.
Technology
Historically, our technology strategy has been to selectively acquire licenses from third-parties, as well as develop our own proprietary technology. Our selection process incorporates many factors, including the cost of the technology, the ability to meet our customers' requirements, raw material and energy consumption rates, product quality, capital costs, maintenance requirements and reliability. Most of the technology licensed from third-party providers is perpetual and has been paid in full. We own an intellectual property portfolio developed from focused research in both process and product technology. After acquiring or developing a technology, we devote considerable effort to effectively employ the technology and further its development, with a focus towards continuous improvement of our competitive positions.
Conversely, we have selectively granted licenses to our patented Energx ® technology for LLDPE production and for proprietary LDPE reactor mixing technology. We have also granted several licenses for EDC/VCM technology, including the direct chlorination process and catalyst, and S-PVC (Suspension PVC for thermoplastic process) process and technology.
Segment and Geographic Information
Information regarding sales, income from operations and assets attributable to our Olefins and Vinyls segments, and geographical information is presented in Note 21 to our consolidated financial statements included in Item 8 of this Form 10-K.

7
Table of Contents

Available Information
Our Web site address is www.westlake.com. We make our Web site content available for information purposes only. It should not be relied upon for investment purposes, nor is it incorporated by reference in this Form 10-K. We make available on this Web site under "Investor Relations/SEC Filings," free of charge, our proxy statements, annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those materials as soon as reasonably practicable after we electronically file those materials with, or furnish those materials to, the SEC. The SEC also maintains a Web site at www.sec.gov that contains reports, proxy statements and other information regarding SEC registrants, including us.
We intend to satisfy the requirement under Item 5.05 of Form 8-K to disclose any amendments to our Code of Ethics and any waiver from a provision of our Code of Ethics by posting such information on our Web site at www.westlake.com under "Investor Relations/Corporate Governance."
 
Item 1A. Risk Factors
Cyclicality in the petrochemical industry has in the past, and may in the future, result in reduced operating margins or operating losses.
Our historical operating results reflect the cyclical and volatile nature of the petrochemical industry. The industry is mature and capital intensive. Margins in this industry are sensitive to supply and demand balances both domestically and internationally, which historically have been cyclical. The cycles are generally characterized by periods of tight supply, leading to high operating rates and margins, followed by periods of oversupply primarily resulting from excess new capacity additions, leading to reduced operating rates and lower margins.
Moreover, profitability in the petrochemical industry is affected by the worldwide level of demand along with vigorous price competition which may intensify due to, among other things, new industry capacity. In general, weak economic conditions either in the United States, Europe or the rest of the world tend to reduce demand and put pressure on margins. It is not possible to predict accurately the supply and demand balances, market conditions and other factors that will affect industry operating margins in the future.
New olefins capacity additions in Asia, the Middle East and North America, a number of which have been announced in recent years, may lead to periods of over-supply and lower profitability. As a result, our Olefins segment operating margins may be negatively impacted.
Continued slow recovery in the U.S. construction markets and budgetary constraints in municipal spending have contributed to lower North American demand for our vinyls products. Likewise, European industry production capacities currently exceed demand in the region, largely due to the weak economic environment in Europe. Looking forward, our Vinyls segment operating rates and margins may continue to be negatively impacted by the slow recovery of the U.S. construction markets and the European economy.
We sell commodity products in highly competitive markets and face significant competition and price pressure.
We sell our products in highly competitive markets. Due to the commodity nature of many of our products, competition in these markets is based primarily on price and to a lesser extent on performance, product quality, product deliverability and customer service. As a result, we generally are not able to protect our market position for these products by product differentiation and may not be able to pass on cost increases to our customers. Accordingly, increases in raw material and other costs may not necessarily correlate with changes in prices for these products, either in the direction of the price change or in magnitude. Specifically, timing differences in pricing between raw material prices, which may change daily, and contract product prices, which in many cases are negotiated monthly or less often, sometimes with an additional lag in effective dates for increases, have had and may continue to have a negative effect on profitability. Significant volatility in raw material costs tends to place pressure on product margins as sales price increases could lag behind raw material cost increases. Conversely, when raw material costs decrease, customers could seek relief in the form of lower sales prices.

8
Table of Contents

Volatility in costs of raw materials and energy may result in increased operating expenses and adversely affect our results of operations and cash flows.
Significant variations in the costs and availability of raw materials and energy may negatively affect our results of operations. These costs have risen significantly in the past due primarily to oil and natural gas cost increases. We purchase significant amounts of ethane feedstock, natural gas, ethylene and salt to produce several basic chemicals. We also purchase significant amounts of electricity to supply the energy required in our production processes. The cost of these raw materials and energy, in the aggregate, represents a substantial portion of our operating expenses. The prices of raw materials and energy generally follow price trends of, and vary with market conditions for, crude oil and natural gas, which are highly volatile and cyclical. Changes to regulatory policies applicable to the German energy sector for industrial users have contributed to higher prices for industrial users of energy in the future. Our results of operations have been and could in the future be significantly affected by increases in these costs.
Price increases increase our working capital needs and, accordingly, can adversely affect our liquidity and cash flows. In addition, because we utilize the first-in, first-out ("FIFO") method of inventory accounting, during periods of falling raw material prices and declining sales prices, our results of operations for a particular reporting period could be negatively impacted as the lower sales prices would be reflected in operating income more quickly than the corresponding drop in feedstock costs. We use derivative instruments in an attempt to reduce price volatility risk on some feedstock commodities. In the future, we may decide not to hedge any of our raw material costs or any hedges we enter into may not have successful results. Also, our hedging activities involve credit risk associated with our hedging counterparties, and a deterioration in the financial markets could adversely affect our hedging counterparties and their abilities to fulfill their obligations to us.
Lower prices of crude oil, such as those experienced since the third quarter of 2014 and continuing through 2017 (as of December 31, 2017 , approximately 44% lower than their 2014 peak levels), have led to a reduction in the cost advantage for natural gas liquids-based ethylene crackers in North America, such as ours, as compared to naphtha-based ethylene crackers that use crude oil derivatives. As a result, our margins and cash flows have been and may continue to be negatively impacted. This impact could be magnified to the extent crude oil prices drop even further and depending on how long prices remain at these levels. Lower crude oil and natural gas prices could lead to a reduction in hydraulic fracturing in the United States, which could reduce the availability of feedstock and increase prices of feedstock for our operations. Higher natural gas prices could also adversely affect our ability to export products that we produce in the United States outside of the United States. In addition to the impact that this has on our exports from the United States, reduced competitiveness of U.S. producers also has in the past increased the availability of chemicals in North America, as U.S. production that would otherwise have been sold overseas was instead offered for sale domestically, resulting in excess supply and lower prices in North America. We could also face the threat of imported products from countries that have a cost advantage. Additionally, the export of natural gas liquids from the United States or greater restrictions on hydraulic fracturing could restrict the availability of our raw materials in the United States, thereby increasing our costs.
External factors beyond our control can cause fluctuations in demand for our products and in our prices and margins, which may negatively affect our results of operations and cash flows.
External factors beyond our control can cause volatility in raw material prices, demand for our products, product prices and volumes and deterioration in operating margins. These factors can also magnify the impact of economic cycles on our business and results of operations. Examples of external factors include:
•
general economic conditions, including in the United States, Europe and Asia;
•
new capacity additions in North America, Europe, Asia and the Middle East;
•
the level of business activity in the industries that use our products;
•
competitor action;
•
technological innovations;
•
currency fluctuations;
•
increases in interest rates;
•
international events and circumstances;
•
war, sabotage, terrorism and civil unrest;
•
governmental regulation, including in the United States, Europe and Asia;
•
severe weather and natural disasters; and
•
credit worthiness of customers and vendors.

9
Table of Contents

A number of our products are highly dependent on durable goods markets, such as housing and construction, which are themselves particularly cyclical. The significant weakness in the U.S. residential housing market since 2006 and economic weakness in Europe had an adverse effect on demand and margins for our products. If the global economy worsens in general, or the U.S. residential housing market or the European economy worsens in particular, demand for our products and our results of operations and cash flows could be adversely affected.
We may reduce production at or idle a facility for an extended period of time or exit a business because of high raw material prices, an oversupply of a particular product and/or a lack of demand for that particular product, which makes production uneconomical. Temporary outages sometimes last for several quarters or, in certain cases, longer and cause us to incur costs, including the expenses of maintaining and restarting these facilities. Factors such as increases in raw material costs or lower demand in the future may cause us to further reduce operating rates, idle facilities or exit uncompetitive businesses.
Hostilities in the Middle East, the Commonwealth of Independent States (including Ukraine) or elsewhere or the occurrence, or threat of occurrence, of terrorist attacks could adversely affect the economies of the United States, Europe and other developed countries. A lower level of economic activity could result in a decline in demand for our products, which could adversely affect our net sales and margins and limit our future growth prospects. Volatility in prices for crude oil and natural gas could also result in increased feedstock costs. Furthermore, sustained lower prices of crude oil, such as the prices experienced since the third quarter of 2014 and continuing through 2017, have led and may continue to lead to lower margins in the United States. In addition, these risks could cause increased instability in the financial and insurance markets and could adversely affect our ability to access capital and to obtain insurance coverage that we consider adequate or is otherwise required by our contracts with third parties.
We operate internationally and are subject to related risks, including exchange rate fluctuations, exchange controls, political risk and other risks relating to international operations.
We operate internationally and are subject to the risks of doing business on a global basis. These risks include, but are not limited to, fluctuations in currency exchange rates, currency devaluations, imposition of trade barriers (which could, among other things, negatively impact our ability to export our products outside of the U.S.), imposition of tariffs and duties, restrictions on the transfer of funds, changes in law and regulatory requirements, involvement in judicial proceedings in unfavorable jurisdictions, economic instability and disruptions, political unrest and epidemics. If the U.S. administration makes certain changes to its foreign trade policies, such changes could lead to imposition of additional trade barriers and tariffs on us in foreign jurisdictions. Our operating results could be negatively affected by any of these risks.
A deterioration in global economic conditions may have a negative impact on our business and financial condition.
A deterioration in global economic conditions may have a negative impact on our business and our financial condition. Our ability to access the capital markets may be severely restricted at a time when we would like, or need, to access such markets, which could have an impact on our flexibility to react to changing economic and business conditions. In addition, the availability of additional financing at cost effective interest rates cannot be assured. A deterioration in global economic conditions could have an impact on the lenders under our revolving credit facility or on our customers and suppliers, causing them to fail to meet their obligations to us. Additionally, a deterioration in global economic conditions could result in reduced demand for our products, which would have a negative impact on our revenues and profits.
Our inability to compete successfully may reduce our operating profits.
The petrochemical industry is highly competitive. Historically, there have been a number of mergers, acquisitions, spin-offs and joint ventures in the industry. This restructuring activity has resulted in fewer but more competitive producers, many of which are larger than we are and have greater financial resources than we do. Among our competitors are some of the world's largest chemical companies and chemical industry joint ventures. Competition within the petrochemical industry and in the manufacturing of building products is affected by a variety of factors, including:
•
product price;
•
balance of product supply/demand;
•
material, technology and process innovation;
•
technical support and customer service;
•
quality;
•
reliability of raw material and utility supply;
•
availability of potential substitute materials; and
•
product performance.

10
Table of Contents

Changes in the competitive environment could have a material adverse effect on our business and our operations. These changes could include:
•
the emergence of new domestic and international competitors;
•
the rate of capacity additions by competitors;
•
changes in customer base due to mergers;
•
the intensification of price competition in our markets;
•
the introduction of new or substitute products by competitors; and
•
the technological innovations of competitors.
Our production facilities process some volatile and hazardous materials that subject us to operating risks that could adversely affect our operating results.
We have chemical manufacturing sites in the United States, Europe and Asia. Our operations are subject to the usual hazards associated with chemical and plastics manufacturing and the related use, storage, transportation and disposal of feedstocks, products and wastes, including:
•
pipeline leaks and ruptures;
•
explosions;
•
fires;
•
severe weather and natural disasters;
•
mechanical failure;
•
unscheduled downtime;
•
labor difficulties;
•
transportation interruptions;
•
transportation accidents involving our chemical products;
•
remediation complications;
•
chemical spills;
•
discharges or releases of toxic or hazardous substances or gases;
•
storage tank leaks;
•
other environmental risks;
•
sabotage;
•
terrorist attacks; and
•
political unrest.
According to some experts, global climate change could result in heightened hurricane activity in the Gulf of Mexico and other weather and natural disaster hazards worldwide. If this materializes, severe weather and natural disaster hazards could pose an even greater risk for our facilities, particularly those in Louisiana.
All these hazards can cause personal injury and loss of life, catastrophic damage to or destruction of property and equipment and environmental damage, and may result in a suspension of operations and the imposition of civil or criminal penalties. We could become subject to environmental claims brought by governmental entities or third parties. A loss or shutdown over an extended period of operations at any one of our chemical manufacturing facilities would have a material adverse effect on us. We maintain property, business interruption and casualty insurance that we believe is in accordance with customary industry practices, but we cannot be fully insured against all potential hazards incident to our business, including losses resulting from war risks or terrorist acts. As a result of market conditions, premiums and deductibles for certain insurance policies can increase substantially and, in some instances, certain insurance may become unavailable or available only for reduced amounts of coverage. If we were to incur a significant liability for which we were not fully insured, it could have a material adverse effect on our financial condition, results of operations or cash flows.

11
Table of Contents

We are exposed to significant losses from products liability, personal injury and other claims relating to the products we manufacture. Additionally, individuals currently seek, and likely will continue to seek, damages for alleged personal injury or property damage due to alleged exposure to chemicals at our facilities or to chemicals otherwise owned, controlled or manufactured by us. We are also subject to present and future claims with respect to workplace exposure, workers' compensation and other matters. Any such claims, whether with or without merit, could be time consuming, expensive to defend and could divert management's attention and resources. We maintain and expect to continue to maintain insurance for products liability, workplace exposure, workers' compensation and other claims, but the amount and scope of such insurance may not be adequate or available to cover a claim that is successfully asserted against us. In addition, such insurance could become more expensive and difficult to maintain and may not be available to us on commercially reasonable terms or at all. The results of any future litigation or claims are inherently unpredictable, but such outcomes could have a material adverse effect on our financial condition, results of operations or cash flows.
We rely on a limited number of outside suppliers for specified feedstocks and services.
We obtain a significant portion of our raw materials from a few key suppliers. If any of these suppliers is unable to meet its obligations under any present or future supply agreements, we may be forced to pay higher prices to obtain the necessary raw materials. Any interruption of supply or any price increase of raw materials could have a material adverse effect on our business and results of operations. A vendor may choose, subject to existing contracts, to modify its relationship due to general economic concerns or concerns relating to the vendor or us, at any time. Any significant change in the terms that we have with our key suppliers, or any significant additional requirements from our suppliers that we provide them additional security in the form of prepayments or with letters of credits, could materially adversely affect our financial condition, results of operations or cash flows.
We rely heavily on third party transportation, which subjects us to risks and costs that we cannot control. Such risks and costs may materially adversely affect our operations.
We rely heavily on railroads, barges, trucks and other shipping companies to transport raw materials to the manufacturing facilities used by our businesses and to ship finished products to customers. These transport operations are subject to various hazards and risks, including extreme weather conditions, work stoppages and operating hazards (including pipeline leaks and ruptures and storage tank leaks), as well as interstate transportation regulations. In addition, the methods of transportation we utilize, including shipping chlorine and other chemicals by railroad, may be subject to additional, more stringent and more costly regulations in the future. If we are delayed or unable to ship finished products or unable to obtain raw materials as a result of any such new regulations or public policy changes related to transportation safety, or these transportation companies fail to operate properly, or if there were significant changes in the cost of these services due to new or additional regulations, or otherwise, we may not be able to arrange efficient alternatives and timely means to obtain raw materials or ship goods, which could result in a material adverse effect on our business and results of operations.
We may pursue acquisitions, dispositions and joint ventures and/or other transactions that may impact our results of operations and financial condition.
We seek opportunities to maximize efficiency and create stockholder value through various transactions. These transactions may include various domestic and international business combinations, purchases or sales of assets or contractual arrangements or joint ventures that are intended to result in the realization of synergies, the creation of efficiencies or the generation of cash to reduce debt. In this regard, we regularly consider acquisition opportunities that would be consistent or complementary to our existing business strategies. To the extent permitted under our credit facility, the indenture governing our senior notes and other debt agreements, some of these transactions may be financed by additional borrowings by us. Although we would pursue these transactions because we expect them to yield longer-term benefits if the efficiencies and synergies we expect are realized, they could adversely affect our results of operations in the short term because of the costs associated with such transactions and because they may divert management's attention from existing business operations. Other transactions may advance future cash flows from some of our businesses, thereby yielding increased short-term liquidity, but consequently resulting in lower cash flows from these operations over the longer term. These transactions may not yield the business benefits, synergies or financial benefits anticipated by management. Integration of other acquired operations can lead to restructuring charges or other costs. We may have difficulties integrating the operations of other acquired businesses.

12
Table of Contents

Our operations and assets are subject to extensive environmental, health and safety laws and regulations.
We use large quantities of hazardous substances and generate large quantities of hazardous wastes and emissions in our manufacturing operations. Due to the large quantities of hazardous substances and wastes, our industry is highly regulated and monitored by various environmental regulatory authorities such as the EPA and the European Union, which promulgates the Industrial Emission Directive ("IED"). As such, we are subject to extensive international, national, state and local laws, regulations and directives pertaining to pollution and protection of the environment, health and safety, which govern, among other things, emissions to the air, discharges onto land or waters, the maintenance of safe conditions in the workplace, the remediation of contaminated sites, and the generation, handling, storage, transportation, treatment and disposal of waste materials. Some of these laws, regulations and directives are subject to varying and conflicting interpretations. Many of these laws, regulations and directives provide for substantial fines and potential criminal sanctions for violations and require the installation of costly pollution control equipment or operational changes to limit pollution emissions or reduce the likelihood or impact of hazardous substance releases, whether permitted or not. For example, all of our petrochemical facilities in the United States and Europe may require improvements to comply with certain changes in process safety management requirements.
New laws, rules and regulations as well as changes to laws, rules and regulations may also affect us. For example, on April 17, 2012, the EPA promulgated maximum achievable control technology ("MACT") standards for major sources and generally available control technology ("GACT") standards for area sources of PVC production. The rule sets emission limits and work practice standards for total organic air toxics and for three specific air toxics: vinyl chloride, chlorinated di-benzo dioxins and furans ("CD/DF"), and hydrogen chloride and includes requirements to demonstrate initial and continuous compliance with the emission standards. Similarly, the Toxic Substances Control Act ("TSCA") imposes reporting, record-keeping and testing requirements, and restrictions relating to the production, handling, and use of chemical substances. The TSCA reform legislation enacted in June 2016 expanded the EPA's authority to review and regulate new and existing chemicals. In June 2017, the EPA issued three rules that implement the TSCA reform legislation. One rule establishes the EPA's process and criteria for identifying high priority chemicals for risk evaluation. Another rule sets the EPA's approach for determining whether these high priority chemicals present an unreasonable risk to health or the environment. These two rules are currently the subject of legal challenges by environmental groups. The third rule requires industry reporting of chemicals manufactured or processed in the United States over the past 10 years. These rules or future new, amended or proposed laws or rules may result in an increase in regulations, which could increase our costs or reduce our production, which could have a material adverse effect on our business, financial condition, operating results or cash flows. In addition, we cannot accurately predict future developments, such as increasingly strict environmental and safety laws or regulations, and inspection and enforcement policies, as well as resulting higher compliance costs, which might affect the handling, manufacture, use, emission, disposal or remediation of products, other materials or hazardous and non-hazardous waste, and we cannot predict with certainty the extent of our future liabilities and costs under environmental, health and safety laws and regulations. These liabilities and costs may be material.
In March 2011, the EPA proposed amendments to the emission standards for hazardous air pollutants for mercury emissions from mercury cell chlor-alkali plants. These proposed amendments would require improvements in work practices to reduce fugitive mercury emissions. We operate a mercury cell production unit at our Natrium facility. We cannot predict the timing or content of the final regulation, or its ultimate cost to, or impact on us.
Our operations produce greenhouse gas ("GHG") emissions, which have been the subject of increased scrutiny and regulation. In December 2015, the United States joined the international community at the 21st Conference of the Parties of the United Nations Framework Convention on Climate Change in Paris, France. The resulting Paris Agreement calls for the parties to undertake "ambitious efforts" to limit the average global temperature and to conserve and enhance sinks and reservoirs of greenhouse gases. The United States signed the Paris Agreement in April 2016, and the Paris Agreement went into effect in November 2016. However, in June 2017, the Trump Administration announced that the United States intends to withdraw from the Paris Agreement. Pursuant to the terms of the Paris Agreement, the earliest date the United States can effectively withdraw is November 2020. The United States' adherence to the exit process and/or the terms on which the United States may reenter the Paris Agreement or a separately negotiated agreement are unclear at this time. Legislation to regulate GHG emissions has also been introduced in the United States Congress, and there has been a wide-ranging policy debate regarding the impact of these gases and possible means for their regulation. Some of the proposals would require industries to meet stringent new standards that would require substantial reductions in carbon emissions. Those reductions could be costly and difficult to implement.

13
Table of Contents

Various jurisdictions have considered or adopted laws and regulations on GHG emissions, with the general aim of reducing such emissions. The EPA currently requires certain industrial facilities to report their GHG emissions, and to obtain permits with stringent control requirements before constructing or modifying new facilities with significant GHG emissions. In the European Union, the Emissions Trading Scheme obligates certain emitters to obtain GHG emission allowances to comply with a cap and trade system for GHG emissions. In addition, the European Union has committed to reduce domestic GHG emissions by at least 40% below the 1990 level by 2030. As our chemical manufacturing processes result in GHG emissions, these and other GHG laws and regulations could affect our costs of doing business.
Under the IED, European Union member state governments are expected to adopt rules and implement environmental permitting programs relating to air, water and waste for industrial facilities. In this context, concepts such as the "best available technique" are being explored. Future implementation of these concepts may result in technical modifications in our European facilities. In addition, under the Environmental Liability Directive, European Union member states can require the remediation of soil and groundwater contamination in certain circumstances, under the "polluter pays principle." We are unable to predict the impact these requirements and concepts may have on our future costs of compliance.
We also may face liability for alleged personal injury or property damage due to exposure to chemicals or other hazardous substances at our facilities or to chemicals that we otherwise manufacture, handle or own. Although these types of claims have not historically had a material impact on our operations, a significant increase in the success of these types of claims could have a material adverse effect on our business, financial condition, operating results or cash flows.
Environmental laws may have a significant effect on the nature and scope of, and responsibility for, cleanup of contamination at our current and former operating facilities, the costs of transportation and storage of raw materials and finished products, the costs of reducing emissions and the costs of the storage and disposal of wastewater. The U.S. Comprehensive Environmental Response, Compensation, and Liability Act ("CERCLA"), similar state laws and certain European directives impose joint and several liability for the costs of remedial investigations and actions on the entities that generated waste, arranged for disposal of the wastes, transported to or selected the disposal sites and the past and present owners and operators of such sites. All such potentially responsible parties (or any one of them, including us) may be required to bear all of such costs regardless of fault, legality of the original disposal or ownership of the disposal site. In addition, CERCLA, similar state laws and certain European directives could impose liability for damages to natural resources caused by contamination.
Although we seek to take preventive action, our operations are inherently subject to accidental spills, discharges or other releases of hazardous substances that may make us liable to governmental entities or private parties. This may involve contamination associated with our current and former facilities, facilities to which we sent wastes or by-products for treatment or disposal and other contamination. Accidental discharges may occur in the future, future action may be taken in connection with past discharges, governmental agencies may assess damages or penalties against us in connection with any past or future contamination, or third parties may assert claims against us for damages allegedly arising out of any past or future contamination. In addition, we may be liable for existing contamination related to certain of our facilities for which, in some cases, we believe third parties are liable in the event such third parties fail to perform their obligations.
Capital projects are subject to risks, including delays and cost overruns, which could have an adverse impact on our financial condition and results of operations.
We have capital expansion plans for our facilities. Expansion projects may be subject to delays or cost overruns, including delays or cost overruns resulting from any one or more of the following:
•
unexpectedly long delivery times for, or shortages of, key equipment, parts or materials;
•
shortages of skilled labor and other personnel necessary to perform the work;
•
delays and performance issues;
•
failures or delays of third-party equipment vendors or service providers;
•
unforeseen increases in the cost of equipment, labor and raw materials;
•
work stoppages and other labor disputes;
•
unanticipated actual or purported change orders;
•
disputes with contractors and suppliers;
•
design and engineering problems;
•
latent damages or deterioration to equipment and machinery in excess of engineering estimates and assumptions;
•
financial or other difficulties of our contractors and suppliers;

14
Table of Contents

•
sabotage;
•
terrorist attacks;
•
interference from adverse weather conditions; and
•
difficulties in obtaining necessary permits or in meeting permit conditions.
Significant cost overruns or delays could materially affect our financial condition and results of operations. Additionally, actual capital expenditures could materially exceed our planned capital expenditures.
Our level of debt could adversely affect our ability to operate our business.
As of December 31, 2017 , our indebtedness, including the current portion, totaled $3.8 billion , and our debt represented approximately 42% of our total capitalization. Our annual interest expense for 2017 was $ 159 million , net of interest capitalized of $4 million . Our level of debt and the limitations imposed on us by our existing or future debt agreements could have significant consequences on our business and future prospects, including the following:
•
a portion of our cash flows from operations will be dedicated to the payment of interest and principal on our debt and will not be available for other purposes;
•
we may not be able to obtain necessary financing in the future for working capital, capital expenditures, acquisitions, debt service requirements or other purposes;
•
our less leveraged competitors could have a competitive advantage because they have greater flexibility to utilize their cash flows to improve their operations;
•
we may be exposed to risks inherent in interest rate fluctuations because some of our borrowings are at variable rates of interest, which would result in higher interest expense in the event of increases in interest rates;
•
we could be vulnerable in the event of a downturn in our business that would leave us less able to take advantage of significant business opportunities and to react to changes in our business and in market or industry conditions; and
•
should we pursue additional expansions of existing assets or acquisition of third party assets, we may not be able to obtain additional liquidity at cost effective interest rates.
These factors could be magnified or accelerated to the extent we were to finance future acquisitions with significant amounts of debt.
To service our indebtedness and fund our capital requirements, we will require a significant amount of cash. Our ability to generate cash depends on many factors beyond our control.
Our ability to make payments on and to refinance our indebtedness and to fund planned capital expenditures and pay cash dividends will depend on our ability to generate cash in the future, including any distributions that we may receive from Westlake Partners. This is subject to general economic, financial, currency, competitive, legislative, regulatory and other factors that are beyond our control.
Our business may not generate sufficient cash flows from operations, we may not receive sufficient distributions from Westlake Partners, and currently anticipated cost savings and operating improvements may not be realized on schedule. We also generate revenues denominated in currencies other than that of our indebtedness and may have difficulty converting those revenues into the currency of our indebtedness. We may need to refinance all or a portion of our indebtedness on or before maturity. In addition, we may not be able to refinance any of our indebtedness, including our credit facility and our senior notes, on commercially reasonable terms or at all. All of these factors could be magnified if we were to finance any future acquisitions with significant amounts of debt.
The Credit Agreement and the indenture governing certain of our senior notes impose significant operating and financial restrictions, which may prevent us from capitalizing on business opportunities and taking some actions.
The Credit Agreement and the indenture governing certain of our senior notes impose significant operating and financial restrictions on us. These restrictions limit our ability to:
•
pay dividends on, redeem or repurchase our capital stock;
•
make investments and other restricted payments;
•
incur additional indebtedness or issue preferred stock;
•
create liens;
•
permit dividend or other payment restrictions on our restricted subsidiaries;

15
Table of Contents

•
sell all or substantially all of our assets or consolidate or merge with or into other companies;
•
engage in transactions with affiliates; and
•
engage in sale-leaseback transactions.
These limitations are subject to a number of important qualifications and exceptions. However, the effectiveness of many of these restrictions in the indenture governing certain of our senior notes is currently suspended under the indenture because those notes are currently rated investment grade by at least two nationally recognized credit rating agencies. The Credit Agreement also requires us to maintain a quarterly total leverage ratio.
These covenants may adversely affect our ability to finance future business opportunities or acquisitions. A breach of any of these covenants could result in a default in respect of the related debt. If a default occurred, the relevant lenders could elect to declare the debt, together with accrued interest and other fees, to be immediately due and payable. In addition, any acceleration of debt under the Credit Agreement will constitute a default under some of our other debt, including the indentures governing our senior notes.
Our participation in joint ventures and similar arrangements exposes us to a number of risks, including risks of shared control.
We are party to several joint ventures and similar arrangements, including an investment, together with Lotte Chemical USA Corporation ("Lotte"), in a joint venture to build an ethylene facility, LACC, LLC ("LACC"). Our participation in joint ventures and similar arrangements, by their nature, requires us to share control with unaffiliated third parties. In particular, with respect to our investment in LACC, we are a 10% holder and, therefore, our partner Lotte will have primary control over operations, including management of the contractors responsible for constructing the ethylene facility. If there are differences in views among joint venture participants in how to operate a joint venture that result in delayed decisions or the failure to make decisions, or our joint venture partners do not fulfill their obligations, the affected joint venture may not be able to operate according to its business plan and fulfill its obligations. In that case, we may be required to write down the value of our investment in a joint venture, increase the level of financial or other commitments to the joint venture or, if we have contractual agreements with the joint venture, our operations may be materially adversely affected. Any of the foregoing could have a material adverse effect on our financial condition, results of operations or cash flows.
LACC may incur additional costs or delays in the construction of the LACC ethylene facility.
We have a commitment to contribute up to $225 million toward the construction of the LACC ethylene facility, which equates to approximately 10% of the equity in LACC. If there are cost overruns, our investment could be diluted below 10% if we do not make additional contributions to maintain our ownership position. The construction of the LACC ethylene facility without delays or significant cost overruns is subject to substantial risks, including:
•
shortages and inconsistent quality of equipment, materials, and labor;
•
labor costs and productivity;
•
work stoppages;
•
contractor or supplier delay or non-performance under construction or other agreements or non-performance by other major participants in construction projects;
•
delays in or failure to receive necessary permits, approvals, tax credits, and other regulatory authorizations;
•
delays associated with start-up activities, including major equipment failure, system integration, and operations, and/or unforeseen engineering problems;
•
changes in project design or scope;
•
impacts of new and existing laws and regulations, including environmental laws and regulations;
•
the outcome of legal challenges to projects, including legal challenges to regulatory approvals;
•
failure to construct in accordance with licensing requirements;
•
continued public and policymaker support for such projects;
•
adverse weather conditions or natural disasters;
•
sabotage;
•
terrorist attacks;
•
environmental and geological conditions;

16
Table of Contents

•
delays or increased costs to interconnect facilities; and
•
other unanticipated cost increases.
Regulations concerning the transportation of hazardous chemicals and the security of chemical manufacturing facilities could result in higher operating costs.
Targets such as chemical manufacturing facilities may be at greater risk of terrorist attacks than other targets. As a result, the chemical industry responded to the issues surrounding the terrorist attacks of September 11, 2001 by implementing initiatives relating to the security of chemicals industry facilities and the transportation of hazardous chemicals. Simultaneously, local, state, national and international governments put into effect a regulatory process that led to new regulations impacting the security of chemical plant locations and the transportation of hazardous chemicals. Our business or our customers' businesses could be adversely affected because of the cost of complying with these regulations.
A change in tax laws, treaties or regulations, or their interpretation or application, could have a negative impact on our business and results of operations.
We are subject to changes in applicable tax laws, treaties or regulations in the jurisdictions in which we operate. A material change in these tax laws, treaties or regulations, or their interpretation or application, could have a negative impact on our business and results of operations.
We may have difficulties integrating the operations of future acquired businesses.
If we are unable to integrate or to successfully manage businesses that we may acquire in the future, our business, financial condition and results of operations could be adversely affected. We may not be able to realize the operating efficiencies, synergies, cost savings or other benefits expected from the acquisitions for a number of reasons, including the following:
•
we may fail to integrate the businesses we acquire into a cohesive, efficient enterprise;
•
our resources, including management resources, are limited and may be strained if we engage in a large acquisition or significant number of acquisitions, and acquisitions may divert our management's attention from initiating or carrying out programs to save costs or enhance revenues; and
•
our failure to retain key employees and contracts of the businesses we acquire.
Future acquisitions could lead to significant restructuring or other changes.
Regulations related to "conflict minerals" could adversely impact our business .
The Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 ("Dodd-Frank Act") contains provisions to improve transparency and accountability concerning the supply of certain minerals, known as conflict minerals, originating from the Democratic Republic of Congo and adjoining countries (collectively, the "Covered Countries"). The term "conflict minerals" encompasses tantalum, tin, tungsten (and their ores) and gold.
In August 2012, pursuant to the Dodd-Frank Act, the SEC adopted new annual disclosure and reporting requirements applicable to any company that files periodic public reports with the SEC, if any conflicts minerals are necessary to the functionality or production of a product manufactured, or contracted to be manufactured, by that company. These new annual reporting requirements require companies to describe reasonable country of origin inquiries, due diligence measures and the results of those activities and related determinations.
Because we have a highly complex, multi-layered supply chain, we may incur significant costs to comply with these requirements. In addition, the implementation of procedures to comply with these requirements could adversely affect the sourcing, supply and pricing of materials, including components, used in our products. Our suppliers (or suppliers to our suppliers) may not be able or willing to provide all requested information or to take other steps necessary to ensure that no conflict minerals financing or benefiting armed groups are included in materials or components supplied to us for our manufacturing purposes. Also, we may encounter challenges to satisfy customers that may require all of the components of products purchased by them to be certified as conflict free. If we are not able to meet customer certification requirements, customers may choose to disqualify us as a supplier. In addition, since the applicability of the new conflict minerals requirements is limited to companies that file periodic reports with the SEC, not all of our competitors will need to comply with these requirements unless they are imposed by customers. As a result, those competitors may have cost and other advantages over us.

17
Table of Contents

Our operations could be adversely affected by labor relations.
The vast majority of our employees in Europe, and some of our employees in North America, are represented by labor unions and works councils. Our operations may be adversely affected by strikes, work stoppages and other labor disputes.
We have certain material pension and other postretirement employment benefit ("OPEB") obligations. Future funding obligations related to these obligations could restrict cash available for our operations, capital expenditures or other requirements or require us to borrow additional funds .
We have certain non-U.S. defined benefit pension plans covering current and former employees associated with our European operations that we have not funded and are not obligated to fund under applicable law. In addition, we assumed certain U.S. and non-U.S. tax-qualified and non-tax-qualified pension obligations, as well as OPEB obligations, in connection with the Merger. The non-tax-qualified pension liabilities and OPEB obligations to provide retiree health benefits assumed as a result of the Merger are unfunded. As of December 31, 2017 , the projected benefit obligation for our pension and OPEB plans were approximately $949 million and $76 million , respectively. The fair value of pension investment assets was $668 million as of December 31, 2017 . The total underfunded status of the pension obligations calculated on a projected benefit obligation basis as of December 31, 2017 was approximately $281 million , including the Westlake Salaried Plan, which was underfunded by approximately $120 million on an individual plan basis.
The unfunded OPEB obligations as of December 31, 2017 were approximately $76 million . We will require future operating cash flows to fund our pension and OPEB obligations, which could restrict available cash for our operations, capital expenditures and other requirements. We may also not generate sufficient cash to satisfy these obligations, which could require us to seek funding from other sources, including through additional borrowings, which could materially increase our outstanding debt or debt service requirements.
If our goodwill, indefinite-lived intangible assets or other intangible assets become impaired in the future, we may be required to record non-cash charges to earnings, which could be significant.
Under GAAP, we review goodwill and indefinite-lived intangible assets for impairment on an annual basis or more frequently if events or circumstances indicate that their carrying value may not be recoverable. Other intangible assets are reviewed if events or circumstances indicate that their carrying value may not be recoverable. The process of impairment testing for our goodwill and intangible assets involves a number of judgments and estimates made by management including the fair values of assets and liabilities, future cash flows, our interpretation of current economic indicators and market conditions, overall economic conditions and our strategic operational plans with regards to our business units. If the judgments and estimates used in our analysis are not realized or change due to external factors, then actual results may not be consistent with these judgments and estimates, and our goodwill and intangible assets may become impaired in future periods. If our goodwill, indefinite-lived intangible assets or other intangible assets are determined to be impaired in the future, we may be required to record non-cash charges to earnings during the period in which the impairment is determined, which could be significant and have an adverse effect on our financial condition and results of operations.
The trading price of our common stock may negatively impact us.
Volatility in the capital and credit markets may cause downward pressure on stock prices and credit availability. A decline in the market value of our common stock could make it more difficult for us to raise any equity capital.
The conversion of Axiall's Enterprise Resource Planning ("ERP") information systems to Westlake's ERP information systems may negatively impact our operations.
We are highly dependent on our information systems infrastructure in order to process orders, track inventory, ship products in a timely manner, prepare invoices to our customers, maintain regulatory compliance and otherwise carry on our business in the ordinary course. Because Axiall had its own ERP information systems, we currently operate on multiple ERP information systems, which complicates our processing, reporting and analysis of business transactions and other information. Since we must process and reconcile our information from multiple systems, the chance of errors is increased, and we may incur significant additional costs related thereto. Inconsistencies in the information from multiple ERP systems could adversely impact our ability to manage our business efficiently and may result in heightened risk to our ability to maintain our books and records and comply with regulatory requirements. We expect to transition the Axiall systems to Westlake's ERP systems. The transition involves numerous risks, including:
•
diversion of management's attention away from normal daily business operations;
•
delays and cost overruns;
•
loss of or delays in accessing data;

18
Table of Contents

•
increased demand on our operations support personnel;
•
initial dependence on unfamiliar systems while training personnel to use new systems; and
•
increased operating expenses resulting from training, conversion and transition support activities.
Any of the foregoing could result in a material increase in information technology compliance or other related costs and could materially negatively impact our operations. In addition, any failures in the transition to Westlake's ERP system could delay and/or impede our ability to order materials and services, manufacture products, fill and ship customer orders, invoice customers, generate management reports and timely prepare consolidated financial statements and maintain appropriate internal control over financial reporting, and thus, could unfavorably impact our operations and regulatory compliance in a significant manner.
Failure to adequately protect critical data and technology systems could materially affect our operations.
Information technology system failures, network disruptions and breaches of data security could disrupt our operations by causing delays or cancellation of customer orders, impede the manufacture or shipment of products or cause standard business processes to become ineffective, resulting in the unintentional disclosure of information or damage to our reputation. While we have taken steps to address these concerns by implementing network security and internal control measures, there can be no assurance that a system failure, network disruption or data security breach will not have a material adverse effect on our business, financial condition, operating results or cash flows.
Fluctuations in foreign currency exchange and interest rates could affect our consolidated financial results.
We earn revenues, pay expenses, own assets and incur liabilities in countries using currencies other than the U.S. dollar. Because our consolidated financial statements are presented in U.S. dollars, we must translate revenues and expenses into U.S. dollars at the average exchange rate during each reporting period, as well as assets and liabilities into U.S. dollars at exchange rates in effect at the end of each reporting period. Therefore, increases or decreases in the value of the U.S. dollar against other major currencies will affect our net revenues, operating income and the value of balance sheet items denominated in foreign currencies. Because of the geographic diversity of our operations, weaknesses in various currencies might occur in one or many of such currencies over time. From time to time, we may use derivative financial instruments to further reduce our net exposure to currency exchange rate fluctuations. However, fluctuations in foreign currency exchange rates, such as the recent strengthening of the U.S. dollar against major currencies, including, in particular, the Canadian dollar, could nevertheless materially adversely affect our financial results.
In addition, we are exposed to volatility in interest rates. When appropriate, we may use derivative financial instruments to reduce our exposure to interest rate risks. However, our financial risk management program may not be successful in reducing the risks inherent in exposures to interest rate fluctuations.
Our property insurance has only partial coverage for acts of terrorism and, in the event of terrorist attack, we could lose net sales and our facilities.
As a result of the terrorist attacks of September 11, 2001 and other events, our insurance carriers created certain exclusions for losses from terrorism from our property insurance policies. While separate terrorism insurance coverage is available, premiums for full coverage are very expensive, especially for chemical facilities, and the policies are subject to high deductibles. Available terrorism coverage typically excludes coverage for losses from acts of war and from acts of foreign governments as well as nuclear, biological and chemical attacks. We have determined that it is not economically prudent to obtain full terrorism insurance, especially given the significant risks that are not covered by such insurance. Where feasible we have secured some limited terrorism insurance coverage on our property where insurers have included it in their overall programs. In the event of a terrorist attack impacting one or more of our facilities, we could lose the net sales from the facilities and the facilities themselves, and could become liable for any contamination or for personal or property damage due to exposure to hazardous materials caused by any catastrophic release that may result from a terrorist attack.
Westlake Partners' tax treatment depends on its status as a partnership for federal income tax purposes, and it not being subject to a material amount of entity-level taxation. We depend in part on distributions from Westlake Partners to generate cash for our operations, capital expenditures, debt service and other uses. If the Internal Revenue Service ("IRS") were to treat Westlake Partners as a corporation for federal income tax purposes, or if Westlake Partners become subject to entity-level taxation for state tax purposes, its cash available for distribution would be substantially reduced, which would also likely cause a substantial reduction in the value of its common units that we hold.
Despite the fact that Westlake Partners is organized as a limited partnership under Delaware law, it would be treated as a corporation for U.S. federal income tax purposes unless it satisfies a "qualifying income" requirement (the "Qualifying Income

19
Table of Contents

Exception") under Section 7704 of the Internal Revenue Code of 1986, as amended (the "Code"). Failure to meet the Qualifying Income Exception would cause Westlake Partners to be treated as a corporation for U.S. federal income tax purposes.
Prior to its initial public offering, Westlake Partners requested and obtained a favorable private letter ruling from the IRS to the effect that, based on facts presented in the private letter ruling request, income from the production, transportation, storage and marketing of ethylene and its co-products constitutes "qualifying income" within the meaning of Section 7704 of the Code. Failure to meet the Qualifying Income Exception or a change in current law could cause Westlake Partners to be treated as a corporation for U.S. federal income tax purposes or otherwise subject Westlake Partners to taxation as an entity.
We will be controlled by our principal stockholder and its affiliates as long as they own a majority of our common stock, and our other stockholders will be unable to affect the outcome of stockholder voting during that time. Our interests may conflict with those of the principal stockholder and its affiliates, and we may not be able to resolve these conflicts on terms possible in arms-length transactions.
As long as TTWF LP (the "principal stockholder") and its affiliates (the "principal stockholder affiliates") own a majority of our outstanding common stock, they will be able to exert significant control over us, and our other stockholders, by themselves, will not be able to affect the outcome of any stockholder vote. As a result, the principal stockholder, subject to any fiduciary duty owed to our minority stockholders under Delaware law, will be able to control all matters affecting us (some of which may present conflicts of interest), including:
•
the composition of our Board of Directors and, through the Board, any determination with respect to our business direction and policies, including the appointment and removal of officers and the determination of compensation;
•
any determinations with respect to mergers or other business combinations or the acquisition or disposition of assets;
•
our financing decisions, capital raising activities and the payment of dividends; and
•
amendments to our amended and restated certificate of incorporation or amended and restated bylaws.
The principal stockholder will be permitted to transfer a controlling interest in us without being required to offer our other stockholders the ability to participate or realize a premium for their shares of common stock. A sale of a controlling interest to a third party may adversely affect the market price of our common stock and our business and results of operations because the change in control may result in a change of management decisions and business policy. Because we have elected not to be subject to Section 203 of the General Corporation Law of the State of Delaware, the principal stockholder may find it easier to sell its controlling interest to a third party than if we had not so elected.
In addition to any conflicts of interest that arise in the foregoing areas, our interests may conflict with those of the principal stockholder affiliates in a number of other areas, including:
•
business opportunities that may be presented to the principal stockholder affiliates and to our officers and directors associated with the principal stockholder affiliates, and competition between the principal stockholder affiliates and us within the same lines of business;
•
the solicitation and hiring of employees from each other; and
•
agreements with the principal stockholder affiliates relating to corporate services that may be material to our business.
We may not be able to resolve any potential conflicts with the principal stockholder affiliates, and even if we do, the resolution may be less favorable than if we were dealing with an unaffiliated party, particularly if the conflicts are resolved while we are controlled by the principal stockholder affiliates. Our amended and restated certificate of incorporation provides that the principal stockholder affiliates have no duty to refrain from engaging in activities or lines of business similar to ours and that the principal stockholder affiliates will not be liable to us or our stockholders for failing to present specified corporate opportunities to us.

Item 1B. Unresolved Staff Comments
None.
 

20
Table of Contents

Item 2. Properties
Our principal manufacturing facilities and principal products are set forth below. Except as noted, we own each of these facilities.
    Location
 
    Principal Products
Lake Charles, Louisiana
 
Ethylene, polyethylene, styrene, VCM, chlorine, caustic soda,
   chlorinated derivative products, electricity
Longview, Texas (1)
 
Polyethylene, polyethylene wax
Calvert City, Kentucky (2)
 
PVC, VCM, chlorine, caustic soda, ethylene
Plaquemine, Louisiana
 
PVC, VCM, chlorine, caustic soda, electricity
Geismar, Louisiana
 
PVC, VCM, chlorine, caustic soda
Gendorf, Bavaria, Germany (1)
 
PVC, VCM, chlorine, caustic soda
Burghausen, Bavaria, Germany (1)
 
PVC
Knapsack, North Rhine-Westphalia, Germany (1)
 
PVC, VCM, chlorine, caustic soda
Cologne, North Rhine-Westphalia, Germany (1)
 
PVC

______________________________
(1)
We lease the land on which our facilities are located.
(2)
We lease a portion of the land on which our Calvert City facility is located.
Olefins
Our olefins facility at our Lake Charles site consists of three tracts on approximately 1,700 acres in Lake Charles, each within three miles of one another. The site includes two ethylene plants, which are owned by OpCo, two polyethylene plants and a styrene monomer plant. The combined capacity of OpCo's two Lake Charles ethylene plants is approximately 3.0 billion pounds per year. The capacity of our two polyethylene plants is approximately 1.5 billion pounds per year and the capacity of our styrene plant is approximately 570 million pounds per year. One of our polyethylene plants has two production units that use gas phase technology with the capability to manufacture both LLDPE and HDPE.
Our Lake Charles site includes a marine terminal that provides for worldwide shipping capabilities. The site also is located near rail transportation facilities, which allows for efficient delivery of raw materials and prompt shipment of our products to customers. In addition, the site is connected by pipeline systems to our ethylene feedstock sources in both Texas and Louisiana. Within the site, OpCo's ethylene plants are connected by pipeline systems to our polyethylene and styrene plants.
Our Longview site consists of three polyethylene plants, a specialty polyethylene wax plant, and a 200-mile ethylene pipeline owned by OpCo that runs from Mont Belvieu to our Longview site. The plants are located inside a large Eastman Chemical Company ("Eastman") facility where Eastman produces a number of other chemical products. We can access ethylene to support our polyethylene operations either by purchasing ethylene from Eastman at the site or by transporting ethylene from OpCo's Lake Charles plant into the Gulf Coast grid and by transporting ethylene through our ethylene pipeline into our Longview facility. The technologies we use to produce polyethylene at Longview are similar to the technologies that we employ at Lake Charles. The Longview facility has a total capacity of approximately 1.1 billion pounds per year.
Vinyls
Our Calvert City site is situated on approximately 750 acres on the Tennessee River in Kentucky and includes an ethylene plant, which is owned by OpCo, a chlor-alkali plant, a VCM plant and a PVC plant. The capacity of OpCo's Calvert City ethylene plant is approximately 730 million pounds per year and the capacity of our chlor-alkali plant is approximately 550 million pounds of chlorine and 605 million pounds of caustic soda per year. Our chlorine plant utilizes efficient, state-of-the-art membrane technology. Our VCM plant has a capacity of approximately 1.5 billion pounds per year and our Calvert City PVC plant has a capacity of approximately 1.5 billion pounds per year. In January 2016, OpCo announced an expansion project to increase the ethylene capacity of its ethylene plant at our Calvert City facility. The expansion was completed in 2017 and, along with other initiatives, increased ethylene capacity by approximately 100 million pounds annually.

21
Table of Contents

Our vinyls facility at our Lake Charles site consists of two tracts of land making up approximately 1,690 acres, each within three miles of the other. The site operates a diverse portfolio of manufacturing plants, including three chlor-alkali plants, two VCM plants, a chlorinated derivative products plant and cogeneration assets. Our Lake Charles chlor-alkali plants are designed to produce approximately 2.8 billion pounds of chlorine and approximately 3.0 billion pounds of caustic soda per year. Our chlorine plants utilize both membrane and diaphragm technology. Our Lake Charles VCM plants have a capacity of approximately 2.1 billion pounds per year and our chlorinated derivative products plants have a capacity of approximately 715 million pounds per year. Our Lake Charles cogeneration assets have the capacity to generate approximately 420 Megawatts of electricity per year.
Our Plaquemine site is located on approximately 860 acres on the west bank of the Mississippi River in Iberville Parish and includes a chlor-alkali plant, a VCM plant, a PVC plant and cogeneration assets. The capacity of Plaquemine's chlor-alkali plant is approximately 940 million pounds of chlorine and approximately 1.0 billion pounds of caustic soda per year. Our chlorine plant utilizes diaphragm technology. Our Plaquemine VCM plant has a capacity of approximately 1.6 billion pounds per year and our PVC plant has a capacity of approximately 1.9 billion pounds per year. Our Plaquemine cogeneration assets have the capacity to generate approximately 240 Megawatts of electricity per year.
Our Geismar site is situated on approximately 185 acres on the east bank of the Mississippi River and includes a chlor-alkali plant, a VCM plant and a PVC plant. Our Geismar chlor-alkali plant is designed to produce approximately 700 million pounds of chlorine and approximately 770 million pounds of caustic soda per year. Our chlorine plant utilizes membrane technology. Our Geismar VCM plant has a capacity of approximately 850 million pounds per year and our PVC plant has a capacity of approximately 730 million pounds per year.
Our other North American vinyls manufacturing sites consist of facilities in Natrium, Longview and Beauharnois and include five chlor-alkali plants and four chlorinated derivative products plants. In addition, we have PVC resin and PVC compounds facilities located in Aberdeen, Gallman, Madison and Prairie, Mississippi. The chlor-alkali plants have a combined capacity of approximately 1.0 billion pounds of chlorine and approximately 1.1 billion pounds of caustic soda per year, the PVC plant has a capacity of approximately 1.0 billion pounds per year and our chlorinated derivative products plants have a combined capacity of approximately 1.3 billion pounds per year.
Our European vinyls manufacturing sites consist of five facilities in Germany and one facility in the United Kingdom, and include two membrane chlor-alkali plants, two VCM plants and six PVC plants. The chlor-alkali plants have a combined capacity of approximately 950 million pounds of chlorine and approximately 1.0 billion pounds of caustic soda per year, the VCM plants have a combined capacity of approximately 1.5 billion pounds per year and the PVC plants have a combined capacity of approximately 1.7 billion pounds per year.
As of February 14, 2018 , we owned 24 building products plants, consisting of 13 PVC pipe plants, eight siding, trim and mouldings plants, two profile plants producing PVC fence, decking, windows and door profiles and one film and sheet plant. The majority of our plants are strategically located near major markets and serve customers throughout the United States, Canada and Asia. The combined capacity of our building product plants is approximately 2.0 billion pounds per year. In addition, we have 19 company-owned building products distribution branches in Canada.
Headquarters
Our principal executive offices are located in Houston, Texas. Some of our office space is leased, at market rates, from an affiliate of our principal stockholder. See Note 18 to the audited consolidated financial statements appearing elsewhere in this Form 10-K and "Certain Relationships and Related Transactions" in our proxy statement to be filed with the SEC pursuant to Regulation 14A with respect to our 2018 annual meeting of stockholders (the "Proxy Statement").
 
Item 3. Legal Proceedings
In addition to the matters described under Item 1. Business — Environmental and Note 20 to our consolidated financial statements included in Item 8 of this Form 10-K, we are involved in various legal proceedings incidental to the conduct of our business. We do not believe that any of these legal proceedings will have a material adverse effect on our financial condition, results of operations or cash flows.

Item 4. Mine Safety Disclosure
Not Applicable.
 

22
Table of Contents

Executive Officers of the Registrant
James Chao (age 70) . Mr. Chao has been our Chairman of the Board of Directors since July 2004 and became a director in June 2003. From May 1996 to July 2004, he served as our Vice Chairman. Mr. Chao has over 45 years of global experience in the chemical industry. In addition, Mr. Chao has been the Chairman of the Board of Westlake Partners' general partner since its formation in March 2014. From June 2003 until November 2010, Mr. Chao was the executive chairman of Titan Chemicals Corp. Bhd. He has served as a Special Assistant to the Chairman of China General Plastics Group and worked in various financial, managerial and technical positions at Mattel Incorporated, Developmental Bank of Singapore, Singapore Gulf Plastics Pte. Ltd. and Gulf Oil Corporation. Mr. Chao, along with his brother Albert Chao, assisted their father T.T. Chao in founding Westlake Chemical Corporation. Mr. Chao is on the board of Baylor College of Medicine and KIPP (Knowledge Is Power Program). Mr. Chao received his B.S. degree from Massachusetts Institute of Technology and an M.B.A. from Columbia University.
Albert Chao (age 68) . Mr. Chao has been our President since May 1996 and a director since June 2003. Mr. Chao became our Chief Executive Officer in July 2004. Mr. Chao has over 40 years of global experience in the chemical industry. In 1985, Mr. Chao assisted his father T.T. Chao and his brother James Chao in founding Westlake Chemical Corporation, where he served as Executive Vice President until he succeeded James Chao as President. In addition, Mr. Chao has been the President, Chief Executive Officer and a director of Westlake Partners' general partner since its formation in March 2014. He has held positions in the Controller's Group of Mobil Oil Corporation, in the Technical Department of Hercules Incorporated, in the Plastics Group of Gulf Oil Corporation and has served as Assistant to the Chairman of China General Plastics Group and Deputy Managing Director of a plastics fabrication business in Singapore. Mr. Chao is a trustee of Rice University. Mr. Chao received a bachelor's degree from Brandeis University and an M.B.A. from Columbia University.
M. Steven Bender (age 61). Mr. Bender has been our Executive Vice President and Chief Financial Officer since July 2017. From February 2008 to July 2017, Mr. Bender served as our Senior Vice President and Chief Financial Officer. In addition, Mr. Bender served as our Treasurer from July 2011 to April 2017, a position he also held from February 2008 until December 2010. From February 2007 to February 2008, Mr. Bender served as our Vice President, Chief Financial Officer and Treasurer and from June 2005 to February 2007, he served as our Vice President and Treasurer. In addition, Mr. Bender has been the Senior Vice President, Chief Financial Officer and a director of Westlake Partners' general partner since its formation in March 2014, and its Treasurer since April 2015. Prior to joining Westlake, from June 2002 until June 2005, Mr. Bender served as Vice President and Treasurer of KBR, Inc., and from 1996 to 2002 he held the position of Assistant Treasurer for Halliburton Company. Prior to that, he held various financial positions within that company. Additionally, he was employed by Texas Eastern Corporation for over a decade in a variety of increasingly responsible audit, finance and treasury positions. Mr. Bender received a Bachelor of Business Administration from Texas A&M University and an M.B.A. from Southern Methodist University. Mr. Bender is also a Certified Public Accountant.
Robert F. Buesinger (age 61) . Mr. Buesinger has been our Executive Vice President, Vinyl Products since July 2017. From April 2010 to July 2017, Mr. Buesinger served as our Senior Vice President, Vinyls. Prior to joining us, Mr. Buesinger served as the General Manager and President of Chevron Phillips Chemical Company L.P.'s Performance Pipe Division from February 2010 to March 2010. From June 2008 to January 2010, Mr. Buesinger held the position of General Manager in the Alpha Olefins and Poly Alpha Olefins business of Chevron Phillips Chemical Company L.P. From April 2005 to May 2008, he served as the President and Managing Director of Chevron Phillips Singapore Chemicals Pte. Ltd. and Asia Region General Manager for Chevron Phillips Chemical Company L.P. Prior to that, he held various technical and sales management positions within that company. Mr. Buesinger holds a B.S. in Chemical Engineering from Tulane University.
Lawrence E. (Skip) Teel (age 59). Mr. Teel has been our Executive Vice President, Olefins since July 2017. From July 2014 to July 2017, Mr. Teel served as our Senior Vice President, Olefins and, from July 2012 to July 2014, he served as our Vice President, Olefins. In addition, Mr. Teel has been the Senior Vice President, Olefins of Westlake Partners' general partner since July 2014. Mr. Teel joined us in September 2009 as Director, Olefins and Feedstock after a 23-year career with Lyondell Chemical Company where he served as the Vice President, Refining from August 2006 to May 2008. From 2001 to 2006, Mr. Teel held the position of Director, Corporate Planning and Business Development at Lyondell Chemical Company. During his career, he has held a variety of marketing, operations and general management assignments. Mr. Teel received a B.S. in Chemical Engineering from New Mexico State University and an M.S. in Finance from the University of Houston.

23
Table of Contents

L. Benjamin Ederington (age 47). Mr. Ederington has been our Senior Vice President, General Counsel, Chief Administrative Officer and Corporate Secretary since July 2017. From December 2015 to July 2017, Mr. Ederington served as our Vice President, General Counsel, Chief Administrative Officer and Corporate Secretary and, from October 2013 to December 2015, he served as our Vice President, General Counsel and Corporate Secretary. In addition, Mr. Ederington has been the Vice President, General Counsel, Secretary and a director of Westlake Partners' general partner since its formation in March 2014. Prior to joining Westlake, he held a variety of senior legal positions at LyondellBasell Industries, N.V. and its predecessor companies, LyondellBasell Industries AF SCA and Lyondell Chemical Company, including most recently as Associate General Counsel, Commercial & Strategic Transactions from March 2010 to September 2013. He began his legal career more than 20 years ago at the law firm of Steptoe & Johnson, LLP. Mr. Ederington holds a B.A. from Yale University and received his J.D. from Harvard University.
Andrew Kenner (age 53). Mr. Kenner has been our Senior Vice President, Chemical Manufacturing since July 2017. From July 2008 to July 2017, Mr. Kenner served as our Vice President, Manufacturing. Mr. Kenner joined us after a 19-year career at Valero Energy Corporation where he served as Vice President and General Manager of Valero's Delaware City Refinery from September 2005 to July 2008. From August 2004 to September 2005, Mr. Kenner held the position of Vice President and General Manager of Valero's Houston Refinery. Mr. Kenner holds a B.S. in Aerospace Engineering from Texas A&M University and a M.S. in Chemical Engineering from the University of Texas at Austin.
George J. Mangieri (age 67) . Mr. Mangieri has been our Senior Vice President and Chief Accounting Officer since July 2017. From February 2007 to July 2017, Mr. Mangieri served as our Vice President and Chief Accounting Officer and, from April 2000 to February 2007, he served as our Vice President and Controller. In addition, Mr. Mangieri has been the Vice President and Chief Accounting Officer of Westlake Partners' general partner since its formation in March 2014. Prior to joining us, Mr. Mangieri served as Vice President and Controller of Zurn Industries, Inc. from 1998 to 2000. He previously was employed as Vice President and Controller for Imo Industries, Inc. in New Jersey, and spent over 10 years in public accounting with Ernst & Young LLP, where he served as Senior Manager. He received his Bachelor of Science degree from Monmouth College and is a Certified Public Accountant.

24
Table of Contents

PART II

Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Price Range of Common Stock
As of February 14, 2018 , there were 39 holders of record of our common stock. Our common stock is listed on the New York Stock Exchange under the symbol "WLK." Set forth below are the high and low closing prices for our common stock, as reported on the New York Stock Exchange composite tape for the periods indicated and the cash dividends declared in these periods.
 
 
High
 
Low
 
Cash Dividends
Declared
Year Ended December 31, 2017
 
 
 
 
 
 
4th Quarter
 
$
106.53

 
$
83.10

 
$
0.2100

3rd Quarter
 
83.55

 
65.85

 
0.2100

2nd Quarter
 
67.34

 
60.09

 
0.1906

1st Quarter
 
67.21

 
57.29

 
0.1906

Year Ended December 31, 2016
 
 
 
 
 
 
4th Quarter
 
$
59.17

 
$
49.84

 
$
0.1906

3rd Quarter
 
53.50

 
41.21

 
0.1906

2nd Quarter
 
52.22

 
39.88

 
0.1815

1st Quarter
 
53.60

 
41.01

 
0.1815

The $1.0 billion unsecured revolving credit facility (the "Credit Agreement") and the indenture governing the Senior Notes restrict our ability to pay dividends or other distributions on our equity securities. However, the effectiveness of these restrictions in the indenture governing the senior notes is currently suspended because the senior notes are currently rated investment grade by at least two nationally recognized credit rating agencies. See "Management's Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Debt" for additional information.
Issuer Purchases of Equity Securities
The following table provides information on our purchase of equity securities during the quarter ended December 31, 2017 :
Period
 
Total Number
of Shares
Purchased (1)
 
Average Price
Paid Per
Share
 
Total Number
of Shares
Purchased as Part
of Publicly
Announced Plans
or Programs (2)
 
Maximum Number
(or Approximate
Dollar Value) of
Shares that
May Yet Be
Purchased Under the
Plans or Programs  (2)
October 2017
 
3,202

 
$
83.28

 
—

 
$
171,285,000

November 2017
 
—

 
$
—

 
—

 
$
171,285,000

December 2017
 
—

 
$
—

 
—

 
$
171,285,000

Total
 
3,202

 
$
83.28

 
—

 
 

______________________________
(1)
Represents shares withheld in satisfaction of withholding taxes due upon the vesting of restricted stock units granted to our employees under the 2013 Plan.
(2)
In November 2014, our Board of Directors authorized a $250 million stock repurchase program (the "2014 Program"). In November 2015, our Board of Directors approved the expansion of the 2014 Program by an additional $150 million. As of December 31, 2017 , 4,193,598 shares of our common stock had been acquired at an aggregate purchase price of approximately $229 million under the 2014 Program. Transaction fees and commissions are not reported in the average price paid per share in the table above. Decisions regarding the amount and the timing of purchases under the 2014 Program will be influenced by our cash on hand, our cash flows from operations, general market conditions and other factors. The 2014 Program may be discontinued by our Board of Directors at any time.

25
Table of Contents

Equity Compensation Plan Information
Securities authorized for issuance under equity compensation plans are as follows:
Plan Category
 
Number of securities 
to be issued upon
exercise of outstanding options,
warrants and rights
(a)
 
Weighted-average
exercise price of
outstanding
options, warrants 
and rights
(b)
 
Number of  securities
remaining available
for future issuance under equity
compensation plans
(excluding securities
reflected in column
(a))
(c)
Equity compensation plans approved by security holders
 
1,933,467

 
$
26.95

 
4,855,527

Equity compensation plans not approved by security holders
 
N/A

 
N/A

 
N/A

Total
 
1,933,467

 
$
26.95

 
4,855,527

Other information regarding our equity compensation plans is set forth in the section entitled "Executive Compensation" in our Proxy Statement, which information is incorporated herein by reference.

26
Table of Contents

Item 6. Selected Financial and Operational Data (1)  
 
 
Year Ended December 31,
 
 
2017
 
2016
 
2015
 
2014
 
2013
 
 
 
 
 
 
 
 
 
 
 
 
 
(dollars in millions, except share amounts, per share data and volume data)
Statement of Operations Data:
 
 
 
 
 
 
 
 
 
 
Net sales
 
$
8,041

 
$
5,076

 
$
4,463

 
$
4,415

 
$
3,759

Gross profit
 
1,769

 
981

 
1,185

 
1,317

 
1,101

Selling, general and administrative expenses
 
399

 
258

 
218

 
179

 
144

Amortization of intangibles
 
108

 
38

 
7

 
5

 
4

Transaction and integration-related costs
 
29

 
104

 
—

 
9

 
—

Income from operations
 
1,233

 
581

 
960

 
1,124

 
953

Interest expense
 
(159
)
 
(79
)
 
(35
)
 
(37
)
 
(18
)
Other income (expense), net (2)
 
7

 
56

 
38

 
(3
)
 
7

Income before income taxes
 
1,081

 
558

 
963

 
1,084

 
942

Provision for (benefit from) income taxes
 
(258
)
 
138

 
298

 
399

 
332

Net income
 
1,339

 
420

 
665

 
685

 
610

Net income attributable to noncontrolling
   interests
 
35

 
21

 
19

 
6

 
—

Net income attributable to
   Westlake Chemical Corporation
 
$
1,304

 
$
399

 
$
646

 
$
679

 
$
610

Earnings Per Share Attributable to
   Westlake Chemical Corporation: (3)
 
 
 
 
 
 
 
 
 
 
Basic
 
$
10.05

 
$
3.07

 
$
4.88

 
$
5.09

 
$
4.57

Diluted
 
$
10.00

 
$
3.06

 
$
4.86

 
$
5.07

 
$
4.55

Weighted average shares outstanding (3)
 
 
 
 
 
 
 
 
 
 
Basic
 
129,087,043

 
129,367,712

 
131,823,707

 
133,111,230

 
133,224,256

Diluted
 
129,540,013

 
129,974,822

 
132,301,812

 
133,643,414

 
133,779,250

Balance Sheet Data (end of period):
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
1,531

 
$
459

 
$
663

 
$
881

 
$
461

Marketable securities
 
—

 
—

 
520

 
—

 
239

Restricted cash
 
1

 
161

 
—

 
—

 
—

Working capital (4)
 
1,496

 
1,225

 
1,652

 
1,475

 
1,244

Total assets
 
12,076

 
10,890

 
5,569

 
5,208

 
4,054

Total long-term debt, net
 
3,127

 
3,679

 
758

 
758

 
757

Total Westlake Chemical Corporation
   stockholders' equity
 
4,874

 
3,524

 
3,266

 
2,912

 
2,419

Cash dividends declared per share (3)
 
$
0.8012

 
$
0.7442

 
$
0.6930

 
$
0.5820

 
$
0.4125

Other Operating Data:
 
 
 
 
 
 
 
 
 
 
Cash flows from:
 
 
 
 
 
 
 
 
 
 
Operating activities
 
$
1,538

 
$
834

 
$
1,079

 
$
1,032

 
$
753

Investing activities
 
(652
)
 
(2,563
)
 
(1,006
)
 
(773
)
 
(1,002
)
Financing activities
 
160

 
1,533

 
(287
)
 
165

 
(80
)
Depreciation and amortization
 
601

 
378

 
246

 
208

 
158

Capital expenditures
 
577

 
629

 
491

 
431

 
679

EBITDA (5)
 
1,841

 
1,015

 
1,244

 
1,329

 
1,118


27
Table of Contents

 
 
Year Ended December 31,
 
 
2017
 
2016
 
2015
 
2014
 
2013
 
 
 
 
 
 
 
 
 
 
 
 
 
(dollars in millions, except share amounts, per share data and volume data)
External Sales Volume
   (millions of pounds):
 
 
 
 
 
 
 
 
 
 
Olefins Segment
 
 
 
 
 
 
 
 
 
 
Polyethylene
 
2,363

 
2,392

 
2,445

 
2,364

 
2,244

Styrene, feedstock and other
 
828

 
794

 
1,182

 
941

 
1,094

Vinyls Segment
 
 
 
 
 
 
 
 
 
 
PVC, caustic soda and other
 
15,997

 
8,118

 
5,026

 
3,174

 
1,995

Building products
 
1,193

 
770

 
629

 
572

 
487


______________________________
(1)
The historical selected financial and operational data should be read together with Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations, and Item 8, Financial Statements and Supplementary Data included in this Form 10-K.
(2)
Other income (expense), net is composed of the realized gain from previously held outstanding shares of common stock of Axiall, financing costs incurred in connection with the Merger, interest income, income or loss from equity method investments, dividend income, gains or losses from sales of securities, foreign exchange currency gains or losses, gain on acquisition, impairment of equity method investments, management fee income and other gains and losses.
(3)
On February 14, 2014, our Board of Directors authorized a two-for-one split of our common stock. Stockholders of record as of February 28, 2014 were entitled to one additional share for every share outstanding, which was distributed on March 18, 2014. All share amounts and per share data for the year ended December 31, 2013 have been restated to reflect the effect of the two-for-one stock split.
(4)
Working capital equals current assets less current liabilities.
(5)
EBITDA (a non-GAAP financial measure) is calculated as net income before interest expense, income taxes, depreciation and amortization. The body of accounting principles generally accepted in the United States is commonly referred to as "GAAP." For this purpose a non-GAAP financial measure is generally defined by the Securities and Exchange Commission ("SEC") as one that purports to measure historical and future financial performance, financial position or cash flows, but excludes or includes amounts that would not be so adjusted in the most comparable GAAP measures. We have included EBITDA in this Form 10-K because our management considers it an important supplemental measure of our performance and believes that it is frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry, some of which present EBITDA when reporting their results. We regularly evaluate our performance as compared to other companies in our industry that have different financing and capital structures and/or tax rates by using EBITDA. EBITDA allows for meaningful company-to-company performance comparisons by adjusting for factors such as interest expense, depreciation and amortization and taxes, which often vary from company to company. In addition, we utilize EBITDA in evaluating acquisition targets. Management also believes that EBITDA is a useful tool for measuring our ability to meet our future debt service, capital expenditures and working capital requirements, and EBITDA is commonly used by us and our investors to measure our ability to service indebtedness. EBITDA is not a substitute for the GAAP measures of earnings or of cash flows and is not necessarily a measure of our ability to fund our cash needs. In addition, it should be noted that companies calculate EBITDA differently and, therefore, EBITDA as presented in this Form 10-K may not be comparable to EBITDA reported by other companies. EBITDA has material limitations as a performance measure because it excludes (1) interest expense, which is a necessary element of our costs and ability to generate revenues because we have borrowed money to finance our operations, (2) depreciation, which is a necessary element of our costs and ability to generate revenues because we use capital assets and (3) income taxes, which is a necessary element of our operations. We compensate for these limitations by relying primarily on our GAAP results and using EBITDA only supplementally. The following table reconciles EBITDA to net income and to net cash provided by operating activities.

28
Table of Contents

Reconciliation of EBITDA to Net Income and to Net Cash Provided by Operating Activities

 
 
Year Ended December 31,
 
 
2017
 
2016
 
2015
 
2014
 
2013
 
 
 
 
 
 
 
 
 
 
 
 
 
(dollars in millions)
Net cash provided by operating activities
 
$
1,538

 
$
834

 
$
1,079

 
$
1,032

 
$
753

Changes in operating assets and liabilities
and other
 
(733
)
 
(313
)
 
(374
)
 
(288
)
 
(49
)
Deferred income taxes
 
534

 
(101
)
 
(40
)
 
(59
)
 
(94
)
Net income
 
1,339

 
420

 
665

 
685

 
610

Add:
 
 
 
 
 
 
 
 
 
 
Depreciation and amortization
 
601

 
378

 
246

 
208

 
158

Interest expense
 
159

 
79

 
35

 
37

 
18

Provision for (benefit from) income taxes
 
(258
)
 
138

 
298

 
399

 
332

EBITDA
 
$
1,841

 
$
1,015

 
$
1,244

 
$
1,329

 
$
1,118


29
Table of Contents

Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations
Overview
We are a vertically integrated global manufacturer and marketer of petrochemicals, polymers and building products. Our two principal operating segments are Olefins and Vinyls. We use the majority of our internally-produced basic chemicals to produce higher value-added chemicals and building products.
Consumption of the basic chemicals that we manufacture in the commodity portions of our olefins and vinyls processes has increased significantly since we began operations in 1986. Our olefins and vinyls products are some of the most widely used chemicals in the world and are upgraded into a wide variety of higher value-added chemical products used in many end-markets. Petrochemicals are typically manufactured in large volume by a number of different producers using widely available technologies. The petrochemical industry exhibits cyclical commodity characteristics, and margins are influenced by changes in the balance between supply and demand and the resulting operating rates, the level of general economic activity and the price of raw materials. The cycle is generally characterized by periods of tight supply, leading to high operating rates and margins, followed by a decline in operating rates and margins primarily as a result of excess new capacity additions. Due to the significant size of new plants, capacity additions are built in large increments and typically require several years of demand growth to be absorbed.
Since 2009 and continuing through 2017, a cost advantage for ethane-based ethylene producers over naphtha-based ethylene producers has allowed a strong export market for polyethylene and ethylene derivatives and higher margins for North American chemical producers, including Westlake. Continued strong global demand for polyethylene has benefited operating margins and cash flows for our Olefins segment in recent years. However, we have seen a significant reduction in the cost advantage enjoyed by North American ethane-based ethylene producers due to lower crude oil prices, beginning in the third quarter of 2014 and continuing through 2017 (which has resulted in reduced prices and margins). Looking forward, new ethylene and polyethylene capacity additions in North America, Asia and the Middle East, and a number of new capacities announced in recent years, may lead to periods of over-supply and lower profitability. As a result, our Olefins segment operating margins may be negatively impacted.
Since the U.S. housing market collapse in 2008, continued slow recovery in the U.S. construction markets and budgetary constraints in municipal spending have contributed to lower North American demand for our vinyls products, which has negatively impacted our Vinyls segment operating rates and margins. However, since late 2010, the PVC industry in the U.S. has experienced an increase in PVC resin exports, driven largely by more competitive feedstock and energy cost positions in the U.S. As a consequence, the U.S. PVC resin industry operating rates have improved since 2010. In addition, our July 2014 acquisition of Vinnolit Holdings GmbH and its subsidiary companies ("Vinnolit"), an integrated global leader in specialty PVC resins, has contributed to improved operating margins and cash flows for our Vinyls segment. Globally, there were large chlor-alkali capacity additions between 2008 and 2015 resulting in excess capacity and lower industry operating rates which exerted downward pressure on caustic soda pricing. Announced capacity is now complete and increasing demand driven by the improving economic growth and U.S. producers' competitive export position is expected to result in improved operating rates and caustic soda pricing. Westlake is the second-largest purchaser of ethylene in the U.S. and lower prices of ethylene could positively impact our Vinyls segment.
We purchase significant amounts of ethane feedstock, natural gas, ethylene and salt from external suppliers for use in production of basic chemicals in the olefins and vinyls chains. We also purchase significant amounts of electricity to supply the energy required in our production processes. While we have agreements providing for the supply of ethane feedstock, natural gas, ethylene, salt and electricity, the contractual prices for these raw materials and energy vary with market conditions and may be highly volatile. Factors that have caused volatility in our raw material prices in the past, and which may do so in the future include:
•
the availability of feedstock from shale gas and oil drilling;
•
supply and demand for crude oil;
•
shortages of raw materials due to increasing demand;
•
ethane and liquefied natural gas exports;
•
capacity constraints due to higher construction costs for investments, construction delays, strike action or involuntary shutdowns;
•
the general level of business and economic activity; and
•
the direct or indirect effect of governmental regulation.

30
Table of Contents

Significant volatility in raw material costs tends to put pressure on product margins as sales price increases could lag behind raw material cost increases. Conversely, when raw material costs decrease, customers may seek immediate relief in the form of lower sales prices. We currently use derivative instruments to reduce price volatility risk on feedstock commodities and lower overall costs. Normally, there is a pricing relationship between a commodity that we process and the feedstock from which it is derived. When this pricing relationship deviates from historical norms, we have from time to time entered into derivative instruments and physical positions in an attempt to take advantage of this relationship.
Our historical results have been significantly affected by our plant production capacity, our efficient use of that capacity and our ability to increase capacity. Since our inception, we have followed a disciplined growth strategy that focuses on plant acquisitions, new plant construction and internal expansion. We evaluate each expansion project on the basis of its ability to produce sustained returns in excess of our cost of capital and its ability to improve efficiency or reduce operating costs. We also regularly look at acquisition opportunities that would be consistent with, or complimentary to, our overall business strategies. Depending on the size of the acquisition, any such acquisitions could require external financing.
As noted above in Item 1A, "Risk Factors," we are subject to extensive environmental regulations, which may impose significant additional costs on our operations in the future. Further, concerns about GHG emissions and their possible effects on climate change has led to the enactment of regulations, and to proposed legislation and additional regulations, that could affect us in the form of increased cost of feedstocks and fuel, other increased costs of production and decreased demand for our products. While we do not expect any of these enactments or proposals to have a material adverse effect on us in the near term, we cannot predict the longer-term effect of any of these regulations or proposals on our future financial condition, results of operations or cash flows.
Non-GAAP Financial Measures
The body of accounting principles generally accepted in the United States is commonly referred to as "GAAP." For this purpose, a non-GAAP financial measure is generally defined by the SEC as one that purports to measure historical or future financial performance, financial position or cash flows, but excludes or includes amounts that would not be so adjusted in the most comparable GAAP measures. In this report, we disclose non-GAAP financial measures, primarily earnings before interest, taxes, depreciation and amortization ("EBITDA"). EBITDA is calculated as net income before interest expense, income taxes, depreciation and amortization. The non-GAAP financial measures described in this Form 10-K are not substitutes for the GAAP measures of earnings and cash flows.
EBITDA is included in this Form 10-K because our management considers it an important supplemental measure of our performance and believes that it is frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry, some of which present EBITDA when reporting their results. We regularly evaluate our performance as compared to other companies in our industry that have different financing and capital structures and/or tax rates by using EBITDA. In addition, we utilize EBITDA in evaluating acquisition targets. Management also believes that EBITDA is a useful tool for measuring our ability to meet our future debt service, capital expenditures and working capital requirements, and EBITDA is commonly used by us and our investors to measure our ability to service indebtedness. EBITDA is not a substitute for the GAAP measures of earnings or of cash flows and is not necessarily a measure of our ability to fund our cash needs. In addition, it should be noted that companies calculate EBITDA differently and, therefore, EBITDA as presented for us may not be comparable to EBITDA reported by other companies. EBITDA has material limitations as a performance measure because it excludes interest expense, depreciation and amortization, and income taxes.
Recent Developments
On December 22, 2017, the U. S. Tax Cuts and Jobs Act (the "Tax Act") was signed into law. The Tax Act, among other changes, reduces the U.S. corporate income tax rate from 35% to 21% effective January 1, 2018 and also requires a one-time deemed repatriation of foreign earnings at specified rates. We are subject to the provisions of the Financial Accounting Standards Board Accounting Standard Codification 740, Income Taxes, which requires the revaluation of deferred tax assets and liabilities in the period the tax rate change is enacted. The SEC staff guidance allows registrants to record provisional amounts during a measurement period when the registrant does not have the necessary information available, prepared or analyzed (including computations) in reasonable detail to complete its accounting for the change in tax law. The measurement period ends when a company has obtained, prepared and analyzed the information necessary to finalize its accounting, not to exceed one year. Under the above accounting guidance, we made a provisional adjustment in the 2017 consolidated financial statements. We recognized a one-time income tax benefit of approximately $591 million for items that we could reasonably estimate such as revaluation of deferred tax assets and liabilities and the one-time U.S. tax on the mandatory deemed repatriation of our post-1986 foreign earnings.

31
Table of Contents

On December 18, 2017, we delivered notices to redeem all of the outstanding Westlake 4.625% Senior Notes due 2021 ( $625 million aggregate principal amount) and all of the outstanding Eagle Spinco Inc. 4.625% Senior Notes due 2021 ($63 million aggregate principal amount) (collectively, the "2021 Notes") at a redemption price equal to 102.31% of the principal amount of the 2021 Notes plus accrued and unpaid interest on the 2021 Notes to the redemption date. The 2021 Notes were redeemed on February 15, 2018 using cash on hand, including the net proceeds from the November 2017 offering of $500 million aggregate principal amount of Westlake's 4.375% Senior Notes due 2047 and the November 2017 remarketing of $250 million aggregate principal amount of Louisiana Local Government Environmental Facilities and Community Development Authority Revenue Refunding Bonds (GO Zone) (Non-AMT) (the "Refunding Bonds").
On December 5, 2017, Westlake Partners increased the capacity of its existing revolving credit agreement with Westlake Chemical Finance Corporation from $300 million to $600 million. The facility maturity date is April 29, 2021.
On November 28, 2017, we closed the public offering of $500 million aggregate principal amount of 4.375% Senior Notes due 2047. On November 29, 2017, we closed the remarketing of $250 million aggregate principal amount of the Refunding Bonds. We issued $250 million aggregate principal amount of 3.50% Senior Notes due 2032 to collateralize our obligations under the loan agreement relating to the Refunding Bonds.
On September 29, 2017, Westlake Partners completed a secondary offering of 5,175,000 common units at a price of $22.00 per unit and purchased an additional 5.0% newly-issued limited partner interest in Westlake Chemical OpCo LP ("OpCo") for approximately $229 million, resulting in an aggregate 18.3% limited partner interest in OpCo effective July 1, 2017. Net proceeds to Westlake Partners from the sale of the units was $111 million, net of underwriting discounts, structuring fees and estimated offering expenses of approximately $3 million. Westlake Partners used the proceeds from the offering and the existing revolving credit facility with Westlake Chemical Finance Corporation, our subsidiary, to fund the purchase of the additional 5.0% interest in OpCo.
During September 2017, we directed the Louisiana Local Government Authority Environmental Facilities and Community Development Authority (the "Authority") to optionally redeem in full $250 million aggregate principal amount of the Authority's 6 ¾% tax-exempt revenue bonds due November 2032 on November 1, 2017 at a redemption price of par. The 6 ¾% tax-exempt revenue bonds due November 2032 were issued by the Authority in December 2007 under the Gulf Opportunity Zone Act of 2005 (the "GO Zone Act") for our benefit and were subject to optional redemption by the Authority at any time on or after November 1, 2017 for 100.0% of the principal plus accrued unpaid interest, if any. The 6 ¾% tax-exempt revenue bonds due November 2032 were redeemed on November 1, 2017. In connection with the redemption of the 6 ¾% tax-exempt revenue bonds due November 2032, the Authority caused the Westlake 6 ¾% senior notes to be surrendered to the trustee for cancellation.
On August 30, 2017, following Westlake Partners' cash distribution for the second quarter of 2017, the requirement under Westlake Partners' partnership agreement for the conversion of all subordinated units was satisfied. As a result, effective August 30, 2017, 12,686,115 subordinated units owned by us converted into common units on a one-for-one basis and thereafter participate on terms equal with all other common units in distributions of available cash.
On August 1, 2017, we, Westlake Partners and OpCo executed an Investment Management Agreement (the "Investment Management Agreement") that authorized Westlake to invest Westlake Partners' and OpCo's excess cash.
On August 1, 2017, our wholly-owned subsidiary, Westlake Chemical Finance Corporation, entered into an amendment to the revolving credit facility with Westlake Partners, resulting in the extension of the credit facility's maturity date from April 29, 2018 to April 29, 2021.
We completed an upgrade and capacity expansion of our Calvert City ethylene unit in April 2017. The expansion, along with other initiatives, increased ethylene capacity by approximately 100 million pounds annually to a total annual ethylene capacity of approximately 730 million pounds.


32
Table of Contents

Results of Operations
Segment Data
 
 
Year Ended December 31,
 
 
2017
 
2016
 
2015
 
 
 
 
 
 
 
 
 
(dollars in millions, except per share data)
Net external sales
 
 
 
 
 
 
Olefins
 
 
 
 
 
 
Polyethylene
 
$
1,518

 
$
1,463

 
$
1,651

Styrene, feedstock and other
 
533

 
431

 
609

Total Olefins
 
2,051

 
1,894

 
2,260

Vinyls
 
 
 
 
 
 
PVC, caustic soda and other
 
4,769

 
2,493

 
1,718

Building products
 
1,221

 
689

 
485

Total Vinyls
 
5,990

 
3,182

 
2,203

Total
 
$
8,041

 
$
5,076

 
$
4,463

 
 
 
 
 
 
 
Income (loss) from operations
 
 
 
 
 
 
Olefins
 
$
655

 
$
558

 
$
747

Vinyls
 
647

 
174

 
255

Corporate and other
 
(69
)
 
(151
)
 
(42
)
Total income from operations
 
1,233

 
581

 
960

Interest expense
 
(159
)
 
(79
)
 
(35
)
Other income (expense), net
 
7

 
56

 
38

Provision for (benefit from) income taxes
 
(258
)
 
138

 
298

Net income
 
1,339

 
420

 
665

Net income attributable to noncontrolling interests
 
35

 
21

 
19

Net income attributable to Westlake Chemical Corporation
 
$
1,304

 
$
399

 
$
646

Diluted earnings per share
 
$
10.00

 
$
3.06

 
$
4.86

 
 
Year Ended December 31,
 
 
2017
 
2016
 
 
Average Sales
Price
 
Volume
 
Average Sales
Price
 
Volume
Product sales price and volume percentage change
   from prior year
 
 
 
 
 
 
 
 
Olefins
 
+9
%
 
-1
 %
 
-9
 %
 
-7
 %
Vinyls
 
+14
%
 
+74
 %
 
-4
 %
 
+48
 %
Company average
 
+12
%
 
+46
 %
 
-6
 %
 
+20
 %
 
 
Year Ended December 31,
 
 
2017
 
2016
 
2015
Average industry prices (1)
 
 
 
 
 
 
Ethane (cents/lb)
 
8.3

 
6.6

 
6.2

Propane (cents/lb)
 
18.1

 
11.4

 
10.7

Ethylene (cents/lb) (2)
 
28.0

 
26.9

 
30.6

Polyethylene (cents/lb) (3)
 
71.1

 
65.3

 
71.6

Styrene (cents/lb) (4)
 
86.5

 
64.8

 
60.7

Caustic ($/short ton) (5)
 
800.4

 
645.0

 
581.0

Chlorine ($/short ton) (6)
 
323.8

 
297.7

 
266.9

PVC (cents/lb) (7)
 
62.6

 
54.7

 
51.0



33
Table of Contents

______________________________
(1)
Industry pricing data was obtained through IHS. We have not independently verified the data.
(2)
Represents average North American spot prices of ethylene over the period as reported by IHS.
(3)
Represents average North American net transaction prices of polyethylene low density GP-Film grade over the period as reported by IHS.
(4)
Represents average North American contract prices of styrene over the period as reported by IHS.
(5)
Represents average North American undiscounted contract prices of caustic soda over the period as reported by IHS.
(6)
Represents average North American contract prices of chlorine (into chemicals) over the period as reported by IHS.
(7)
Represents average North American contract prices of PVC over the period as reported by IHS. Effective January 1, 2017, IHS made a non-market downward adjustment of 15 cents per pound to PVC prices. For comparability, we adjusted each prior-year period's PVC price downward by 15 cents per pound consistent with the IHS non-market adjustment.
Summary
For the year ended December 31, 2017 , net income attributable to Westlake Chemical Corporation was $1,304 million , or $10.00 per diluted share, on net sales of $8,041 million . This represents an increase in net income attributable to Westlake Chemical Corporation of $905 million , or $6.94 per diluted share, compared to 2016 net income attributable to Westlake Chemical Corporation of $399 million , or $3.06 per diluted share, on net sales of $5,076 million . Net income for the year ended December 31, 2017 increased versus the prior year primarily due to (1) the tax benefit recorded in the fourth quarter of 2017 of approximately $591 million, or $4.54 per diluted share, resulting from the reduction of the federal corporate income tax rate under the Tax Act; (2) earnings contributed by Axiall, which was acquired on August 31, 2016; (3) higher sales prices for our major products, resulting in improved margins; and (4) lower transaction and integration-related costs associated with the integration of Axiall. These increases versus the prior year were partially offset by (1) higher interest expense due to the debt assumed as a result of the Axiall acquisition; (2) higher unabsorbed fixed manufacturing and other costs associated with turnarounds; and (3) the realized gain in 2016 of $49 million from the previously held common stock of Axiall. Net sales for the year ended December 31, 2017 increase d $2,965 million to $8,041 million compared to net sales for the year ended December 31, 2016 of $5,076 million , mainly due to higher sales contributed by Axiall and higher sales prices for our major products. Income from operations was $1,233 million for the year ended December 31, 2017 as compared to $581 million for the year ended December 31, 2016 , an increase of $652 million . The increase in income from operations was mainly a result of earnings contributed by Axiall, higher sales prices for our major products and lower transaction and integration-related costs, partially offset by higher unabsorbed fixed manufacturing and other costs associated with turnarounds and unplanned outages, as compared to 2016. Pre-tax transaction and integration-related costs for the year ended December 31, 2017 were $29 million , or $0.16 per diluted share after tax, as compared to $104 million in 2016.
2017 Compared with 2016
Net Sales. Net sales increase d by $2,965 million , or 58% , to $8,041 million in 2017 from $5,076 million in 2016 , primarily attributable to higher sales volume contributed by Axiall and higher sales prices for our major products. Overall sales volumes increased by 46% in 2017 as compared to 2016 , primarily attributable to higher sales contributed by Axiall. Average sales prices for 2017 increased by 12% as compared to 2016 .
Gross Profit. Gross profit margin percentage increase d to 22% in 2017 from 19% in 2016 . The gross profit margin for 2017 was higher primarily due to higher sales prices for our major products and higher sales volumes for caustic soda, chlorine and PVC resin contributed primarily by Axiall, as compared to 2016. These increases were offset by higher unabsorbed fixed manufacturing and other costs associated with turnarounds and unplanned outages and a proportionately larger sales volume for the Vinyls segment, for which industry margins in 2017 and 2016 were lower as compared to the Olefins industry.
Selling, General and Administrative Expenses. Selling, general and administrative expenses increase d by $141 million , or 55% , in 2017 as compared to 2016 , primarily because a full year of Axiall's expenses were included in 2017, as compared to only four months in 2016 and an increase in employee compensation.
Amortization of Intangibles. Amortization of intangibles are comprised of amortization expense for customer relationships, trade name and other intangibles assets. The amortization expense increased by $70 million in 2017 , as compared to 2016 , because a full year of expense related to the intangible assets acquired in Axiall acquisition was included in 2017, as compared to only four months in 2016.

34
Table of Contents

Transaction and Integration-related Costs . Transaction and integration-related costs were $29 million in 2017 as compared to $104 million in 2016. Transaction and integration-related costs were $75 million lower in 2017 as compared to 2016 predominantly because significant transaction and integration-related costs were incurred at the time of the Merger in 2016. The transaction and integration costs in 2017 primarily consisted of severance benefits provided to former Axiall employees in conjunction with the Merger and integration costs and consulting fees related to the Merger. The transaction and integration costs in 2016 primarily consisted of severance benefits provided to former Axiall executives in conjunction with the Merger, including the conversion of Axiall restricted stock units into our restricted stock units, transitional service expenses for certain former Axiall employees, retention agreement costs and consulting and professional fees related to the Merger.
Interest Expense. Interest expense increase d by $80 million to $159 million in 2017 from $79 million in 2016 , primarily as a result of higher average debt outstanding for the year as well as decreased capitalized interest on major capital projects in 2017 as compared to 2016. The debt balance increased in August 2016 to finance the Merger. See "Liquidity and Capital Resources—Debt" below for further discussion of our indebtedness.
Other Income (Expense), Net. Other income, net decrease d by $49 million to $7 million in 2017 from $56 million in 2016 . The decrease was mainly attributable to the realized gain in 2016 of $49 million from the previously held common stock of Axiall.
Income Taxes. The effective income tax rate was a benefit of 24% in 2017 as compared to an expense of 25% in 2016 . The effective income tax rate for 2017 was below the U.S. federal statutory rate of 35% primarily due to the approximately $591 million income tax benefit as a result of the revaluation of deferred tax assets and liabilities and the one-time U.S. tax on the mandatory deemed repatriation of our post-1986 foreign earnings as part of the Tax Act, the domestic manufacturing deduction, depletion deductions, income attributable to noncontrolling interests, foreign earnings rate differential and foreign withholding tax related to such earnings. The effective income tax rate for 2016 was below the U.S. federal statutory rate of 35% primarily due to the benefit of state tax credits, the domestic manufacturing deduction, depletion deductions, income attributable to noncontrolling interests, the non-recognition of tax related to the gain recognized on previously held outstanding shares of common stock of Axiall, the benefit in prior years' and current-year tax credits for increased research and development expenditures and adjustments related to prior years' tax returns as filed, change in state apportionment and the foreign earnings rate differential, partially offset by state income taxes and nondeductible transaction costs related to the Merger.
Olefins Segment
Net Sales. Net sales increase d by $157 million , or 8% , to $2,051 million in 2017 from $1,894 million in 2016 , mainly due to higher sales prices for our major products compared to the prior year. Average sales prices for the Olefins segment increased by 9% in 2017 as compared to 2016 , while average sales volumes decreased by 1% in 2017 as compared to 2016, primarily due to lower polyethylene sales.
Income from Operations. Income from operations was $655 million in 2017 as compared to $558 million in 2016 . This increase was mainly attributable to higher olefins integrated product margins, primarily due to higher sales prices for our major products, higher operating rates and lower costs associated with turnarounds and unplanned outages as compared to the prior year. These increases were partially offset by higher energy costs. Income from operations for 2016 was negatively impacted by the planned turnaround and expansion of the Lake Charles Petro 1 ethylene unit along with other unplanned outages. Trading activity for 2017 resulted in a loss of $4 million as compared to a gain of $20 million for 2016 .
Vinyls Segment
Net Sales. Net sales increase d by $2,808 million , or 88% , to $5,990 million in 2017 from $3,182 million in 2016 . This increase was mainly attributable to higher sales volume contributed primarily by Axiall and higher sales prices for our major products. Average sales volumes increased by 74% in 2017 , as compared to 2016 primarily because a full year of Axiall's operations was included in 2017 as compared to only four months of Axiall's operations included in 2016. Average sales prices for the Vinyls segment increased by 14% in 2017 as compared to 2016 .
Income from Operations . Income from operations was $647 million in 2017 as compared to $174 million in 2016 . This increase was mainly attributable to earnings contributed by Axiall and higher sales prices and volumes for our major products. These increases were partially offset by higher unabsorbed fixed manufacturing and other costs associated with the planned turnaround and expansion at the Calvert City facility and other turnarounds and unplanned outages in addition to higher energy costs in 2017, as compared to 2016.

35
Table of Contents

2016 Compared with 2015
Net Sales. Net sales increased by $613 million , or 14% , to $5,076 million in 2016 from $4,463 million in 2015 . This increase was mainly attributable to sales contributed by Axiall and higher sales volume for PVC resin, partially offset by lower sales prices for all our major products and lower sales volumes for our major olefins products, as compared to the prior year. Average sales prices for 2016 decreased by 6% as compared to 2015 . Sales prices for the year ended December 31, 2016 were negatively impacted by lower crude oil prices as compared to the prior year. Overall sales volumes increased by 20% in 2016 as compared to 2015 , primarily attributable to sales contributed by Axiall, as compared to the prior year.
Gross Profit. Gross profit margin percentage decreased to 19% in 2016 from 27% in 2015 . The decrease in gross profit margin percentage was mainly the result of lower sales prices for our major products, as compared to the prior year, and the lost sales, lower production rates, unabsorbed fixed manufacturing costs and other costs associated with the turnaround and expansion of OpCo's Lake Charles Petro 1 ethylene unit, the unplanned outage at our Calvert City facility and other planned turnarounds and unplanned outages. Sales prices decreased an average of 6% for the year ended December 31, 2016 as compared to 2015 . In addition, gross profit for the year ended December 31, 2016 included the negative impact of selling higher cost Axiall inventory recorded at fair value. The decrease in gross profit for the year ended December 31, 2016 was partially offset by lower average feedstock and energy costs and higher product margins at our European operations, as compared to the prior year.
Selling, General and Administrative Expenses. Selling, general and administrative expenses increased $40 million , or 18% , in 2016 as compared to 2015 . The increase was mainly attributable to general and administrative costs incurred by Axiall for the period from August 31, 2016 to December 31, 2016 , partially offset by lower consulting and professional fees, as compared to 2015 .
Amortization of Intangibles. The increase in amortization expense of $31 million in 2016 as compared to 2015 was mainly because of customer relationships, trade name and other intangibles assets acquired in the Merger.
Transaction and Integration-related Costs. Transaction and integration-related costs were $104 million in 2016 and primarily consisted of severance benefits provided to former Axiall executives in conjunction with the Merger, including the conversion of Axiall restricted stock units into our restricted stock units, transitional service expenses for certain former Axiall employees, retention agreement costs and consulting and professional fees related to the Merger.
Interest Expense. Interest expense increased by $44 million to $79 million in 2016 from $35 million in 2015 , largely as a result of higher average debt outstanding, partially offset by increased capitalized interest on major capital projects in 2016 as compared to 2015 . See "Liquidity and Capital Resources-Debt" below for a further discussion of our indebtedness.
Other Income (Expense), Net. Other income, net increased $18 million to $56 million in 2016 from $38 million in 2015 . This increase was primarily attributable to the realized gain of approximately $49 million from the previously held outstanding shares of common stock of Axiall and higher interest income for 2016 as compared to the prior year, partially offset by the expenses related to the bridge loan facility and other financing costs in connection with the Merger. Other income (expense), net for 2015 included a gain of approximately $16 million related to the bargain purchase gain from the acquisition of a controlling interest in Suzhou Huasu Plastics Co., Ltd. ("Huasu"), net of related expenses, partially offset by the impairment and loss from the disposition of an equity method investment.
Income Taxes. The effective income tax rate was 25% in 2016 as compared to 31% in 2015 . The effective income tax rate for 2016 was below the U.S. federal statutory rate of 35% primarily due to the benefit of state tax credits, the domestic manufacturing deduction, depletion deductions, income attributable to noncontrolling interests, the non-recognition of tax related to the gain recognized on previously held outstanding shares of common stock of Axiall, the benefit in prior years' and current-year tax credits for increased research and development expenditures and adjustments related to prior years' tax returns as filed, change in state apportionment and the foreign earnings rate differential, partially offset by state income taxes and nondeductible transaction costs related to the Merger. The effective income tax rate for 2015 was below the U.S. federal statutory rate of 35% primarily due to the benefit of state tax credits, the domestic manufacturing deduction, income attributable to noncontrolling interests, the non-recognition of tax related to the bargain purchase of a controlling interest in Huasu, the foreign earnings rate differential and the increased benefit in certain prior years' deductions due to a change in the calculation methodology of the domestic manufacturing deduction and adjustments related to prior years' tax returns as filed, partially offset by state income taxes.

36
Table of Contents

Olefins Segment
Net Sales. Net sales decreased by $366 million , or 16% , to $1,894 million in 2016 from $2,260 million in 2015 , mainly due to lower sales prices for our major products and lower sales volumes for most of our major products as compared to the prior year. Average sales prices for the Olefins segment decreased by 9% in 2016 as compared to 2015 , while average sales volumes decreased by 7% in 2016 as compared to 2015 .
Income from Operations. Income from operations was $558 million in 2016 as compared to $747 million in 2015 . This decrease was predominantly attributable to lower olefins integrated product margins, primarily as a result of lower sales prices as compared to 2015 , and the lost sales, lower production rates, unabsorbed fixed manufacturing costs and other costs related to the turnaround and expansion of OpCo's Lake Charles Petro 1 ethylene unit and other planned turnarounds and unplanned outages in 2016. Trading activity for 2016 resulted in a gain of $20 million as compared to a loss of $11 million for 2015 .
Vinyls Segment
Net Sales. Net sales increased by $979 million , or 44% , to $3,182 million in 2016 from $2,203 million in 2015 . This increase was primarily attributable to sales contributed by Axiall and higher sales volume for PVC resin, partially offset by lower sales prices for our major products. Average sales prices for the Vinyls segment decreased by 4% in 2016 as compared to 2015 . Average sales volumes increased by 48% in 2016 as compared to 2015 , primarily related to sales contributed by Axiall, as compared to the prior year.
Income from Operations . Income from operations was $174 million in 2016 as compared to $255 million in 2015 . This decrease was primarily driven by the lost sales, lower production rates, unabsorbed fixed manufacturing costs and other costs associated with the unplanned outage at our Calvert City facility and the planned turnaround at our Lake Charles vinyls facility in 2016 . Income from operations for the year ended December 31, 2016 was also lower as a result of lower sales prices for our major products, partially offset by higher product margins at our European operations, as compared to 2015 . In addition, income from operations for the year ended December 31, 2016 included the negative impact of selling higher cost Axiall inventory recorded at fair value.
Cash Flows
Operating Activities
Operating activities provide d cash of $1,538 million in 2017 compared to cash provided of $834 million in 2016 . The $704 million increase in cash flows from operating activities was mainly due to an increase in income from operations and a decrease in working capital requirements. Income from operations increase d by $652 million in 2017 , as compared to the prior year, mainly as a result of higher sales prices, resulting in a higher margin, as well as higher earnings contributed by Axiall. Changes in components of working capital, which we define for purposes of this cash flow discussion as accounts receivable, inventories, prepaid expenses and other current assets, less accounts payable and accrued liabilities, provide d cash of $155 million in 2017 , compared to $59 million of cash provide d in 2016 , a favorable change of $96 million . The favorable change was mainly due to a decrease in cash usage in 2017 of $141 million resulting from higher accounts payable and accrued liabilities, partially offset by higher accounts receivables, resulting in an increase in cash usage of $90 million , as compared to 2016.
Operating activities provided cash of $834 million in 2016 compared to cash provided of $1,079 million in 2015 . The $245 million decrease in cash flows from operating activities was mainly due to a decrease in income from operations, an increase in working capital requirements, and an increase in deferred turnaround costs associated with OpCo's Lake Charles Petro 1 turnaround, partially offset by lower income taxes paid as compared to 2015 . Income from operations decreased by $379 million in 2016 , as compared to the prior year, mostly attributable to (1) lower sales prices for all of our major products; (2) transaction and integration-related costs associated with the Merger; and (3) the lost sales, lower production rates, unabsorbed fixed manufacturing costs and other costs associated with the turnaround and expansion of OpCo's Lake Charles Petro 1 ethylene unit, the unplanned outage at our Calvert City facility and other planned turnarounds and unplanned outages. Changes in components of working capital, which we define for purposes of this cash flow discussion as accounts receivable, net, inventories, prepaid expenses and other current assets, less accounts payable and accrued liabilities provided cash of $59 million in 2016 , compared to $128 million of cash provided in 2015 , an unfavorable change of $69 million . The change was mainly due to an increase of $161 million in inventory, partially offset by a decrease in current liabilities (accounts payable and accrued liabilities) of $90 million .

37
Table of Contents

Investing Activities
Net cash use d for investing activities during 2017 was $652 million as compared to net cash used of $2,563 million in 2016 . We used $2,438 million of cash, net of cash acquired, for the acquisition of Axiall in 2016. Capital expenditures were $577 million in 2017 compared to $629 million in 2016 . Capital expenditures in 2017 were incurred on several projects, including the upgrade and expansion of OpCo's Calvert City ethylene plant at our Calvert City site. Capital expenditures in 2016 were primarily incurred on the upgrade and expansion of OpCo's Petro 1 ethylene unit at our Lake Charles site. The remaining capital expenditures in 2017 and 2016 primarily related to projects to improve production capacity or reduce costs, maintenance and safety projects and environmental projects at our various facilities. In addition, we spent $66 million in 2017 related to our contribution to LACC to fund the construction costs of the ethylene plant, as compared to $17 million in 2016. Please see "Liquidity and Capital Resources—Liquidity and Financing Arrangements" below for further discussion. We did not purchase any securities in 2017 compared to a total of $138 million of securities purchased in 2016. Other 2016 investing activity was related to the receipt of proceeds of $663 million from the sales and maturities of our investments.
Net cash used for investing activities during 2016 was $2,563 million as compared to net cash used of $1,006 million in 2015 . We used $2,438 million , net of cash acquired, for the acquisition of Axiall. Capital expenditures were $629 million in 2016 compared to $491 million in 2015 . Capital expenditures in 2016 were mainly incurred on the upgrade and expansion of OpCo's Petro 1 ethylene unit at our Lake Charles site and OpCo's Calvert City ethylene plant at our Calvert City site. Capital expenditures in 2015 were primarily incurred on the upgrade and expansion of OpCo's Petro 1 ethylene unit at our Lake Charles site. The remaining capital expenditures in 2016 and 2015 primarily related to projects to improve production capacity or reduce costs, maintenance and safety projects and environmental projects at our various facilities. Purchases of securities in 2016 totaled $138 million and were comprised of corporate debt securities, U.S. government debt securities and equity securities. We also received aggregate proceeds of $663 million from the sales and maturities of our investments in 2016 . The 2015 activity was primarily related to the purchases of securities and the receipt of proceeds from the sales and maturities of our investments. In addition, we acquired cash of $16 million , net of cash paid, in connection with the acquisition of a controlling interest in Huasu.
Financing Activities
Net cash provide d by financing activities during 2017 was $160 million as compared to net cash provided of $1,533 million in 2016 . We received net proceeds in 2017 of (1) $495 million from the issuance in November 2017 of the 4.375% Senior Notes due 2047; (2) $250 million from the remarketing in November 2017 of the Refunding Bonds; (3) $111 million from the issuance of Westlake Partners common units as a result of its secondary offering in September 2017; and (4) $225 million from a drawdown under the Credit Agreement. In 2017, we used cash of (1) $150 million for the repayment of our prior term loan; (2) $250 million for the redemption of the 6 ¾% tax exempt revenue bonds due November 2032; and (3) $550 million for the repayment of borrowings under the Credit Agreement. During 2017, the restriction on $154 million of cash was also removed as a result of the repayment of our term loan. The remaining 2017 activity was primarily related to the $103 million payment of cash dividends, the $28 million payment of cash distributions to noncontrolling interests, the $6 million payment of debt issuance costs and activities related to Huasu's short-term notes payable to banks in connection with payments of suppliers through letters of credit. The 2016 activity was mainly related to the issuance of senior notes and our prior term loan and borrowings under the Credit Agreement, partially offset by repayment of borrowings under the Credit Agreement, the payment of cash dividends, the payment of cash distributions to noncontrolling interests, the payment of debt issuance costs and the repurchase of shares of our common stock.
Net cash provided by financing activities during 2016 was $1,533 million as compared to net cash used of $287 million in 2015 . Net proceeds from (1) the issuance of senior notes and (2) our term loan and the drawdown of the Credit Agreement were $1,429 million and $608 million , respectively, partially offset by the $125 million partial repayment of the Credit Agreement in 2016 . The remaining 2016 activity was primarily related to the $97 million payment of cash dividends, the 17 million payment of cash distributions to noncontrolling interests, $36 million payment of debt issuance costs and the $67 million of cash used for the repurchases of shares of our common stock, partially offset by the receipt of proceeds of $2 million from the exercise of stock options. The 2015 activity was mainly related to the payment of cash dividends, the payment of cash distributions to noncontrolling interests, the proceeds from and the repayments of Huasu's short-term notes payable to banks and the repurchase of shares of our common stock.
Liquidity and Capital Resources
Liquidity and Financing Arrangements
Our principal sources of liquidity are from cash and cash equivalents, cash from operations, short-term borrowings under the Credit Agreement and our long-term financing.

38
Table of Contents

In November 2014, our Board of Directors authorized a $250 million stock repurchase program (the "2014 Program"). In November 2015, our Board of Directors approved the expansion of the 2014 Program by an additional $150 million. As of December 31, 2017 , we had repurchased 4,193,598 shares of our common stock for an aggregate purchase price of approximately $229 million under the 2014 Program. During the year ended December 31, 2017 , no shares of our common stock were repurchased under the 2014 Program. Purchases under the 2014 Program may be made either through the open market or in privately negotiated transactions. Decisions regarding the amount and the timing of purchases under the 2014 Program will be influenced by our cash on hand, our cash flow from operations, general market conditions and other factors. The 2014 Program may be discontinued by our Board of Directors at any time.
We are party to a joint venture investment with Lotte Chemical USA Corporation ("Lotte") to build an ethylene facility, LACC, LLC ("LACC"). The ethylene facility is located adjacent to our vinyls facility in Lake Charles. Pursuant to the contribution and subscription agreement, we agreed to make a maximum capital commitment to LACC of up to $225 million to fund the construction costs of the ethylene plant, which represents approximately 10% of the interests in LACC. The construction of the ethylene plant commenced in January 2016, with an anticipated start-up during the first quarter of 2019 . As of December 31, 2017 , we had funded approximately $125 million of our portion of the construction costs of the ethylene plant.
In November 2017, we closed our public offering of $500 million aggregate principal amount of 4.375% Senior Notes due 2047. Also in November 2017, the Authority completed the offering of $250 million aggregate principal amount of 3.50% tax-exempt Refunding Bonds due November 1, 2032.  The net proceeds from the offering of 3.50% tax-exempt Refunding Bonds due November 1, 2032 were used to redeem $250 million aggregate principal amount of the Authority's 6 ¾% tax-exempt revenue bonds due November 1, 2032 issued by the Authority under the GO Zone Act in December 2007.
On February 15, 2018, all of the 2021 Senior Notes ($688 million aggregate principal amount) were redeemed.
We believe that our sources of liquidity as described above are adequate to fund our normal operations and ongoing capital expenditures. Funding of any potential large expansions or any potential acquisitions would likely necessitate and therefore depend on our ability to obtain additional financing in the future. We may not be able to access additional liquidity at cost effective interest rates due to the volatility of the commercial credit markets.
Cash and Cash Equivalents
As of December 31, 2017 , our cash and cash equivalents totaled $1,531 million . In addition, we have the Credit Agreement available to supplement cash if needed, as described under "Debt" below.
Debt
As of December 31, 2017 , our indebtedness, including the current portion, totaled $3,837 million . See Note 9 to the audited consolidated financial statements appearing elsewhere in this Form 10-K for a discussion of our long-term indebtedness. Defined terms used in this section have the definitions assigned to such terms in Note 9 to the consolidated financial statements.
Our ability to make payments on our indebtedness and to fund planned capital expenditures will depend on our ability to generate cash in the future, which is subject to general economic, financial, competitive, legislative, regulatory and other factors that are beyond our control. Based on our current level of operations and unless we were to undertake a new expansion or large acquisition, we believe our cash flows from operations, available cash and available borrowings under the Credit Agreement will be adequate to meet our normal operating needs for the foreseeable future.
Credit Agreement
On August 23, 2016, we and certain of our subsidiaries entered into an unsecured revolving credit facility (the "Credit Agreement"), by and among us, the other borrowers and guarantors referred to therein, the lenders from time to time party thereto (collectively, the "Lenders"), the issuing banks party thereto and JPMorgan Chase Bank, National Association, as Administrative Agent. Under the Credit Agreement, the Lenders have committed to provide an unsecured five-year revolving credit facility in an aggregate principal amount of up to $1 billion. The Credit Agreement includes a $150 million sub-limit for letters of credit, and any outstanding letters of credit will be deducted from availability under the facility. The Credit Agreement also provides for a discretionary $50 million commitment for swing-line loans to be provided on a same-day basis. We may also increase the size of the facility, in increments of at least $25 million, up to a maximum of $500 million, subject to certain conditions and if certain Lenders agree to commit to such an increase.

39
Table of Contents

At December 31, 2017 , we had under the Credit Agreement (i) no borrowings outstanding, (ii) outstanding letters of credit totaling $6 million and (iii) borrowing availability of $994 million. Borrowings under the Credit Agreement will bear interest, at our option, at either (a) LIBOR plus a spread ranging from 1.00% to 1.75% that will vary depending on our credit rating or (b) Alternate Base Rate plus a spread ranging from 0.00% to 0.75% that will vary depending on our credit rating. The Credit Agreement also requires an undrawn commitment fee ranging from 0.10% to 0.25% that will vary depending on our credit rating.
Our obligations under the Credit Agreement are guaranteed by our current and future material domestic subsidiaries, subject to certain exceptions. The Credit Agreement contains certain affirmative and negative covenants, including a quarterly total leverage ratio financial maintenance covenant. The Credit Agreement also contains certain events of default and if and for so long as an event of default has occurred and is continuing, any amounts outstanding under the Credit Agreement will accrue interest at an increased rate, the Lenders can terminate their commitments thereunder and payments of any outstanding amounts could be accelerated by the Lenders. As of December 31, 2017 , we were in compliance with the total leverage ratio financial maintenance covenant. See Note 9 to the consolidated financial statements for more information regarding the Credit Agreement.
GO Zone Bonds and IKE Zone Bonds
In November 2017, the Authority completed the offering of $250 million aggregate principal amount of 3.50% tax-exempt revenue refunding bonds due November 1, 2032, the net proceeds of which were used to redeem $250 million aggregate principal amount of the Authority's 6 ¾% tax-exempt revenue bonds due November 1, 2032 issued by the Authority under the GO Zone Act in December 2007. In November 2017, the Authority completed the remarketing of $250 million aggregate principal amount of 3.50% tax-exempt revenue refunding bonds due November 1, 2032 (the "Refunding Bonds"). The Refunding Bonds are subject to optional redemption by the Authority upon the direction of the Company at any time on or after November 1, 2027, for 100% of the principal plus accrued interest.
In July 2010, the Authority completed the reoffering of $100 million of the 6 ½% 2029 GO Zone Bonds. In connection with the reoffering of the 6 ½% 2029 GO Zone Bonds, the Company issued $100 million of the 6 ½% 2029 GO Zone Senior Notes. In December 2010, the Authority issued $89 million of the 6 ½% 2035 GO Zone Bonds. In connection with the issuance of the 6 ½% 2035 GO Zone Bonds, the Company issued $89 million of the 6 ½% 2035 GO Zone Senior Notes. In December 2010, the Authority completed the offering of $65 million of the 6 ½% 2035 IKE Zone Senior Notes under Section 704 of the IKE Zone Act.
The 6 ½% 2029 GO Zone Bonds are subject to optional redemption by the Authority upon the direction of the Company at any time prior to August 1, 2020 for 100% of the principal plus accrued interest and a discounted "make whole" payment. On or after August 1, 2020, the 6 ½% 2029 GO Zone Bonds are subject to optional redemption by the Authority upon the direction of the Company for 100% of the principal plus accrued interest. The 6 ½% 2035 GO Zone Bonds and the 6 ½% 2035 IKE Zone Senior Notes are subject to optional redemption by the Authority upon the direction of the Company at any time prior to November 1, 2020 for 100% of the principal plus accrued interest and a discounted "make whole" payment. On or after November 1, 2020, the 6 ½% 2035 GO Zone Bonds and the 6 ½% 2035 IKE Zone Senior Notes are subject to optional redemption by the Authority upon the direction of the Company for 100% of the principal plus accrued interest. See Note 9 to the consolidated financial statements for more information regarding the tax-exempt bonds and the Tax-Exempt Bond Related Senior Notes.
3.60% Senior Notes due 2022
In July 2012, we issued $250 million aggregate principal amount of the 3.60% 2022 Senior Notes. We may optionally redeem the 3.60% 2022 Senior Notes at any time and from time to time prior to April 15, 2022 (three months prior to the maturity date) for 100% of the principal plus accrued interest and a discounted "make whole" payment. On or after April 15, 2022, we may optionally redeem the 3.60% 2022 Senior Notes for 100% of the principal plus accrued interest. The holders of the 3.60% 2022 Senior Notes may require us to repurchase the 3.60% 2022 Senior Notes at a price of 101% of their principal amount, plus accrued and unpaid interest to the date of repurchase, upon the occurrence of both a "change of control" and, within 60 days of such change of control, a "below investment grade rating event" (as such terms are defined in the indenture governing the 3.60% 2022 Senior Notes). See Note 9 to the consolidated financial statements for more information regarding the 3.60% 2022 Senior Notes.

40
Table of Contents

3.60% Senior Notes due 2026 and 5.0% Senior Notes due 2046
In August 2016, we completed the private offering of $750 million aggregate principal amount of our 3.60% 2026 Senior Notes and $700 million aggregate principal amount of our 5.0% 2046 Senior Notes. All of our domestic subsidiaries that guarantee other indebtedness of ours or of another guarantor of the 3.60% 2026 Senior Notes or 5.0% 2046 Senior Notes in excess of $40 million are guarantors of the 3.60% 2026 Senior Notes and the 5.0% 2046 Senior Notes. The 3.60% 2026 Senior Notes and the 5.0% 2046 Senior Notes and guarantees are unsecured and rank equally with our existing and future senior unsecured obligations and each guarantor's existing and future senior unsecured obligations. See Note 9 to the consolidated financial statements for more information regarding the 3.60% 2026 Senior Notes and the 5.0% 2046 Senior Notes.
4.625% Senior Notes due 2021 and 4.875% Senior Notes due 2023
In September 2016, we completed offers to exchange (the "Axiall Exchange Offers") any and all of the $688 million aggregate principal amount of the 4.625% Subsidiary 2021 Senior Notes and the $450 million aggregate principal amount of the 4.875% Subsidiary 2023 Senior Notes (together with the 4.625% Subsidiary 2021 Senior Notes, the "Subsidiary Notes") issued by Axiall for new senior notes issued by us having the same maturity and interest rates as the Subsidiary Notes. Pursuant to the Axiall Exchange Offers, $625 million aggregate principal amount of the 4.625% Subsidiary 2021 Senior Notes and $434 million aggregate principal amount of the 4.875% Subsidiary 2021 Senior Notes were exchanged for an identical amount of 4.625% Westlake 2021 Senior Notes and 4.875% Westlake 2021 Senior Notes, respectively, leaving outstanding $63 million aggregate principal amount of 4.625% Subsidiary 2021 Senior Notes and $16 million aggregate amount of 4.875% Subsidiary 2021 Notes. In December 2017, we delivered notices for the optional redemption of all of the outstanding 4.625% Westlake 2021 Senior Notes and 4.625% Subsidiary 2021 Senior Notes (collectively, the "2021 Notes"). The 2021 Notes were redeemed on February 15, 2018 at a redemption price equal to 102.313% of the principal amount of the 2021 Notes plus accrued and unpaid interest on the 2021 Notes to the redemption date. The $16 million of the aggregate principal amount of the 4.875% Subsidiary 2023 Senior Notes are the senior unsecured obligations of Eagle Spinco Inc. The $434 million aggregate principal amount of the 4.875% Westlake 2023 Senior Notes are our senior obligations and are guaranteed on a senior basis by certain of our existing and future domestic subsidiaries. The 4.875% Westlake 2023 Senior Notes and guarantees are unsecured and rank equally with our existing and future senior unsecured obligations and each guarantor's existing and future senior unsecured obligations. All of our domestic subsidiaries that guarantee other indebtedness of ours or of another guarantor of the 4.875% Westlake 2023 Senior Notes in excess of $40 million are guarantors of the 4.875% Westlake 2023 Senior Notes. See Note 9 to the consolidated financial statements for more information regarding the 4.625% Westlake 2021 Senior Notes, the 4.625% Subsidiary 2021 Senior Notes, the 4.875% Westlake 2023 Senior Notes and the 4.875% Subsidiary 2023 Senior Notes.
In December 2017, we delivered notices for the optional redemption of all of the outstanding 4.625% Westlake 2021 Senior Notes and 4.625% Subsidiary 2021 Senior Notes (collectively, the "2021 Notes"). The 2021 Notes were optionally redeemed on February 15, 2018 at a redemption price equal to 102.313% of the principal amount of the 2021 Notes plus accrued and unpaid interest on the 2021 Notes to the redemption date.
4.375% Senior Notes due 2047
In November 2017, we completed the registered public offering of $500 million aggregate principal amount of 4.375% Senior Notes due November 15, 2047.  We may optionally redeem the 4.375% 2047 Senior Notes at any time and from time to time prior to May 15, 2047 (six months prior to the maturity date) for 100% of the principal plus accrued interest and a discounted "make whole" payment. On or after May 15, 2047, we may optionally redeem the 4.375% 2047 Senior Notes for 100% of the principal amount plus accrued interest. The holders of the 4.375% 2047 Senior Notes may require us to repurchase the 4.375% 2047 Senior Notes at a price of 101% of their principal amount, plus accrued and unpaid interest to, but not including, the date of repurchase, upon the occurrence of both a "change of control" and, within 60 days of such change of control, a "below investment grade rating event" (as such terms are defined in the indenture governing the 4.375% 2047 Senior Notes). See Note 9 to the consolidated financial statements for more information regarding the 4.375% 2047 Senior Notes.
Revenue Bonds
In December 1997, we entered into a loan agreement with a public trust established for public purposes for the benefit of the Parish of Calcasieu, Louisiana. The public trust issued $11 million principal amount of tax-exempt waste disposal revenue bonds in order to finance our construction of waste disposal facilities for an ethylene plant. The waste disposal revenue bonds expire in December 2027 and are subject to redemption and mandatory tender for purchase prior to maturity under certain conditions. Interest on the waste disposal revenue bonds accrues at a rate determined by a remarketing agent and is payable quarterly. The interest rate on the waste disposal revenue bonds at December 31, 2017 and 2016 was 1.73% and 0.79% , respectively.

41
Table of Contents

As of December 31, 2017, we were in compliance with all of the covenants with respect to the Tax-Exempt Related Senior Notes, the 4.625% Westlake 2021 Senior Notes, the 4.625% Subsidiary 2021 Senior Notes, the 3.60% 2022 Senior Notes, the 4.875% Westlake 2023 Senior Notes, the 4.875% Subsidiary 2023 Senior Notes, the 3.60% 2026 Senior Notes, the 5.0% 2046 Senior Notes, the 4.375% 2047 Senior Notes, the Credit Agreement and our waste disposal revenue bonds.
Westlake Chemical Partners LP Credit Arrangements
Our subsidiary, Westlake Chemical Finance Corporation, is the lender party to a $600 million revolving credit facility with Westlake Chemical Partners LP ("Westlake Partners"), originally entered into on April 29, 2015. The revolving credit facility is scheduled to mature on April 29, 2021. Borrowings under the revolver bear interest at LIBOR plus a spread ranging from 2.0% to 3.0% (depending on Westlake Partners' consolidated leverage ratio), payable quarterly. Westlake Partners may pay all or a portion of the interest on any borrowings in kind, in which case any such amounts would be added to the principal amount of the loan. As of December 31, 2017 , outstanding borrowings under the credit facility totaled $254 million and bore interest at the LIBOR rate plus 2.0% .
Our subsidiary, Westlake Development Corporation, is the lender party to a $600 million revolving credit facility with OpCo. The revolving credit facility matures in 2019. As of December 31, 2017 , outstanding borrowings under the credit facility totaled $220 million and bore interest at the LIBOR rate plus 3.0%, which is accrued in arrears quarterly.
We consolidate Westlake Partners and OpCo for financial reporting purposes as we have a controlling financial interest. As such, the revolving credit facilities described above between our subsidiaries and Westlake Partners and OpCo are eliminated upon consolidation.
Contractual Obligations and Commercial Commitments
In addition to long-term debt, we are required to make payments relating to various types of obligations. The following table summarizes our contractual obligations as of December 31, 2017 relating to long-term debt, operating leases, capital leases, pension benefits funding, post-retirement healthcare benefits, purchase obligations and interest payments for the next five years and thereafter. The amounts do not include deferred charges and other items classified in other liabilities in the consolidated balance sheet due to the uncertainty of the future payment schedule.
 
 
Payment Due by Period
 
 
Total
 
2018
 
2019-2020
 
2021-2022
 
Thereafter
 
 
 
 
 
 
 
 
 
 
 
 
 
(dollars in millions)
Contractual Obligations
 
 
 
 
 
 
 
 
 
 
Long-term debt
 
$
3,853

 
$
688

 
$
—

 
$
250

 
$
2,915

Operating leases
 
1,029

 
108

 
170

 
100

 
651

Capital leases
 
22

 
3

 
6

 
4

 
9

Pension benefits funding
 
143

 
6

 
11

 
15

 
111

Post-retirement healthcare benefits
 
110

 
8

 
16

 
16

 
70

Purchase obligations
 
5,264

 
1,522

 
1,777

 
1,080

 
885

Interest payments
 
2,438

 
144

 
280

 
276

 
1,738

Asset retirement obligations
 
38

 
4

 
2

 
1

 
31

Investment in LACC
 
100

 
54

 
46

 
—

 
—

Total
 
$
12,997

 
$
2,537

 
$
2,308

 
$
1,742

 
$
6,410

Other Commercial Commitments
 
 
 
 
 
 
 
 
 
 
Standby letters of credit
 
$
47

 
$
41

 
$
—

 
$
—

 
$
6

Pension Benefits Funding. This represents the projected timing of contributions to our defined benefit pension plans which cover certain eligible employees in the United States and non-U.S. countries.
Post-retirement Healthcare Benefits. This represents the projected timing of contributions to our post-retirement healthcare benefits to the employees of two subsidiaries who meet certain minimum age and service requirements.

42
Table of Contents

Purchase Obligations. Purchase obligations include agreements to purchase goods and services that are enforceable and legally binding and that specify all significant terms, including a minimum quantity and price. We are party to various obligations to purchase goods and services, including commitments to purchase various feedstock, utilities, nitrogen, oxygen, product storage, pipeline usage and logistic support, in each case in the ordinary course of our business, as well as various purchase commitments for our capital projects. The amounts shown in the table above reflect our estimates based on the contractual quantities and the prices in effect under contractual agreements as of December 31, 2017 .
Interest Payments. Interest payments are based on interest rates in effect at December 31, 2017 .
Asset retirement obligations. This includes the estimated costs and timing of payments to satisfy our recognized asset retirement obligations.
Investment in LACC. This includes our portion of the forecasted capital contributions related to the engineering, procurement and construction of LACC's new ethylene plant.
Standby Letters of Credit. This includes (1) our obligation under an $11 million letter of credit issued in connection with the $11 million tax-exempt waste disposal revenue bonds and (2) other letters of credit totaling $30 million issued primarily to support commercial obligations and obligations under our insurance programs, including workers' compensation claims.
Uncertain income tax positions. We have recognized a liability for our uncertain income tax positions of approximately $4 million as of December 31, 2017 . We do not believe we are likely to pay any material amounts during the year ending December 31,  2018 . The ultimate resolution and timing of payment for remaining matters continues to be uncertain and are therefore excluded from the Contractual Obligations table above.
Off-Balance Sheet Arrangements
None.
Critical Accounting Policies
Critical accounting policies are those that are important to our financial condition and require management's most difficult, subjective or complex judgments. Different amounts would be reported under different operating conditions or under alternative assumptions. We have evaluated the accounting policies used in the preparation of the accompanying consolidated financial statements and related notes and believe those policies are reasonable and appropriate.
We apply those accounting policies that we believe best reflect the underlying business and economic events, consistent with GAAP. Our more critical accounting policies include those related to long-lived assets, fair value estimates, accruals for long-term employee benefits, accounts receivable, income taxes and environmental and legal obligations. Inherent in such policies are certain key assumptions and estimates. We periodically update the estimates used in the preparation of the financial statements based on our latest assessment of the current and projected business and general economic environment. Our significant accounting policies are summarized in Note 1 to the audited consolidated financial statements appearing elsewhere in this Form 10-K. We believe the following to be our most critical accounting policies applied in the preparation of our financial statements.
Long-Lived Assets. Key estimates related to long-lived assets include useful lives, recoverability of carrying values and existence of any retirement obligations. Such estimates could be significantly modified. The carrying values of long-lived assets could be impaired by significant changes or projected changes in supply and demand fundamentals (which would have a negative impact on operating rates or margins), new technological developments, new competitors with significant raw material or other cost advantages, adverse changes associated with the United States and world economies, the cyclical nature of the chemical and refining industries and uncertainties associated with governmental actions.
We evaluate long-lived assets for potential impairment indicators whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable, including when negative conditions such as significant current or projected operating losses exist. Our judgments regarding the existence of impairment indicators are based on legal factors, market conditions and the operational performance of our businesses. Actual impairment losses incurred could vary significantly from amounts estimated. Long-lived assets assessed for impairment are grouped at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. Additionally, future events could cause us to conclude that impairment indicators exist and that associated long-lived assets of our businesses are impaired. Any resulting impairment loss could have a material adverse impact on our financial condition and results of operations.

43
Table of Contents

The estimated useful lives of long-lived assets range from one to 40 years. Depreciation and amortization of these assets, including amortization of deferred turnaround costs, under the straight-line method over their estimated useful lives totaled $601 million , $378 million and $246 million in 2017, 2016 and 2015 , respectively. If the useful lives of the assets were found to be shorter than originally estimated, depreciation or amortization charges would be accelerated.
We defer the costs of planned major maintenance activities, or turnarounds, and amortize the costs over the period until the next planned turnaround of the affected unit. Total costs deferred on turnarounds were $47 million , $77 million and $3 million in 2017, 2016 and 2015 , respectively. Amortization in 2017, 2016 and 2015 of previously deferred turnaround costs was $30 million , $22 million and $18 million , respectively. As of December 31, 2017 , deferred turnaround costs, net of accumulated amortization, totaled $111 million. Expensing turnaround costs as incurred would likely result in greater variability of our quarterly operating results and would adversely affect our financial position and results of operations.
Additional information concerning long-lived assets and related depreciation and amortization appears in Notes 6 and 7 to the audited consolidated financial statements appearing elsewhere in this Form 10-K.
Fair Value Estimates. We develop estimates of fair value to allocate the purchase price paid to acquire a business to the assets acquired and liabilities assumed in an acquisition, to assess impairment of long-lived assets, goodwill and intangible assets and to record marketable securities, derivative instruments and pension plan assets. We use all available information to make these fair value determinations, including the engagement of third-party consultants. At December 31, 2017 , our recorded goodwill was $1,012 million , which was associated with the acquisition of Axiall, our specialty PVC pipe business and our Longview facilities. In addition, we record all derivative instruments, pension plan assets and certain marketable securities at fair value. The fair value of these items is determined by quoted market prices or from observable market-based inputs. See Notes 12 and 14 to the consolidated financial statements for more information.
Business Combinations and Intangible Assets Including Goodwill. We account for business combinations using the acquisition method of accounting, and accordingly, the assets and liabilities of the acquired business are recorded at their fair values at the date of acquisition. The excess of the purchase price over the estimated fair value is recorded as goodwill. Any changes in the estimated fair values of the net assets recorded for acquisitions prior to the finalization of more detailed analysis, but not to exceed one year from the date of acquisition, will change the amount of the purchase price allocable to goodwill. Any subsequent changes to any purchase price allocations that are material to our consolidated financial results will be adjusted in the same period's financial statements, including the effect on earnings of changes in depreciation, amortization or other income effects, if any, as a result of the change to the provisional amounts, calculated as if the accounting had been completed at the acquisition date. All acquisition costs are expensed as incurred and in-process research and development costs are recorded at fair value as an indefinite-lived intangible asset and assessed for impairment thereafter until completion, at which point the asset is amortized over its expected useful life. Separately recognized transactions associated with business combinations are generally expensed subsequent to the acquisition date. The application of business combination and impairment accounting requires the use of significant estimates and assumptions. Goodwill is tested for impairment at least annually, or when events or changes in circumstances indicate the fair value of a reporting unit with goodwill has been reduced below its carrying value. We perform our annual impairment tests for the Olefins and Vinyls reporting units in October and April, respectively. The fair values of the reporting units are calculated using both a discounted cash flow methodology and a market value methodology. The discounted cash flow projections are based on a forecast to reflect the cyclicality of the business. The forecast is based on historical results and estimates by management, including its strategic and operational plans, and financial performance of the market. The future cash flows are discounted to present value using an applicable discount rate. The significant assumptions used in determining the fair value of the reporting unit using the market value methodology include the determination of appropriate market comparables and the estimated multiples of EBITDA a willing buyer is likely to pay. Even if the fair values of the reporting units decreased by 10%, the carrying values of the reporting units would not have exceeded their fair values. See Item 1A, "Risk Factors—If our goodwill, indefinite-lived intangible assets or other intangible assets become impaired in the future, we may be required to record non-cash charges to earnings, which could be significant."
The results of operations of acquired businesses are included in our consolidated financial statements from the acquisition date.
Long-Term Employee Benefit Costs. Our costs for long-term employee benefits, particularly pension and postretirement medical and life benefits, are incurred over long periods of time and involve many uncertainties over those periods. The net periodic benefit cost attributable to current periods is based on several assumptions about such future uncertainties and is sensitive to changes in those assumptions. It is our responsibility, often with the assistance of independent experts, to select assumptions that represent the best estimates of those uncertainties. It is also our responsibility to review those assumptions periodically and, if necessary, adjust the assumptions to reflect changes in economic or other factors.

44
Table of Contents

Accounting for employee retirement plans involves estimating the cost of benefits that are to be provided in the future and attempting to match, for each employee, that estimated cost to the period worked. To accomplish this, we rely extensively on advice from actuaries, and we make assumptions about inflation, investment returns, mortality, employee turnover and discount rates that ultimately impact amounts recorded. Changes in these assumptions may result in different expense and liability amounts. One of the more significant assumptions relates to the discount rate for measuring benefit obligations. At December 31, 2017 , the projected pension benefit obligations for U.S. and non-U.S. plans were calculated using assumed weighted average discount rates of 3.4% and 1.8% , respectively. The discount rates were determined using a benchmark pension discount curve and applying spot rates from the curve to each year of expected benefit payments to determine the appropriate discount rate. As a result of the funding relief provided by the enactment of the Bipartisan Budget Act of 2015, no minimum funding requirements are expected during 2018 for the U.S. pension plans. Additional information on the 2018 funding requirements and key assumptions underlying these benefit costs appear in Note 12 to the audited consolidated financial statements appearing elsewhere in this Form 10-K.
The following table reflects the sensitivity of the benefit obligation of our pension plans to changes in the actuarial assumptions:
 
 
2017
 
 
U.S. Plans
 
Non-U.S. Plans
 
 
 
 
 
 
 
(dollars in millions)
Projected benefit obligation, end of year
 
$
807

 
$
128

Discount rate increases by 100 basis points
 
(88
)
 
(20
)
Discount rate decreases by 100 basis points
 
107

 
26

A one-percentage point increase or decrease in assumed healthcare trend rates would not have a significant effect on the amounts reported for the healthcare plans.
While we believe that the amounts recorded in the consolidated financial statements appearing elsewhere in this Form 10-K related to these retirement plans are based on the best estimates and judgments available, the actual outcomes could differ from these estimates.
Income Taxes . We utilize the liability method of accounting for income taxes. Under the liability method, deferred tax assets or liabilities are recorded based upon temporary differences between the tax basis of assets and liabilities and their carrying values for financial reporting purposes. Deferred tax expense or benefit is the result of changes in the deferred tax assets and liabilities during the period. Valuation allowances are recorded against deferred tax assets when it is considered more likely than not that the deferred tax assets will not be realized.
Environmental and Legal Obligations. We consult with various professionals to assist us in making estimates relating to environmental costs and legal proceedings. We accrue an expense when we determine that it is probable that a liability has been incurred and the amount is reasonably estimable. While we believe that the amounts recorded in the accompanying consolidated financial statements related to these contingencies are based on the best estimates and judgments available, the actual outcomes could differ from our estimates. Additional information about certain legal proceedings and environmental matters appears in Note 20 to the audited consolidated financial statements appearing elsewhere in this Form 10-K.
Asset Retirement Obligations. We recognize asset retirement obligations in the period in which the liability becomes probable and reasonably estimable. Initially, the asset retirement obligation is recorded at fair value and capitalized as a component of the carrying value of the long-lived asset to which the obligation relates. The liability is recorded at its future value each period, and the capitalized cost is depreciated over the estimated useful life of the related asset. Upon settlement of the liability, a gain or loss is recorded. We have conditional asset retirement obligations for the removal and disposal of hazardous materials from certain of our manufacturing facilities.
We also have conditional asset retirement obligations that have not been recognized because the fair values of the conditional legal obligations cannot be measured due to the indeterminate settlement date of the obligations. Settlements of the unrecognized conditional asset retirement obligations are not expected to have a material adverse effect on our financial condition, results of operations or cash flows in any individual reporting period.
Recent Accounting Pronouncements
See Note 1 to the audited consolidated financial statements for a full description of recent accounting pronouncements, including expected dates of adoption and estimated effects on results of operations and financial condition, which is incorporated herein by reference.

45
Table of Contents

Item 7A. Quantitative and Qualitative Disclosures about Market Risk
Commodity Price Risk
A substantial portion of our products and raw materials are commodities whose prices fluctuate as market supply and demand fundamentals change. Accordingly, product margins and the level of our profitability tend to fluctuate with changes in the business cycle. We try to protect against such instability through various business strategies. Our strategies include ethylene product feedstock flexibility and moving downstream into the olefins and vinyls products where pricing is more stable. We use derivative instruments in certain instances to reduce price volatility risk on feedstocks and products. Based on our open derivative positions at December 31, 2017 , a hypothetical $0.10 increase in the price of a gallon of ethane would have increased our income before taxes by $3 million and a hypothetical $0.10 increase in the price of a gallon of propane would have increased our income before taxes by $4 million. Additional information concerning derivative commodity instruments appears in Notes 14 and 15 to the consolidated financial statements.
Interest Rate Risk
We are exposed to interest rate risk with respect to fixed and variable rate debt. At December 31, 2017 , we had $3,842 million aggregate principal amount of fixed rate debt. We are subject to the risk of higher interest cost if and when this debt is refinanced. If interest rates were 1% higher at the time of refinancing, our annual interest expense would increase by approximately $38 million. Also, at December 31, 2017 , we had $11 million principal amount of variable debt outstanding, which represents the tax exempt waste disposal revenue bonds. We do not currently hedge our variable interest rate debt, but we may do so in the future. The average variable interest rate for our variable rate debt of $11 million as of December 31, 2017 was 1.73% . A hypothetical 100 basis point increase in the average interest rate on our variable rate debt would not result in a material change in the interest expense.
Foreign Currency Exchange Rate Risk
We are exposed to foreign currency exchange rate risk associated with our international operations. However, the effect of fluctuations in foreign currency exchange rates caused by our international operations has not had a material impact on our overall operating results. We may engage in activities to mitigate our exposure to foreign currency exchange risk in certain instances through the use of currency exchange derivative instruments, including forward exchange contracts, cross-currency swaps or spot purchases. A forward exchange contract obligates us to exchange predetermined amounts of specified currencies at a stated exchange rate on a stated date. A cross-currency swap obligates us to make periodic payments in the local currency and receive periodic payments in our functional currency based on the notional amount of the instrument.

46
Table of Contents

Item 8.
Financial Statements and Supplementary Data

Index to Consolidated Financial Statements

 
Page
 
 
Management's Report on Internal Control over Financial Reporting
Report of Independent Registered Public Accounting Firm
Consolidated Financial Statements:
 
Consolidated Balance Sheets as of December 31, 2017 and 2016
Consolidated Statements of Operations for the Years Ended December 31, 2017, 2016 and 2015
Consolidated Statements of Comprehensive Income for the Years Ended
   December 31, 2017, 2016 and 2015
Consolidated Statements of Changes in Stockholders' Equity for the Years Ended
   December 31, 2017, 2016 and 2015
Consolidated Statements of Cash Flows for the Years Ended December 31, 2017, 2016 and 2015
Notes to Consolidated Financial Statements
Financial statement schedules not included in this Form 10-K have been omitted because they are not applicable or because the required information is shown in the financial statements or notes thereto.



MANAGEMENT'S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING
The management of Westlake Chemical Corporation is responsible for establishing and maintaining adequate internal control over financial reporting. Westlake's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.
Westlake management assessed the effectiveness of the Company's internal control over financial reporting as of December 31, 2017 . In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control—Integrated Framework (2013). Based on its assessment, Westlake's management has concluded that the Company's internal control over financial reporting was effective as of December 31, 2017 based on those criteria.
PricewaterhouseCoopers LLP, the independent registered public accounting firm that audited the financial statements included in this Annual Report on Form 10-K, has also audited the effectiveness of internal control over financial reporting as of December 31, 2017 as stated in their report that appears on the following page.

47
Table of Contents


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders
of Westlake Chemical Corporation


Opinions on the Financial Statements and Internal Control over Financial Reporting
We have audited the accompanying consolidated balance sheets of Westlake Chemical Corporation and its subsidiaries as of December 31, 2017 and 2016, and the related consolidated statements of operations, of comprehensive income, of changes in stockholders' equity and of cash flows for each of the three years in the period ended December 31, 2017, including the related notes (collectively referred to as the "consolidated financial statements"). We also have audited the Company's internal control over financial reporting as of December 31, 2017, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2017 and 2016, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2017 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2017, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.
Basis for Opinions
The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Report on Internal Control over Financial Reporting. Our responsibility is to express opinions on the Company's consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.
Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

Definition and Limitations of Internal Control over Financial Reporting
A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.

48

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.




/s/PricewaterhouseCoopers LLP

Houston, Texas    
February 21, 2018


We have served as the Company's auditor since 1986, which includes periods before the Company became subject to SEC reporting requirements.



























49
WESTLAKE CHEMICAL CORPORATION
CONSOLIDATED BALANCE SHEETS



 
 
December 31,
 
 
2017
 
2016
 
 
 
 
 
 
 
(in millions of dollars, except
par values and share amounts)
ASSETS
 
 
 
 
Current assets
 
 
 
 
Cash and cash equivalents
 
$
1,531

 
$
459

Accounts receivable, net
 
1,001

 
939

Inventories
 
900

 
801

Prepaid expenses and other current assets
 
30

 
48

Restricted cash
 
1

 
161

Total current assets
 
3,463

 
2,408

Property, plant and equipment, net
 
6,412

 
6,420

Goodwill
 
1,012

 
947

Customer relationships, net
 
616

 
611

Other intangible assets, net
 
161

 
176

Other assets, net
 
412

 
328

Total assets
 
$
12,076

 
$
10,890

LIABILITIES AND EQUITY
 
 
 
 
Current liabilities
 
 
 
 
Accounts payable
 
$
600

 
$
496

Accrued liabilities
 
657

 
538

Current portion of long-term debt, net
 
710

 
—

Term loan
 
—

 
149

Total current liabilities
 
1,967

 
1,183

Long-term debt, net
 
3,127

 
3,679

Deferred income taxes
 
1,111

 
1,650

Pension and other post-retirement benefits
 
344

 
365

Other liabilities
 
158

 
121

Total liabilities
 
6,707

 
6,998

Commitments and contingencies (Note 20)
 


 


Stockholders' equity
 
 
 
 
Preferred stock, $0.01 par value, 50,000,000 shares authorized; no shares
issued and outstanding
 
—

 
—

Common stock, $0.01 par value, 300,000,000 shares authorized; 134,651,380 and
134,651,380 shares issued at December 31, 2017 and 2016, respectively
 
1

 
1

Common stock, held in treasury, at cost; 5,232,875 and 5,726,377 shares
at December 31, 2017 and 2016, respectively
 
(302
)
 
(319
)
Additional paid-in capital
 
555

 
551

Retained earnings
 
4,613

 
3,412

Accumulated other comprehensive income (loss)
 
7

 
(121
)
Total Westlake Chemical Corporation stockholders' equity
 
4,874

 
3,524

Noncontrolling interests
 
495

 
368

Total equity
 
5,369

 
3,892

Total liabilities and equity
 
$
12,076

 
$
10,890

The accompanying notes are an integral part of these consolidated financial statements.

50
WESTLAKE CHEMICAL CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS


 
 
Year Ended December 31,
 
 
2017
 
2016
 
2015
 
 
 
 
 
 
 
 
 
(in millions of dollars,
except share amounts and per share data)
Net sales
 
$
8,041

 
$
5,076

 
$
4,463

Cost of sales
 
6,272

 
4,095

 
3,278

Gross profit
 
1,769

 
981

 
1,185

Selling, general and administrative expenses
 
399

 
258

 
218

Amortization of intangibles
 
108

 
38

 
7

Transaction and integration-related costs
 
29

 
104

 
—

Income from operations
 
1,233

 
581

 
960

Other income (expense)
 
 
 
 
 
 
Interest expense
 
(159
)
 
(79
)
 
(35
)
Other income, net
 
7

 
56

 
38

Income before income taxes
 
1,081

 
558

 
963

Provision for (benefit from) income taxes
 
(258
)
 
138

 
298

Net income
 
1,339

 
420

 
665

Net income attributable to noncontrolling interests
 
35

 
21

 
19

Net income attributable to Westlake Chemical Corporation
 
$
1,304

 
$
399

 
$
646

Earnings per common share attributable to
   Westlake Chemical Corporation:
 
 
 
 
 
 
Basic
 
$
10.05

 
$
3.07

 
$
4.88

Diluted
 
$
10.00

 
$
3.06

 
$
4.86

Weighted average shares outstanding
 
 
 
 
 
 
Basic
 
129,087,043

 
129,367,712

 
131,823,707

Diluted
 
129,540,013

 
129,974,822

 
132,301,812

Dividends per common share
 
$
0.8012

 
$
0.7442

 
$
0.6930



The accompanying notes are an integral part of these consolidated financial statements.

51
WESTLAKE CHEMICAL CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME


 
 
Year Ended December 31,
 
 
2017
 
2016
 
2015
 
 
 
 
 
 
 
 
 
(in millions of dollars)
Net income
 
$
1,339

 
$
420

 
$
665

Other comprehensive income (loss), net of income taxes
 
 
 
 
 
 
Pension and other post-retirement benefits liability
 
 
 
 
 
 
Pension and other post-retirement reserves adjustment
   (excluding amortization)
 
19

 
60

 
18

Amortization of benefits liability
 
2

 
1

 
3

Income tax provision on pension and other post-retirement
   benefits liability
 
(7
)
 
(24
)
 
(6
)
Foreign currency translation adjustments
 
 
 
 
 
 
Foreign currency translation
 
124

 
(34
)
 
(60
)
Income tax provision on foreign currency translation
 
(5
)
 
—

 
—

Available-for-sale investments
 
 
 
 
 
 
Unrealized holding gains (losses) on investments
 
—

 
62

 
(4
)
Reclassification of net realized gains to net income
 
—

 
(54
)
 
(4
)
Income tax benefit (provision) on available-for-sale investments
 
—

 
(3
)
 
3

Other comprehensive income (loss)
 
133

 
8

 
(50
)
Comprehensive income
 
1,472

 
428

 
615

Comprehensive income attributable to noncontrolling interests,
   net of tax of $1, $0 and $0 for 2017, 2016 and 2015, respectively
 
40

 
21

 
19

Comprehensive income attributable to Westlake Chemical Corporation
 
$
1,432

 
$
407

 
$
596



The accompanying notes are an integral part of these consolidated financial statements.


52
WESTLAKE CHEMICAL CORPORATION
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY


 
 
Common Stock
 
Common Stock,
Held in Treasury
 
 
 
 
 
 
 
 
 
 
 
 
Number of
Shares
 
Amount
 
Number of
Shares
 
At Cost
 
Additional
Paid-in
Capital
 
Retained
Earnings
 
Accumulated Other Comprehensive 
Income (Loss)
 
Noncontrolling Interests
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(in millions of dollars, except share amounts)
Balances at December 31, 2014
 
134,679,064

 
$
1

 
1,787,546

 
$
(96
)
 
$
530

 
$
2,556

 
$
(79
)
 
$
290

 
$
3,202

Net income
 
—

 
—

 
—

 
—

 
—

 
646

 
—

 
19

 
665

Other comprehensive
   income (loss)
 
—

 
—

 
—

 
—

 
—

 
—

 
(50
)
 
—

 
(50
)
Common stock
   repurchased
 
—

 
—

 
2,701,937

 
(163
)
 
—

 
—

 
—

 
—

 
(163
)
Shares issued—stock-
   based compensation
 
(15,820
)
 
—

 
(44,585
)
 
1

 
—

 
—

 
—

 
—

 
1

Stock-based compensation,
   net of tax on stock
   options exercised
 
—

 
—

 
—

 
—

 
12

 
—

 
—

 
—

 
12

Dividends declared
 
—

 
—

 
—

 
—

 
—

 
(92
)
 
—

 
—

 
(92
)
Distributions to
   noncontrolling interests
 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
(15
)
 
(15
)
Noncontrolling interest in
   acquired business
 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
2

 
2

Balances at December 31, 2015
 
134,663,244

 
1

 
4,444,898

 
(258
)
 
542

 
3,110

 
(129
)
 
296

 
3,562

Net income
 
—

 
—

 
—

 
—

 
—

 
399

 
—

 
21

 
420

Other comprehensive
   income
 
—

 
—

 
—

 
—

 
—

 
—

 
8

 
—

 
8

Common stock
   repurchased
 
—

 
—

 
1,511,109

 
(67
)
 
—

 
—

 
—

 
—

 
(67
)
Shares issued—stock-
   based compensation
 
(11,864
)
 
—

 
(117,019
)
 
3

 
5

 
—

 
—

 
—

 
8

Stock-based compensation,
   net of tax on stock
   options exercised
 
—

 
—

 
(112,611
)
 
3

 
4

 
—

 
—

 
—

 
7

Dividends declared
 
—

 
—

 
—

 
—

 
—

 
(97
)
 
—

 
—

 
(97
)
Distributions to
   noncontrolling interests
 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
(17
)
 
(17
)
Noncontrolling interest in
   acquired business
 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
68

 
68

Balances at December 31, 2016
 
134,651,380

 
1

 
5,726,377

 
(319
)
 
551

 
3,412

 
(121
)
 
368

 
3,892

Net income
 
—

 
—

 
—

 
—

 
—

 
1,304

 
—

 
35

 
1,339

Other comprehensive
   income
 
—

 
—

 
—

 
—

 
—

 
—

 
128

 
5

 
133

Shares issued—stock-
   based compensation
 
—

 
—

 
(493,502
)
 
17

 
(6
)
 
—

 
—

 
—

 
11

Stock-based compensation,
   net of tax on stock
   options exercised
 
—

 
—

 
—

 
—

 
14

 
—

 
—

 
—

 
14

Dividends declared
 
—

 
—

 
—

 
—

 
—

 
(103
)
 
—

 
—

 
(103
)
Distributions to
   noncontrolling interests
 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
(28
)
 
(28
)
Issuance of Westlake
   Chemical Partners LP
   common units
 
—

 
—

 
—

 
—

 
(4
)
 
—

 
—

 
115

 
111

Balances at December 31, 2017
 
134,651,380

 
$
1

 
5,232,875

 
$
(302
)
 
$
555

 
$
4,613

 
$
7

 
$
495

 
$
5,369



The accompanying notes are an integral part of these consolidated financial statements.

53
WESTLAKE CHEMICAL CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS

 
 
Year Ended December 31,
 
 
2017
 
2016
 
2015
 
 
 
 
 
 
 
 
 
(in millions of dollars)
Cash flows from operating activities
 
 
 
 
 
 
Net income
 
$
1,339

 
$
420

 
$
665

Adjustments to reconcile net income to net cash provided by operating
   activities
 
 
 
 
 
 
Depreciation and amortization
 
601

 
378

 
246

Stock-based compensation expense
 
23

 
14

 
10

Gains realized on previously held shares of Axiall common stock and
   from sales of securities
 
—

 
(54
)
 
(4
)
Gain on acquisition, net of loss on the fair value remeasurement
   of preexisting equity interest
 
—

 
—

 
(21
)
Loss from disposition of property, plant and equipment
 
22

 
9

 
11

Deferred income taxes
 
(534
)
 
101

 
40

Other losses (gains), net
 
(3
)
 
5

 
6

Changes in operating assets and liabilities, net of effect of business
     acquisitions
 
 
 
 
 
 
Accounts receivable
 
(40
)
 
50

 
63

Inventories
 
(32
)
 
(62
)
 
99

Prepaid expenses and other current assets
 
26

 
11

 
(4
)
Accounts payable
 
86

 
12

 
(22
)
Accrued liabilities
 
115

 
48

 
(8
)
Other, net
 
(65
)
 
(98
)
 
(2
)
Net cash provided by operating activities
 
1,538

 
834

 
1,079

Cash flows from investing activities
 
 
 
 
 
 
Acquisition of business, net of cash acquired
 
(13
)
 
(2,438
)
 
16

Additions to property, plant and equipment
 
(577
)
 
(629
)
 
(491
)
Additions to cost method investment
 
(66
)
 
(17
)
 
—

Proceeds from disposition of equity method investment
 
—

 
—

 
28

Proceeds from sales and maturities of securities
 
—

 
663

 
49

Purchase of securities
 
—

 
(138
)
 
(605
)
Other
 
4

 
(4
)
 
(3
)
Net cash used for investing activities
 
(652
)
 
(2,563
)
 
(1,006
)
Cash flows from financing activities
 
 
 
 
 
 
Debt issuance costs
 
(6
)
 
(36
)
 
—

Dividends paid
 
(103
)
 
(97
)
 
(92
)
Distributions to noncontrolling interests
 
(28
)
 
(17
)
 
(15
)
Proceeds from debt issuance and drawdown of revolver
 
233

 
608

 
53

Net proceeds from issuance of Westlake Chemical Partners LP
   common units
 
111

 
—

 
—

Proceeds from senior notes issuance
 
745

 
1,429

 
—

Repayment of term loan
 
(150
)
 
—

 
—

Restricted cash associated with term loan
 
154

 
(154
)
 
—

Repayment of revolver
 
(550
)
 
(125
)
 
—

Repayment of notes payable
 
(257
)
 
(13
)
 
(74
)
Repurchase of common stock for treasury
 
—

 
(67
)
 
(163
)
Other
 
11

 
5

 
4

Net cash provided by (used for) financing activities
 
160

 
1,533

 
(287
)
Effect of exchange rate changes on cash and cash equivalents
 
26

 
(8
)
 
(4
)
Net increase (decrease) in cash and cash equivalents
 
1,072

 
(204
)
 
(218
)
Cash and cash equivalents at beginning of the year
 
459

 
663

 
881

Cash and cash equivalents at end of the year
 
$
1,531

 
$
459

 
$
663



The accompanying notes are an integral part of these consolidated financial statements.

54
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in millions of dollars, except share amounts and per share data)



1. Description of Business and Significant Accounting Policies
Description of Business
Westlake Chemical Corporation (the "Company") operates as an integrated global manufacturer and marketer of basic chemicals, vinyls, polymers and building products. These products include some of the most widely used chemicals in the world, which are fundamental to many diverse consumer and industrial markets, including flexible and rigid packaging, automotive products, coatings, residential and commercial construction as well as other durable and non-durable goods. The Company's customers range from large chemical processors and plastics fabricators to small construction contractors, municipalities and supply warehouses primarily throughout North America and Europe. The petrochemical industry is subject to price fluctuations and volatile feedstock pricing typical of a commodity-based industry, the effects of which may not be immediately passed along to customers.
Acquisition of Axiall Corporation
On August 31, 2016, the Company completed the acquisition of Axiall Corporation ("Axiall") for $33.00 per share in an all-cash transaction (the "Merger"), pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of June 10, 2016, by and among Westlake, Axiall and Lagoon Merger Sub, Inc., a wholly-owned subsidiary of Westlake (the "Merger Sub"). During the third quarter of 2016, in order to finance a portion of the consideration and related fees and expenses, and for other general corporate purposes, the Company issued $1,450 aggregate principal amount of senior notes. In addition, the Company entered into a $1,000 unsecured revolving credit facility (the "Credit Agreement").
Westlake Chemical Partners LP
In 2014, the Company formed Westlake Chemical Partners LP ("Westlake Partners") to operate, acquire and develop ethylene production facilities and related assets. Westlake Partners' assets consist of a limited partner interest in Westlake Chemical OpCo LP ("OpCo"), as well as the general partner interest in OpCo. OpCo's assets include two ethylene production facilities at the Company's Lake Charles, Louisiana site, one ethylene production facility at the Company's Calvert City, Kentucky site and a 200 -mile common carrier ethylene pipeline that runs from Mont Belvieu, Texas to the Company's Longview, Texas site. As of December 31, 2017 , the Company held an 81.7% limited partner interest in OpCo and a controlling interest in Westlake Partners. The operations of Westlake Partners are consolidated in the Company's financial statements.
Principles of Consolidation
The consolidated financial statements include the accounts of the Company and subsidiaries in which the Company directly or indirectly owns more than a 50% voting interest and exercises control and, when applicable, entities for which the Company has a controlling financial interest or is the primary beneficiary. Investments in majority-owned companies where the Company does not exercise control and investments in nonconsolidated affiliates (20%-50% owned companies, joint ventures and partnerships) are accounted for using the equity method of accounting. Undistributed earnings from joint ventures included in retained earnings were immaterial as of December 31, 2017 . All intercompany transactions and balances are eliminated in consolidation.
Noncontrolling interests represent the direct equity interests held by investors in the Company's consolidated subsidiaries, Westlake Partners and Taiwan Chlorine Industries, Ltd.
Cash and Cash Equivalents
Cash equivalents consist of highly liquid investments that are readily convertible into cash and have a maturity of three months or less at the date of acquisition.
Concentration of Credit Risk
Financial instruments which potentially subject the Company to concentration of risk consist principally of trade receivables from customers engaged in manufacturing polyethylene products, polyvinyl chloride ("PVC") products and PVC pipe products. The Company performs periodic credit evaluations of the customers' financial condition and generally does not require collateral. The Company maintains allowances for potential losses.

55
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

Allowance for Doubtful Accounts
The determination of the allowance for doubtful accounts is based on estimation of the amount of accounts receivable that the Company believes are unlikely to be collected. Estimating this amount requires analysis of the financial strength of the Company's customers, the use of historical experience, the Company's accounts receivable aged trial balance, and specific collectibility analysis. The allowance for doubtful accounts is reviewed quarterly. Past due balances over 90 days and high risk accounts as determined by the analysis of financial strength of customers are reviewed individually for collectibility.
Inventories
Inventories primarily include product, material and supplies. Inventories are stated at lower of cost or net realizable value. Cost is determined using the first-in, first-out ("FIFO") or average method.
Property, Plant and Equipment
Property, plant and equipment are carried at cost, net of accumulated depreciation. Cost includes expenditures for improvements and betterments that extend the useful lives of the assets and interest capitalized on significant capital projects. Capitalized interest was $4 , $10 and $10 for the years ended December 31, 2017 , 2016 and 2015 , respectively. Repair and maintenance costs are charged to operations as incurred. Gains and losses on the disposition or retirement of fixed assets are reflected in the consolidated statement of operations when the assets are sold or retired.
The accounting guidance for asset retirement obligations requires the recording of liabilities equal to the fair value of asset retirement obligations and corresponding additional asset costs, when there is a legal asset retirement obligation as a result of existing or enacted law, statute or contract.
Depreciation is provided by utilizing the straight-line method over the estimated useful lives of the assets as follows:
Classification
 
Years
Buildings and improvements
40
Plant and equipment
25
Ethylene pipeline
35
Other
3-15
Impairment of Long-Lived Assets
The accounting guidance for the impairment or disposal of long-lived assets requires that the Company review long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Long-lived assets assessed for impairment are grouped at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net undiscounted cash flows expected to be generated by the asset. Assets are considered to be impaired if the carrying amount of an asset exceeds the future undiscounted cash flows. The impairment recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or estimated fair value less costs to sell.
Impairment of Goodwill and Intangible Assets
The accounting guidance requires that goodwill is tested for impairment at least annually, or when events or changes in circumstances indicate the fair value of a reporting unit with goodwill has been reduced below its carrying value. The Company performed its annual impairment tests for the Olefins and Vinyls segments' goodwill in October 2017 and April 2017 , respectively, and the impairment tests indicated that the recorded goodwill was not impaired. There has been no impairment of the Olefins or Vinyls segments' goodwill since the goodwill was initially recorded. Other intangible assets with finite lives are amortized over their estimated useful lives and reviewed for impairment in accordance with the provisions of the accounting guidance. See Note 7 for more information on the Company's annual goodwill impairment tests.

56
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

Turnaround Costs
The Company accounts for turnaround costs under the deferral method. Turnarounds are the scheduled and required shutdowns of specific operating units in order to perform planned major maintenance activities. The costs related to the significant overhaul and refurbishment activities include maintenance materials, parts and direct labor costs. The costs of the turnaround are deferred when incurred at the time of the turnaround and amortized (within depreciation and amortization) on a straight-line basis until the next planned turnaround, which ranges from three to six years. Deferred turnaround costs are presented as a component of other assets, net. The cash outflows related to these costs are included in operating activities in the consolidated statement of cash flows.
Business Combinations
The Company records business combinations using the acquisition method of accounting. Under the acquisition method of accounting, identifiable assets acquired and liabilities assumed are recorded at their acquisition date fair values. The excess of the purchase price over the estimated fair value is recorded as goodwill. Changes in the estimated fair values of net assets recorded for acquisitions prior to the finalization of more detailed analysis, but not to exceed one year from the date of acquisition, will adjust the amount of the purchase price allocable to goodwill. Measurement period adjustments are reflected in the period in which they occur.
Income Taxes
The Company utilizes the liability method of accounting for deferred income taxes. Under the liability method, deferred tax assets or liabilities are recorded based upon temporary differences between the tax basis of assets and liabilities and their carrying values for financial reporting purposes. Deferred tax expense or benefit is the result of changes in the deferred tax assets and liabilities during the period. Valuation allowances are recorded against deferred tax assets when it is considered more likely than not that the deferred tax assets will not be realized.
On December 22, 2017, the United States ("U.S.") Tax Cuts and Jobs Act (the "Tax Act") was signed into law. The Tax Act, among other changes, reduces the U.S. corporate income tax rate from 35% to 21%, effective January 1, 2018, and also requires a one-time deemed repatriation of foreign earnings at specified rates. The Company made a provisional adjustment of $591 of income tax benefit in the 2017 consolidated financial statements for items that the Company could reasonably estimate such as revaluation of deferred tax assets and liabilities and a one-time U.S. tax on the mandatory deemed repatriation of the Company's post-1986 foreign earnings. For additional information, see Note 15.
Foreign Currency Translation
Assets and liabilities of foreign subsidiaries are translated to U.S. dollars at the exchange rate as of the end of the year. Statement of operations items are translated at the average exchange rate for the year. The resulting translation adjustment is recorded as a separate component of stockholders' equity.
Revenue Recognition
Revenue is recognized when persuasive evidence of an arrangement exists, products are delivered to the customer, the sales price is fixed or determinable and collectability is reasonably assured. For domestic contracts, title and risk of loss passes to the customer upon delivery under executed customer purchase orders or contracts. For export contracts, the title and risk of loss passes to customers at the time specified by each contract. Provisions for discounts, rebates and returns are provided for in the same period as the related sales are recorded.
Transportation and Freight
Amounts billed to customers for freight and handling costs on outbound shipments are included in net sales in the consolidated statements of operations. Transportation and freight costs incurred by the Company on outbound shipments are included in cost of sales in the consolidated statements of operations.

57
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

Price Risk Management
The accounting guidance for derivative instruments and hedging activities requires that the Company recognize all derivative instruments on the balance sheet at fair value, and changes in the derivative's fair value must be currently recognized in earnings or comprehensive income, depending on the designation of the derivative. If the derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings. If the derivative is designated as a cash flow hedge, the effective portion of the change in the fair value of the derivative is recorded in comprehensive income and is recognized in the statement of operations when the hedged item affects earnings. Ineffective portions of changes in the fair value of cash flow hedges are recognized in earnings currently.
Asset Retirement Obligations
The Company has conditional asset retirement obligations for the removal and disposal of hazardous materials from certain of the Company's manufacturing facilities.
The Company recognizes asset retirement obligations in the period in which the liability becomes probable and reasonably estimable. Recognized asset retirement obligations are initially recorded at fair value and capitalized as a component of the carrying value of the long-lived asset to which the obligation relates. The liability is accreted to its future value each period, and the capitalized cost is depreciated over the estimated useful life of the related asset. Upon settlement of the liability, a gain or loss is recorded. As of December 31, 2017 , the Company had $3 and $18 of asset retirement obligations recorded as accrued liabilities and other liabilities, respectively. As of December 31, 2016 , the Company had $4 and $17 of asset retirement obligations recorded as accrued liabilities and other liabilities, respectively.
The Company also has conditional asset retirement obligations that have not been recognized because the fair values of the conditional legal obligations cannot be measured due to the indeterminate settlement date of the obligations. Settlements of the unrecognized conditional asset retirement obligations are not expected to have a material adverse effects on the Company's financial condition, results of operations or cash flows in any individual reporting period.
Environmental Costs
Environmental costs relating to current operations are expensed or capitalized, as appropriate, depending on whether such costs provide future economic benefits. Remediation liabilities are recognized when the costs are considered probable and can be reasonably estimated. Measurement of liabilities is based on currently enacted laws and regulations, existing technology and undiscounted site-specific costs. Environmental liabilities in connection with properties that are sold or closed are realized upon such sale or closure, to the extent they are probable and estimable and not previously reserved. Recognition of any joint and several liabilities is based upon the Company's best estimate of its final pro rata share of the liability.
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and the disclosure of contingent assets and liabilities. Actual results could differ from those estimates.

58
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

Recent Accounting Pronouncements
Revenue from Contracts with Customers (ASU No. 2014-09)
In May 2014, the Financial Accounting Standards Board ("FASB") issued an accounting standards update on a comprehensive new revenue recognition standard that will supersede the existing revenue recognition guidance. The new accounting guidance creates a framework by which an entity will allocate the transaction price to separate performance obligations and recognize revenue when each performance obligation is satisfied. Under the new standard, entities will be required to use judgment and make estimates, including identifying performance obligations in a contract, estimating the amount of variable consideration to include in the transaction price, allocating the transaction price to each separate performance obligation and determining when an entity satisfies its performance obligations. The standard allows for either "full retrospective" adoption, meaning that the standard is applied to all of the periods presented with a cumulative catch-up as of the earliest period presented, or "modified retrospective" adoption, meaning the standard is applied only to the most current period presented in the financial statements with a cumulative catch-up as of the current period. In July and December 2016, the FASB issued various additional authoritative guidance for the new revenue recognition standard. The accounting standard will be effective for reporting periods beginning after December 15, 2017 and is not expected to have a material impact on the Company's consolidated financial position, results of operations and cash flows. The Company has elected the modified retrospective method of adoption.
Recognition and Measurement of Financial Assets and Financial Liabilities (ASU No. 2016-01)
In January 2016, the FASB issued an accounting standards update making certain changes principally to the current guidance for equity investments, financial liabilities under the fair value option and the presentation and disclosure requirements for financial instruments. Among other things, the guidance (1) requires equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) to be measured at fair value, with changes in fair value recognized in net income; (2) provide entities with a policy election to record equity investments without readily determinable fair values at cost, less impairment, and subsequent adjustments for observable price changes (changes in the basis of these equity investments to be reported in net income); (3) requires an entity that has elected the fair value option for financial liabilities to recognize changes in fair value due to instrument-specific credit risk separately in other comprehensive income; (4) clarified current guidance related to the valuation allowance assessment when recognizing deferred tax assets resulting from unrealized losses on available-for-sale debt securities; and (5) requires specific disclosure pertaining to financial assets and financial liabilities in the financial statements. The accounting standard will be effective for reporting periods beginning after December 15, 2017 and is not expected to have a material impact on the Company's consolidated financial position, results of operations and cash flows.
Leases (ASU No. 2016-02)
In February 2016, the FASB issued an accounting standards update on a new lease standard that will supersede the existing lease guidance. The standard requires a lessee to recognize assets and liabilities related to long-term leases that are classified as operating leases under current guidance on its balance sheet. An asset would be recognized related to the right to use the underlying asset and a liability would be recognized related to the obligation to make lease payments over the term of the lease. The standard also requires expanded disclosures related to leases. The accounting standard will be effective for reporting periods beginning after December 15, 2018. The Company is in the process of evaluating the impact that the new accounting guidance will have on its consolidated financial position, results of operations and cash flows.
Credit Losses (ASU No. 2016-13)
In June 2016, the FASB issued an accounting standards update providing new guidance for the accounting for credit losses on loans and other financial instruments. The new guidance introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments. The standard also modifies the impairment model for available-for-sale debt securities and provides for a simplified accounting model for purchased financial assets with credit deterioration since their origination. The accounting standard will be effective for reporting periods beginning after December 15, 2019 and is not expected to have a material impact on the Company's consolidated financial position, results of operations and cash flows.

59
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

Cash Flows (ASU No. 2016-15)
In August 2016, the FASB issued an accounting standards update providing new guidance on the classification of certain cash receipts and payments including debt extinguishment costs, debt prepayment costs, settlement of zero-coupon debt instruments, contingent consideration payments, proceeds from the settlement of insurance claims and life insurance policies and distributions received from equity method investees in the statement of cash flows. This update is required to be applied using the retrospective transition method to each period presented unless it is impracticable to be applied retrospectively. In such situation, this guidance is to be applied prospectively. The accounting standard will be effective for reporting periods beginning after December 15, 2017 and is not expected to have a material impact on the Company's consolidated financial position, results of operations and cash flows.
Cash Flows (ASU No. 2016-18)
In November 2016, the FASB issued an accounting standards update to clarify certain existing principles in Accounting Standards Codification ("ASC") 230, Cash flows, including providing additional guidance related to transfers between cash and restricted cash and how entities present, in their statement of cash flows, the cash receipts and cash payments that directly affect the restricted cash accounts. The accounting standard will be effective for reporting periods beginning after December 15, 2017. Upon adoption, the Company will retrospectively adjust its financial statements to reflect restricted cash in the beginning and ending cash and restricted cash balances within the statements of cash flows. Transfers between cash and restricted cash will be excluded from net changes in cash and cash equivalents within the statements of cash flows.
Business Combinations (ASU No. 2017-01)
In January 2017, the FASB issued an accounting standards update to assist entities with evaluating when a set of transferred assets and activities is a business. The guidance requires an entity to evaluate if substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets; if so, the set of transferred assets and activities is not a business. The guidance also requires a business to include at least one substantive process and narrows the definition of outputs by more closely aligning it with how outputs are described in ASC 606. The accounting standard will be effective for reporting periods beginning after December 15, 2017 and is not expected to have a material impact on the Company's consolidated financial position, results of operations and cash flows.
Intangibles-Goodwill and Other (ASU No. 2017-04)
In January 2017, the FASB issued an accounting standards update to simplify the subsequent measurement of goodwill. The guidance removes Step 2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. A goodwill impairment will now be the amount by which a reporting unit's carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. The accounting standard will be effective for reporting periods beginning after December 15, 2019 and is not expected to have a material impact on the Company's consolidated financial position, results of operations and cash flows.
Other Income - Gains and Losses from the Derecognition of Nonfinancial Assets (ASU No. 2017-05)
In February 2017, the FASB issued an accounting standards update to clarify the scope of guidance related to other income—gains and losses from the derecognition of nonfinancial assets, and to add guidance for partial sales of nonfinancial assets. The new guidance clarifies that an in substance nonfinancial asset is an asset or group of assets for which substantially all of the fair value consists of nonfinancial assets and the group or subsidiary is not a business. The guidance also outlines that when an entity transfers its controlling interest in a nonfinancial asset, but retains a noncontrolling interest, it will measure the retained interest at fair value resulting in full gain or loss recognition upon sale of the controlling interest. The accounting standard will be effective for reporting periods beginning after December 15, 2017 and is not expected to have a material impact on the Company's consolidated financial position, results of operations and cash flows.

60
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

Compensation - Retirement Benefits (ASU No. 2017-07)
In March 2017, the FASB issued an accounting standards update to improve the presentation of net periodic pension cost and net periodic postretirement benefit cost. The new guidance requires employers to disaggregate the service cost component from the other components of net periodic benefit cost and report the service cost component in the same line item or items as other compensation costs arising from services rendered by the pertinent employees during the period. The amendments also allow only the service cost component to be eligible for capitalization when applicable. The accounting standard will be effective for reporting periods beginning after December 15, 2017 and is not expected to have a material impact on the Company's consolidated financial position, results of operations and cash flows.
Compensation - Stock Compensation (ASU No. 2017-09)
In May 2017, the FASB issued the accounting standards update to provide clarity and reduce both (1) diversity in practice and (2) cost and complexity when applying the guidance in Topic 718, Compensation-Stock Compensation, to a change to the terms or conditions of a share-based payment award. The amendments in this update provide guidance about which changes to the terms or conditions of a share-based payment award require the application of modification accounting in Topic 718. Essentially, an entity will not have to account for the effects of a modification if: (1) the fair value of the modified award is the same immediately before and after the modification; (2) the vesting conditions of the modified award are the same immediately before and after the modification; and (3) the classification of the modified award as either an equity instrument or liability instrument is the same immediately before and after the modification. This update is to be applied prospectively to an award modified on or after the adoption date. Early adoption is permitted. The accounting standard will be effective for reporting periods beginning after December 15, 2017 and is not expected to have a material impact on the Company's consolidated financial position, results of operations and cash flows.
Derivatives and Hedging - Targeted Improvements to Accounting for Hedging Activities (ASU No. 2017-12)
I n August 2017, the FASB issued an accounting standards update to improve financial reporting of hedging relationships, to better portray the economic results of an entity's risk management activities in the financial statements and to simplify application of hedge accounting guidance. The accounting standard eliminates certain hedge effectiveness measurement and reporting requirements and expands the types of permissible hedging strategies. The accounting standard will be effective for reporting periods beginning after December 15, 2018, and interim periods within those fiscal years. Early application is permitted in any interim period after issuance, to be applied retrospectively to the beginning of the fiscal year. The Company is in the process of evaluating the impact that the new accounting guidance will have on its consolidated financial position, results of operations and cash flows.
Recently Adopted Accounting Standards
Investments-Equity Method and Joint Ventures (ASU No. 2016-07)
In March 2016, the FASB issued an accounting standards update providing new guidance for the accounting for equity method investments. The new guidance eliminates the requirement that when an investment qualifies for use of the equity method as a result of an increase in the level of ownership interest or degree of influence, an investor must adjust the investment, results of operations and retained earnings retroactively on a step-by-step basis as if the equity method had been in effect during all previous periods that the investment had been held. In addition, the guidance requires that the equity method investor add the cost of acquiring the additional interest in the investee to the current basis of the investor's previously held interest and adopt the equity method of accounting as of the date the investment becomes qualified for equity method accounting. Therefore, upon qualifying for the equity method of accounting, no retroactive adjustment of the investment is required. The accounting standard is effective for reporting periods beginning after December 15, 2016. The Company adopted this accounting standard effective January 1, 2017 and the adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows.

61
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

Stock Compensation (ASU No. 2016-09)
In March 2016, the FASB issued an accounting standards update to simplify several aspects of the accounting for share-based payment transactions, including income tax consequences, classifications of awards as either equity or liabilities and certain related classifications on the statement of cash flows. In addition, the new guidance permits entities to make an accounting policy election for the impact of forfeitures on the recognition of expense for share-based payment awards. Forfeitures can be estimated, as required today, or recognized when they occur. The accounting standard is effective for reporting periods beginning after December 15, 2016. The Company adopted this accounting standard effective January 1, 2017 and elected to continue estimating forfeitures as required prior to adoption of the accounting standards update. The adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows.
Amendments to the Consolidation Analysis (ASU No. 2016-17)
In October 2016, the FASB issued an accounting standards update making certain changes to the current consolidation guidance. The amendments affect reporting entities that are required to evaluate whether they should consolidate a variable interest entity in certain situations involving entities under common control. Specifically, the amendments change the evaluation of whether a reporting entity is the primary beneficiary of a variable interest entity by changing how a reporting entity that is a single decision maker of a variable interest entity treats indirect interests in the entity held through related parties that are under common control with the reporting entity. The amendments will be effective for annual periods beginning after December 15, 2016. The Company adopted this accounting standard, applied prospectively, effective January 1, 2017, and the adoption did not have a material impact on the Company's consolidated financial position, results of operations and cash flows.
2. Acquisitions
Axiall Corporation
On August 31, 2016, the Company completed its acquisition of, and acquired all the remaining equity interest in, Axiall, a Delaware corporation. Prior to the acquisition, the Company held 3.1 million shares in Axiall. Pursuant to the terms of the Merger Agreement, dated as of June 10, 2016, by and among Westlake, Axiall and the Merger Sub, the Company acquired all of the remaining issued and outstanding shares of common stock of Axiall for $33.00 per share in cash. Pursuant to the Merger Agreement, Merger Sub was merged with and into Axiall, and Axiall survived the Merger as a wholly-owned subsidiary of the Company. The combined company is the third-largest global chlor-alkali producer and the third-largest global PVC producer. The Company's management believes that this strategic acquisition will enhance its strategy of integration and will further strengthen its role in the North American markets.
Axiall produces a highly integrated chain of chlor-alkali and derivative products, including chlorine, caustic soda, vinyl chloride monomer ("VCM"), PVC resin, PVC compounds and chlorinated derivative products. Axiall also manufactures and sells building products, including siding, trim, mouldings, pipe and pipe fittings.
Total consideration transferred for the Merger was $2,540 . The Merger was accounted for under the acquisition method of accounting. The assets acquired and liabilities assumed and the results of operations of the acquired business are included in the Company's Vinyls segment.
For the  year ended December 31, 2016 , the Company recognized  $104  of transaction and integration-related costs. This included acquisition-related costs of  $49  for advisory, consulting and professional fees and other expenses during the year ended December 31, 2016 . Transaction and integration-related costs also included $55  during the year ended December 31, 2016 related to the settlement of Axiall share-based awards, retention agreement costs and severance benefits provided to former Axiall employees in connection with the Merger.
The following table summarizes the consideration transferred and the estimated fair value of identified assets acquired and liabilities assumed at the date of acquisition. The allocation of the consideration transferred is based on management's estimates, judgments and assumptions. When determining the fair values of assets acquired, liabilities assumed and noncontrolling interests of the acquiree, management made significant estimates, judgments and assumptions. Management estimated that consideration paid exceeded the fair value of the net assets acquired. Therefore, goodwill of $942 was recorded. The goodwill recognized is primarily attributable to synergies related to the Company's vinyls integration strategy that are expected to arise from the Merger. All of the goodwill is assigned to the Company's Vinyls segment. As a portion of the goodwill arising from the Merger is attributable to foreign operations, there will be a continuing foreign currency impact to goodwill in the consolidated financial statements.
 
 
Final Purchase Consideration as of August 31, 2016
Closing stock purchase:
 
 
Offer per share
 
$
33.00

Multiplied by number of shares outstanding at acquisition (in thousands of shares)
 
67,277

Fair value of Axiall shares outstanding purchased by the Company
 
2,220

Plus:
 
 
Axiall debt repaid at acquisition
 
247

Seller's transaction costs paid by the Company (1)
 
48

Total fair value of consideration transferred
 
2,515

 
 
 
Fair value of Axiall share-based awards attributed to pre-combination service (2)
 
12

Additional settlement value of shares acquired
 
13

Purchase consideration
 
2,540

 
 
 
Fair value of previously held equity interest in Axiall (3)
 
102

Total fair value allocated to net assets acquired
 
$
2,642


______________________________
(1)
Transactions costs incurred by the seller included legal and advisory costs incurred for the benefit of Axiall's former shareholders and board of directors to evaluate the Company's initial Merger proposals, explore strategic alternatives and negotiate the purchase price.
(2)
The fair value of share-based awards attributable to pre-combination service includes the ratio of the pre-combination service performed to the original service period of the Axiall restricted share units and options, including related dividend equivalent rights.
(3)
Prior to the Merger, the Company owned 3.1 million shares in Axiall. The investment in Axiall was carried at estimated fair value with unrealized gains recorded as a component of accumulated other comprehensive loss in the consolidated balance sheet. The Company recognized a $49 gain for the investment in other income, net in the consolidated statements of operations upon gaining control.

62
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

The following table summarizes the purchase price allocation:
 
 
Net Assets Acquired as of August 31, 2016
Cash
 
$
88

Accounts receivable (1)
 
422

Income tax receivable
 
51

Inventories (2)
 
349

Prepaid expenses and other current assets
 
56

Property, plant and equipment (2)
 
2,942

Customer relationships (weighted average lives of 9.8 years) (3)
 
670

Other intangible assets:
 

Trade name (weighted average lives of 6.8 years)
 
50

Technology (weighted average lives of 5.4 years)
 
42

Supply contracts and leases (weighted average lives of 6.3 years)
 
27

Other assets
 
94

Total assets acquired
 
$
4,791

Accounts and notes payable
 
254

Interest payable
 
8

Income tax payable
 
2

Accrued compensation
 
44

Accrued liabilities
 
154

Deferred income taxes (4)
 
958

Tax reserve non-current
 
3

Pension and other post-retirement obligations
 
311

Other liabilities
 
102

Long-term debt
 
1,187

Total liabilities assumed
 
$
3,023

Total identifiable net assets acquired
 
$
1,768

Noncontrolling interest
 
(68
)
Goodwill
 
942

Total fair value allocated to net assets acquired
 
$
2,642


______________________________
(1)
The fair value of accounts receivable acquired was $422 , with the gross contractual amount being $435 . The Company expects $13 to be uncollectible.
(2)
The Company obtained additional information related to its inventories and property, plant and equipment, which led to an increase in inventories of $43 , a decrease in property plant and equipment of $193 and a corresponding increase in goodwill of $150 compared to the estimated fair values included in the 2016 Form 10-K.
(3)
The Company obtained additional information related to its customer relationship balances which led to an increase in customer relationships of $80 and a corresponding decrease in goodwill compared to the estimated fair values included in the 2016 Form 10-K.
(4)
Decreases in the estimated fair values of identified assets acquired led to a decrease in deferred income taxes of $27 compared to the estimated fair values included in the 2016 Form 10-K.

63
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

The acquired business contributed net sales and net loss of  $976  and  $96 , respectively, to the Company for the period from August 31, 2016 to December 31, 2016. The net loss for the period from August 31, 2016 to December 31, 2016 included integration-related costs and the negative impact of selling higher cost Axiall inventory recorded at fair value. The following unaudited consolidated pro forma information presents consolidated pro forma information as if the Merger had occurred on January 1, 2015:
 
 
Pro Forma
 
 
Year Ended December 31,
 
 
2016
 
2015
Net sales
 
$
7,081

 
$
7,793

 
 
 
 
 
Net income (1)
 
$
397

 
$
663

Net income (loss) attributable to noncontrolling interest
 
23

 
(2
)
Net income attributable to Westlake Chemical Corporation (1)
 
$
374

 
$
665

Earnings per common share attributable to Westlake Chemical Corporation:
 
 
 
 
Basic
 
$
2.88

 
$
5.02

Diluted
 
$
2.86

 
$
5.00


______________________________
(1)
The 2016 pro forma net income amounts include Axiall's historical charges recorded during the eight-month period prior to the closing of the Merger for (1) divestitures; (2) restructuring; and (3) legal and settlement claims, net, of $27 , $23 and $23 , respectively. These amounts have not been eliminated for pro forma results because they do not relate to nonrecurring transaction-specific costs related to the Merger.
The pro forma amounts above have been calculated after applying the Company's accounting policies and adjusting the Axiall results to reflect (1) the increase to depreciation and amortization that would have been charged assuming the fair value adjustments to property, plant and equipment and intangible assets had been applied from January 1, 2015; (2) the elimination of net sales and cost of sales between the Company and Axiall; (3) additional pension service costs; (4) amortization of debt premium and accretion of asset retirement obligations and environmental liabilities as part of the Company's adjustments to fair value; (5) incremental interest expense that would have been incurred assuming the financing arrangements entered into by the Company and the repayment of a portion of Axiall's outstanding debt had occurred on January 1, 2015; (6) the elimination of transaction-related costs; (7) the elimination of Axiall's goodwill impairment charges during 2015; and (8) an adjustment to tax-effect the aforementioned pro forma adjustments using an estimated aggregate statutory income tax rate of the jurisdictions to which the above adjustments relate. The pro forma amounts do not include any potential synergies, cost savings or other expected benefits of the Merger, are presented for illustrative purposes only and are not necessarily indicative of results that would have been achieved if the Merger had occurred as of January 1, 2015 or of future operating performance.
Suzhou Huasu Plastics Co., Ltd.
On June 1, 2015, the Company acquired an additional 35.7% equity interest in Suzhou Huasu Plastics Co., Ltd. ("Huasu") from INEOS Chlor Vinyls Holdings B.V., increasing its interest in Huasu to 95% . Huasu is a PVC joint venture based near Shanghai, in the People's Republic of China and has a combined annual capacity of approximately 300 million pounds of PVC resin and 145 million pounds of PVC film and sheet.
Prior to the acquisition of this 35.7% interest, the Company owned a 59.3% interest in Huasu. The Company accounted for the investment using the equity method of accounting because Huasu did not meet the definition of a variable interest entity and because contractual arrangements giving certain substantive participatory rights to minority shareholders prevented the Company from exercising a controlling financial interest over Huasu. As a result of the Company obtaining control over Huasu, the Company's 59.3% interest was remeasured to fair value, resulting in a loss of $2 , which is included in other income, net in the consolidated statement of operations for the year ended December 31, 2015 .

64
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

The closing date purchase price of $6 was paid with available cash on hand. The acquisition was accounted for under the acquisition method of accounting. The transaction resulted in a bargain purchase acquisition-date gain of $23 and is recognized in other income, net in the consolidated statement of operations for the year ended December 31, 2015. The Company believes there are several factors that contributed to this transaction resulting in a bargain purchase acquisition-date gain, including the slowdown in the growth of, and current weakness in, the Chinese economy. The assets acquired and liabilities assumed and the results of operations of this acquired business are included in the Vinyls segment.
3. Financial Instruments
Cash Equivalents
The Company had $644 and $0 of held-to-maturity securities with original maturities of three months or less, primarily consisting of corporate debt securities, classified as cash equivalents at December 31, 2017 and 2016 , respectively. The Company's investments in held-to-maturity securities were held at amortized cost, which approximates fair value.
Restricted Cash and Cash Equivalents
The Company had restricted cash and cash equivalents of $23 at December 31, 2017 , which was primarily related to balances that are restricted for payment of distributions to certain of the Company's current and former employees. The Company had restricted cash and cash equivalents of $186 at December 31, 2016 , which was primarily related to the balances deposited with and held as security by the lender under the Company's prior term loan facility and for distributions to certain of the Company's current and former employees. The current portion of restricted cash and cash equivalents was $1 and $161 at December 31, 2017 and 2016 , respectively. The non-current portion of restricted cash and cash equivalents was $22 and $25 at December 31, 2017 and 2016 , respectively, and is reflected under other assets, net in the consolidated balance sheets.
Available-for-Sale Marketable Securities
The Company had no available-for-sale securities at December 31, 2017 and 2016 . The proceeds from sales and maturities of available-for-sale securities included in the consolidated statements of cash flows and the gross realized gains included in the consolidated statements of operations are reflected in the table below. No gross realized losses were realized during these periods. The cost of securities sold was determined using the specific identification method.
 
 
Year Ended December 31,
 
 
2017
 
2016
 
2015
Proceeds from sales and maturities of securities
 
$
—

 
$
663

 
$
49

Gross realized gains
 
—

 
54

 
4

4. Accounts Receivable
Accounts receivable consist of the following at December 31:
 
 
2017
 
2016
Trade customers
 
$
974

 
$
820

Affiliates
 
9

 
8

Allowance for doubtful accounts
 
(22
)
 
(18
)
 
 
961

 
810

Federal and state taxes
 
7

 
90

Other
 
33

 
39

Accounts receivable, net
 
$
1,001

 
$
939


65
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

5. Inventories
Inventories consist of the following at December 31:
 
 
2017
 
2016
Finished products
 
$
549

 
$
501

Feedstock, additives and chemicals
 
221

 
217

Materials and supplies
 
130

 
83

Inventories
 
$
900

 
$
801

6. Property, Plant and Equipment
Property, plant and equipment consist of the following at December 31:
 
 
2017
 
2016
Land
 
$
198

 
$
194

Buildings and improvements
 
495

 
465

Plant and equipment
 
7,281

 
6,914

Other
 
388

 
377

 
 
8,362

 
7,950

Less: Accumulated depreciation
 
(2,338
)
 
(1,919
)
 
 
6,024

 
6,031

Construction in progress
 
388

 
389

Property, plant and equipment, net
 
$
6,412

 
$
6,420

Depreciation expense on property, plant and equipment of $449 , $305 and $209 is included in cost of sales in the consolidated statements of operations for the years ended December 31, 2017 , 2016 and 2015 , respectively.
7. Goodwill, Intangibles and Other Assets
Goodwill
The gross carrying amounts of goodwill for the years ended December 31, 2017 and 2016 are as follows:
 
 
Olefins Segment
 
Vinyls Segment
 
Total
Balance at December 31, 2015
 
$
30

 
$
32

 
$
62

Goodwill acquired during the year
 
—

 
888

 
888

Effects of changes in foreign exchange rates
 
—

 
(3
)
 
(3
)
Balance at December 31, 2016
 
30

 
917

 
947

Measurement period adjustment
 
—

 
55

 
55

Effects of changes in foreign exchange rates
 
—

 
10

 
10

Balance at December 31, 2017
 
$
30

 
$
982

 
$
1,012

Olefins Segment Goodwill
The fair value of the Olefins segment, the reporting unit assessed during October 2017, was calculated using both a discounted cash flow methodology and a market value methodology.
The discounted cash flow projections were based on a nine -year forecast, from 2018 to 2026, to reflect the cyclicality of the Company's Olefins business. The forecast was based on prices and spreads projected by IHS Markit ("IHS"), a chemical industry organization offering market and business advisory services for the chemical market, historical results and estimates by management, including its strategic and operational plans. Other significant assumptions used in the discounted cash flow projection included sales volumes based on production capacities. The future cash flows were discounted to present value using a discount rate of 8% . The significant assumptions used in determining the fair values of the reporting units using the market value methodology included the determination of appropriate market comparables and the estimated multiples of EBITDA a willing buyer was likely to pay.

66
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

Vinyls Segment Goodwill
Due to the Merger, the Company reorganized the reporting units of the Vinyls segment during 2017. Goodwill was reassigned based on a relative fair value approach. The fair values of the North America, Europe, Taiwan and China reporting units assessed during the April 2017 impairment test were calculated using both a discounted cash flow methodology and a market value methodology.
The discounted cash flow projections were based on a nine -year forecast, from 2018 to 2026 to reflect the cyclicality of the housing and construction markets as the Company's Vinyls businesses are significantly influenced by those markets. The forecast was based on prices and spreads projected by IHS, historical results and estimates by management, including its strategic and operational plans. Other significant assumptions used in the discounted cash flow projection included sales volumes based on production capacities. The future cash flows were discounted to present value using a discount rate ranging from 9% to 12% . The significant assumptions used in determining the fair values of the reporting units using the market value methodology include the determination of appropriate market comparables and the estimated multiples of EBITDA a willing buyer is likely to pay.
Intangible Assets
Intangible assets consisted of the following at December 31:
 
 
2017
 
2016
 
Weighted
Average
Life
 
 
Cost
 
Accumulated
Amortization
 
Net
 
Cost
 
Accumulated
Amortization
 
Net
 
Customer relationships
 
$
754

 
$
(138
)
 
$
616

 
$
662

 
$
(51
)
 
$
611

 
10
Other intangible assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Licenses and
   intellectual property
 
124

 
(55
)
 
69

 
121

 
(44
)
 
77

 
13
Trademarks
 
93

 
(17
)
 
76

 
88

 
(7
)
 
81

 
13
Other
 
31

 
(15
)
 
16

 
31

 
(13
)
 
18

 
12
   Total other intangible
      assets
 
$
248

 
$
(87
)
 
$
161

 
$
240

 
$
(64
)
 
$
176

 
 
Scheduled amortization of intangible assets for the next five years is as follows: $107 , $106 , $105 , $103 and $81 in 2018 , 2019 , 2020 , 2021 and 2022 , respectively.
Other Assets, net
Other assets, net include net turnaround costs, cost-method investments, equity-method investments, restricted cash and deferred charges.
8. Term Loan
On August 10, 2016, an indirect subsidiary of the Company, Westlake International Holdings II C.V., a limited partnership organized under the laws of the Netherlands (the "CV Borrower"), entered into a credit agreement with Bank of America, N.A., as agent and lender, providing the CV Borrower with a $150 term loan facility. The term loan facility had a scheduled maturity date of March 31, 2017. The term loan was fully repaid in January 2017. The loans thereunder bore interest at a floating interest rate equal to LIBOR plus 2% per annum, payable in arrears on the last day of each three-month period following the date of funding and at maturity.

67
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

9. Long-Term Debt
Long-term debt consisted of the following at December 31:
 
 
December 31, 2017
 
December 31, 2016
 
 
Principal Amount
 
Unamortized Premium, Discount and Debt Issuance Costs
 
Net Long-Term Debt
 
Principal Amount
 
Unamortized Premium, Discount and Debt Issuance Costs
 
Net Long-Term Debt
Revolving credit facility
 
$
—

 
$
—

 
$
—

 
$
325

 
$
—

 
$
325

4.625% senior notes due 2021 (the
   "4.625% Westlake 2021 Senior Notes")
 
625

 
20

 
645

 
625

 
27

 
652

4.625% senior notes due 2021
   (the "4.625% Subsidiary 2021 Senior
   Notes")
 
63

 
2

 
65

 
63

 
3

 
66

3.60% senior notes due 2022 (the "3.60%
   2022 Senior Notes")
 
250

 
(1
)
 
249

 
250

 
(2
)
 
248

4.875% senior notes due 2023 (the
   "4.875% Westlake 2023 Senior Notes")
 
434

 
11

 
445

 
434

 
13

 
447

4.875% senior notes due 2023
   (the "4.875% Subsidiary 2023 Senior
   Notes")
 
16

 
—

 
16

 
16

 
1

 
17

3.60% senior notes due 2026
   (the "3.60% 2026 Senior Notes")
 
750

 
(10
)
 
740

 
750

 
(11
)
 
739

Loan related to tax-exempt waste disposal
   revenue bonds due 2027
 
11

 
—

 
11

 
11

 
—

 
11

6 ½% senior notes due 2029 (the "6 ½%
   2029 GO Zone Senior Notes")
 
100

 
(1
)
 
99

 
100

 
(1
)
 
99

6 ¾% senior notes due 2032 (the "6 ¾%
   2032 GO Zone Senior Notes")
 
—

 
—

 
—

 
250

 
(2
)
 
248

6 ½% senior notes due 2035 (the "6 ½%
2035 GO Zone Senior Notes")
 
89

 
(1
)
 
88

 
89

 
(1
)
 
88

6 ½% senior notes due 2035 (the "6 ½%
2035 IKE Zone Senior Notes")
 
65

 
—

 
65

 
65

 
—

 
65

5.0% senior notes due 2046 (the "5.0%
   2046 Senior Notes")
 
700

 
(25
)
 
675

 
700

 
(26
)
 
674

4.375% senior notes due 2047 (the
   "4.375% 2047 Senior Notes")
 
500

 
(9
)
 
491

 
—

 
—

 
—

3.50% senior notes due 2032 (the "3.50%
   2032 Go Zone Refunding Senior
   Notes")
 
250

 
(2
)
 
248

 
—

 
—

 
—

Total long-term debt
 
3,853

 
(16
)
 
3,837

 
3,678

 
1

 
3,679

Less: Current portion - 4.625%
   Westlake 2021 Senior Notes and 4.625%
   Subsidiary 2021 Senior Notes
 
688

 
22

 
710

 
—

 
—

 
—

Long-Term Debt, net of current portion
 
$
3,165

 
$
(38
)
 
$
3,127

 
$
3,678

 
$
1

 
$
3,679

Credit Agreement
The Company has a $1,000 revolving credit facility that matures on August 23, 2021. The Credit Agreement bears interest at either (a) LIBOR plus a spread ranging from 1.00% to 1.75% or (b) Alternate Base Rate plus a spread ranging from 0.00% to 0.75% , in each case depending on the credit rating of the Company. As of December 31, 2017 , the Company had no borrowings outstanding under the Credit Agreement. As of December 31, 2017 , the Company had outstanding letters of credit totaling $6 and borrowing availability of $994 under the Credit Agreement. The obligations of the Company under the Credit

68
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

Agreement are guaranteed by current and future material domestic subsidiaries of the Company, subject to certain exceptions. The Credit Agreement contains certain affirmative and negative covenants, including a quarterly total leverage ratio financial maintenance covenant. The Credit Agreement also contains certain events of default and if and for so long as an event of default has occurred and is continuing, any amounts outstanding under the Credit Agreement will accrue interest at an increased rate, the Lenders can terminate their commitments thereunder and payments of any outstanding amounts could be accelerated by the Lenders. As of December 31, 2017 , the Company is in compliance with the total leverage ratio financial maintenance covenant.
3.60% Senior Notes due 2026 and 5.0% Senior Notes due 2046
In August 2016, the Company issued $750 aggregate principal amount of the 3.60% 2026 Senior Notes and $700 aggregate principal amount of the 5.0% 2046 Senior Notes . In March 2017 the Company commenced registered exchange offers to exchange the 3.60% 2026 Senior Notes and the 5.0% 2046 Senior Notes for new notes that are identical in all material respects to the 3.60% 2026 Senior Notes and the 5.0% 2046 Senior Notes , except that the offer and issuance of the new Securities and Exchange Commission ("SEC")-registered notes have been registered under the Securities Act of 1933, as amended (the "Securities Act"). The exchange offers expired on April 24, 2017, and approximately 99.97% of the 3.60% 2026 Senior Notes and 100% of the 5.0% 2046 Senior Notes were exchanged. The 3.60% 2026 Senior Notes that were not exchanged in the 3.60% 2026 Senior Notes exchange offer have not been registered under the Securities Act or any state securities laws and may not be offered or sold in the U.S. absent registration or an applicable exemption from registration requirements or a transaction not subject to the registration requirements of the Securities Act or any state securities law.
4.625% Senior Notes due 2021 and 4.875% Senior Notes due 2023
In September 2016, the Company issued $625 aggregate principal amount of the 4.625% Westlake 2021 Senior Notes and $434 aggregate principal amount of the 4.875% Westlake 2023 Senior Notes upon the closing of the Company's offers to exchange any and all of the $688 aggregate principal amount of the outstanding 4.625% senior notes due 2021 issued by Eagle Spinco Inc., a wholly-owned subsidiary of Axiall ("Eagle Spinco"), and the $450 aggregate principal amount of the outstanding 4.875% senior notes due 2023 issued by Axiall. In the exchange offers, $625 aggregate principal amount of the 4.625% Westlake 2021 Senior Notes and $434 aggregate principal amount of the 4.875% Westlake 2023 Senior Notes were issued by the Company, leaving outstanding $63 aggregate principal amount of the 4.625% Subsidiary 2021 Senior Notes and $16 aggregate principal amount of the 4.875% Subsidiary 2023 Senior Notes . In March 2017, the Company commenced registered exchange offers to exchange the 4.625% Westlake 2021 Senior Notes and the 4.875% Westlake 2023 Senior Notes for new SEC-registered notes that are identical in all material respects to the 4.625% Westlake 2021 Senior Notes and the 4.875% Westlake 2023 Senior Notes , except that the offer and issuance of the new notes have been registered under the Securities Act. The exchange offers expired on April 24, 2017, and 100% of both the 4.625% Westlake 2021 Senior Notes and the 4.875% Westlake 2023 Senior Notes were exchanged.
In December 2017, the Company delivered irrevocable notices for the optional redemption of all of the outstanding 4.625% Westlake 2021 Senior Notes and 4.625% Subsidiary 2021 Senior Notes (collectively, the " 2021 Notes"). The 2021 Notes were redeemed on February 15, 2018 at a redemption price equal to 102.313% of the principal amount of the 2021 Notes plus accrued and unpaid interest on the 2021 Notes to the redemption date. The 2021 Notes were classified as a component of current liabilities in the consolidated balance sheet at December 31, 2017 , based on the terms of the redemption.
3.60% Senior Notes due 2022
In July 2012, the Company issued $250 aggregate principal amount of the 3.60% 2022 Senior Notes . The 3.60% 2022 Senior Notes are unsecured and were issued with an original issue discount of $1 . There is no sinking fund and no scheduled amortization of the 3.60% 2022 Senior Notes prior to maturity. The Company may optionally redeem the 3.60% 2022 Senior Notes in accordance with the terms of the 3.60% 2022 Senior Notes . All of the Company's domestic subsidiaries that guarantee other indebtedness of the Company or of another guarantor of the 3.60% 2022 Senior Notes in excess of $5 are guarantors of the 3.60% 2022 Senior Notes .

69
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

4 .375% Senior Notes due 2047
In November 2017, the Company completed the registered public offering of $500 aggregate principal amount of the 4.375% 2047 Senior Notes . The 4.375% 2047 Senior Notes are unsecured and mature on November 15, 2047. There is no sinking fund and no scheduled amortization of the 4.375% 2047 Senior Notes prior to maturity. The Company may optionally redeem the 4.375% 2047 Senior Notes in accordance with the terms of the 4.375% 2047 Senior Notes . All of the Company's domestic subsidiaries that guarantee other indebtedness of the Company or another guarantor or the 4.375% 2047 Senior Notes in excess of $40 are guarantors of the 4.375% 2047 Senior Notes .
The indenture governing the 3.60% 2026 Senior Notes , the 5.0% 2046 Senior Notes , the 4.625% Westlake 2021 Senior Notes , the 4.875% Westlake 2023 Senior Notes , 3.60% 2022 Senior Notes and 4.375% 2047 Senior Notes contains customary events of default and covenants that will restrict the Company and certain of the Company's subsidiaries' ability to (1) incur certain secured indebtedness, (2) engage in certain sale-leaseback transactions and (3) consolidate, merge or transfer all or substantially all of its assets.
IKE Zone Bonds
In December 2010, the Louisiana Local Government Authority Environmental Facilities and Community Development Authority (the "Authority"), a political subdivision of the State of Louisiana, completed the offering of $65 of 6 ½% tax-exempt revenue bonds due November 1, 2035 (the " 6 ½% 2035 IKE Zone Senior Notes ") under Section 704 of the Emergency Economic Stabilization Act of 2008 (the "IKE Zone Act").
GO Zone Bonds
In December 2010, the Authority issued $89 of 6 ½% tax-exempt revenue bonds due November 1, 2035 under the Gulf Opportunity Zone Act of 2005 (the "GO Zone Act") (the " 6 ½% 2035 GO Zone Bonds"). In connection with the issuance of the 6 ½% 2035 GO Zone Bonds, the Company issued $89 of the 6 ½% 2035 GO Zone Senior Notes . In July 2010, the Authority completed the reoffering of $100 of 6 ½% tax-exempt revenue bonds due August 1, 2029 under the GO Zone Act (the " 6 ½% 2029 GO Zone Bonds"). In connection with the reoffering of the 6 ½% 2029 GO Zone Bonds, the Company issued $100 of the 6 ½% 2029 GO Zone Senior Notes . In December 2007, the Authority issued $250 of 6 ¾% tax-exempt revenue bonds due November 1, 2032 under the GO Zone Act (the "6 ¾% 2032 GO Zone Bonds"). In connection with the issuance of the 6 ¾% 2032 GO Zone Bonds, the Company issued $250 of the 6 ¾% 2032 GO Zone Senior Notes .
Each series of the tax-exempt bonds is subject to redemption and the holders may require the bonds to be repurchased upon a change of control or a change in or loss of the current tax status of the bonds. In addition, the bonds are subject to optional redemption by the Authority upon the direction of the Company if certain events have occurred in connection with the operation of the projects for which the bond proceeds may be used, including if the Company has determined that the continued operation of any material portion of the projects would be impracticable, uneconomical or undesirable for any reason.
In September 2017, the Company directed the Authority to optionally redeem in full the $250 aggregate principal amount of the 6 ¾% 2032 GO Zone Bonds on November 1, 2017 . In connection with the redemption of the 6 ¾% 2032 GO Zone Bonds, the Authority was required to cause the GO Zone Bonds trustee to surrender the 6 ¾% 2032 GO Zone Senior Notes to the Senior Notes trustee for cancellation. The 6 ¾% 2032 GO Zone Bonds were redeemed and the 6 ¾% 2032 GO Zone Senior Notes were cancelled on November 1, 2017.
In November 2017, the Authority completed the remarketing of $250 aggregate principal amount of 3.50% tax-exempt revenue refunding bonds due November 1, 2032 (the "3.50% 2032 GO Zone Bonds"). In connection with the remarketing of the 3.50% 2032 GO Zone Bonds, the Company issued $250 of the 3.50% 2032 Senior Notes . The 3.50% 2032 GO Zone Bonds are subject to optional redemption by the Authority upon the direction of the Company at any time on or after November 1, 2027 , for 100% of the principal amount plus accrued interest. The indenture governing the 3.50% 2032 Senior Notes contains customary events of default and covenants that will restrict the Company and certain of the Company's subsidiaries' ability to (1) incur certain secured indebtedness, (2) engage in certain sale-leaseback transactions and (3) consolidate, merge or transfer all of substantially all of its assets.
In connection with each offering of the tax-exempt bonds, the Company entered into a loan agreement with the Authority pursuant to which the Company agreed to pay all of the principal, premium, if any, and interest on the bonds and certain other amounts to the Authority. The net proceeds from the offerings were loaned by the Authority to the Company. The Company used the proceeds to expand, refurbish and maintain certain of its facilities in the Louisiana Parishes of Calcasieu and Ascension. The bonds are unsecured and rank equally in right of payment with other existing and future unsecured senior

70
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

indebtedness. All domestic restricted subsidiaries that guarantee other debt of the Company or of another guarantor of the 6 ½% 2029 GO Zone Senior Notes , the 3.50% 2032 Senior Notes and the 6 ½% 2035 GO Zone Senior Notes (collectively, the "GO Zone Senior Notes") and the 6 ½% 2035 IKE Zone Senior Notes (together with the Go Zone Senior Notes, the "Tax-Exempt Bond Related Senior Notes") in excess of $5 ( $40 in the case of the 3.50% 2032 Senior Notes) are guarantors of the Tax-Exempt Bond Related Senior Notes. As of December 31, 2017 , the Company had drawn all proceeds from the tax-exempt bonds.
The indentures governing the Tax-Exempt Bond Related Senior Notes, excluding the 3.50% 2032 Senior Notes , contain customary covenants and events of default. Accordingly, these agreements generally impose significant operating and financial restrictions on the Company. These restrictions, among other things, provide limitations on incurrence of additional indebtedness, the payment of dividends, certain investments and acquisitions and sales of assets. However, the effectiveness of certain of these restrictions is currently suspended because the Tax-Exempt Bond Related Senior Notes are currently rated investment grade by at least two nationally recognized credit rating agencies. The most significant of these provisions, if it were currently effective, would restrict the Company from incurring additional debt, except specified permitted debt (including borrowings under its credit facility), when the Company's fixed charge coverage ratio is below 2.0 :1. These limitations are subject to a number of important qualifications and exceptions, including, without limitation, an exception for the payment of the Company's regular quarterly dividend of up to $0.10 per share. If the restrictions were currently effective, distributions in excess of $100 would not be allowed unless, after giving pro forma effect to the distribution, the Company's fixed charge coverage ratio is at least 2.0 :1 and such payment, together with the aggregate amount of all other distributions after January 13, 2006, is less than the sum of 50% of the Company's consolidated net income for the period from October 1, 2003 to the end of the most recent quarter for which financial statements have been filed, plus 100% of net cash proceeds received after October 1, 2003 as a contribution to the Company's common equity capital or from the issuance or sale of certain securities, plus several other adjustments.
Revenue Bonds
In December 1997, the Company entered into a loan agreement with a public trust established for public purposes for the benefit of the Parish of Calcasieu, Louisiana. The public trust issued $11 principal amount of tax-exempt waste disposal revenue bonds in order to finance the Company's construction of waste disposal facilities for an ethylene plant. The waste disposal revenue bonds expire in December 2027 and are subject to redemption and mandatory tender for purchase prior to maturity under certain conditions. The interest rate on the waste disposal revenue bonds at December 31, 2017 and 2016 was 1.73% and 0.79% , respectively.
As of December 31, 2017 , the Company was in compliance with all of the covenants with respect to the Tax-Exempt Bond Related Senior Notes, 4.625% Westlake 2021 Senior Notes , 4.625% Subsidiary 2021 Senior Notes , 3.60% 2022 Senior Notes , 4.875% Westlake 2023 Senior Notes , 4.875% Subsidiary 2023 Senior Notes , 3.60% 2026 Senior Notes , 5.0% 2046 Senior Notes , 4.375% 2047 Senior Notes , Credit Agreement and the waste disposal revenue bonds.
The weighted average interest rate on all long-term debt was 4.5% and 4.4% at December 31, 2017 and 2016 , respectively. Unamortized debt issuance costs on long-term debt were $26 and $24 at December 31, 2017 and 2016 , respectively.
Aggregate scheduled maturities of long-term debt during the next five years consist of $250 in 2022. There are no scheduled maturities of debt in 2019 through 2021. The Westlake 4.625% Senior Notes due 2021 and the Eagle Spinco Inc. 4.625% Senior Notes due 2021 were optionally redeemed on February 15, 2018.
10. Stockholders' Equity
The Company's Board of Directors has declared regular quarterly dividends to holders of its common stock aggregating $103 , $97 and $92 for the years ended December 31, 2017 , 2016 and 2015 , respectively.
Common Stock
Each share of common stock entitles the holder to one vote on all matters on which holders are permitted to vote, including the election of directors. There are no cumulative voting rights. Accordingly, holders of a majority of the total votes entitled to vote in an election of directors will be able to elect all of the directors standing for election. Subject to preferences that may be applicable to any outstanding preferred stock, the holders of the common stock will share equally on a per share basis any dividends when, as and if declared by the Board of Directors out of funds legally available for that purpose. If the Company is liquidated, dissolved or wound up, the holders of the Company's common stock will be entitled to a ratable share

71
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

of any distribution to stockholders, after satisfaction of all the Company's liabilities and of the prior rights of any outstanding class of the Company's preferred stock. The Company's common stock has no preemptive or conversion rights or other subscription rights. There are no redemption or sinking fund provisions applicable to the Company's common stock.
Preferred Stock
The Company's charter authorizes the issuance of shares of preferred stock. The Company's Board of Directors has the authority, without shareholder approval, to issue preferred shares from time to time in one or more series, and to fix the number of shares and terms of each such series. The Board may determine the designations and other terms of each series including dividend rates, whether dividends will be cumulative or non-cumulative, redemption rights, liquidation rights, sinking fund provisions, conversion or exchange rights and voting rights.
Stock Repurchase Program
In August 2011, the Company's Board of Directors authorized a stock repurchase program of the Company's common stock totaling $100 (the "2011 Program"). As of March 31, 2015, the Company had repurchased 1,944,161 shares of its common stock for an aggregate purchase price of approximately $100 under the 2011 Program, the full amount of the 2011 Program. In November 2014, the Company's Board of Directors approved a new $250 share repurchase program (the "2014 Program"). On November 20, 2015, the Company's Board of Directors approved the expansion of the 2014 Program by an additional $150 . The total number of shares repurchased by the Company under the 2014 Program was none and 1,511,109 for the years ended December 31, 2017 and 2016 , respectively. Any shares repurchased under the 2011 and 2014 Programs are held by the Company as treasury stock and may be used for general corporate purposes, including for the 2013 Omnibus Incentive Plan. Beginning in 2014, the Company began delivering treasury shares to employees and non-employee directors for options exercised and for the settlement of restricted stock units. The cost of treasury shares delivered was determined using the specific identification method.
11. Accumulated Other Comprehensive Income (Loss)
Changes in accumulated other comprehensive income (loss) by component were as follows:
 
 
Benefits
Liability,
Net of Tax
 
Cumulative
Foreign
Currency
Exchange
 
Net Unrealized
Holding Gains
on Investments,
Net of Tax
 
Total
Balances at December 31, 2015
 
$
(8
)
 
$
(116
)
 
$
(5
)
 
$
(129
)
Other comprehensive income (loss) before
   reclassifications
 
36

 
(34
)
 
57

 
59

Amounts reclassified from accumulated other
   comprehensive income (loss)
 
1

 
—

 
(52
)
 
(51
)
Net other comprehensive income (loss) attributable to
   Westlake Chemical Corporation
 
37

 
(34
)
 
5

 
8

Balances at December 31, 2016
 
29

 
(150
)
 
—

 
(121
)
Other comprehensive income before
   reclassifications
 
12

 
114

 
—

 
126

Amounts reclassified from accumulated other
   comprehensive income (loss)
 
2

 
—

 
—

 
2

Net other comprehensive income attributable to
   Westlake Chemical Corporation
 
14

 
114

 
—

 
128

Balances at December 31, 2017
 
$
43

 
$
(36
)
 
$
—

 
$
7


72
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

The following table provides the details of the amounts reclassified from accumulated other comprehensive income (loss) into net income in the consolidated statements of operations:
Details about Accumulated Other
   Comprehensive Income (Loss) Components
 
Location of Reclassification
(Income (Expense)) in
Consolidated Statements
of Operations
 
Year Ended December 31,
 
2017
 
2016
 
2015
Amortization of pension and other
   post-retirement items
 
 
 
 
 
 
 
 
Net loss
 
(1)
 
$
(2
)
 
$
(2
)
 
$
(3
)
 
 
 
 
(2
)
 
(2
)
 
(3
)
 
 
Benefit from income taxes
 
—

 
1

 
1

 
 
 
 
(2
)
 
(1
)
 
(2
)
Net unrealized gains on available-for-
   sale investments
 
 
 
 
 
 
 
 
Realized gain on available-
   for-sale investments
 
Other income, net
 
—

 
54

 
4

 
 
Provision for income taxes
 
—

 
(2
)
 
(1
)
 
 
 
 
—

 
52

 
3

Total reclassifications for the period
 
 
 
$
(2
)
 
$
51

 
$
1


______________________________
(1)
These accumulated other comprehensive loss components are included in the computation of net periodic benefit cost. For additional information, see Note 12.
12. Employee Benefits
Defined Contribution Plans
U.S. Plans
The Company has defined contribution savings plans covering the eligible U.S. regular full-time and part-time employees, whereby eligible employees may elect to contribute up to 100% of their annual eligible compensation, subject to an annual plan limit in line with the annual elective contribution limit as determined by the Internal Revenue Service. The Company matches its employee's contribution up to a certain percentage of such employee's compensation, per the terms of the respective plans. The Company may, at its discretion and per the terms of the respective plans, make an additional non-matching contribution in an amount as the Board of Directors may determine. For the years ended December 31, 2017 , 2016 and 2015 , the Company recorded approximately $23 , $11 and $8 , respectively, to expense for these contributions.
Further, within a defined contribution savings plan, the Company also makes an annual retirement contribution to substantially all employees of one subsidiary who have completed one year of service. The Company's contributions to the plan are determined as a percentage of employees' base and overtime pay. For the years ended December 31, 2017 , 2016 and 2015 , the Company charged approximately $29 , $17 and $12 , respectively, to expense for these contributions.
Non-U.S. Plans
The Company has various defined contribution plans in Germany, United Kingdom, Italy and Belgium covering eligible employees of the Company's European operations. The Company's contributions to the plans are based on applicable laws in each country. Contributions to the Company's non-U.S. defined contribution plans are made by both the employee and the Company. For the years ended December 31, 2017 , 2016 and 2015 , the Company charged approximately $5 , $2 and $2 , respectively, to expense for its contributions to these plans.

73
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

Defined Benefit Plans
U.S. Plans
The Company has noncontributory defined benefit pension plans that cover certain eligible salaried and wage employees of certain subsidiaries. However, eligibility for the Company's plans has been frozen. Benefits for salaried employees under these plans are based primarily on years of service and employees' pay near retirement. Benefits for wage employees are based upon years of service and a fixed amount as periodically adjusted. The Company recognizes the years of service prior to the Company's acquisition of the subsidiary's facilities for purposes of determining vesting, eligibility and benefit levels for certain employees of the subsidiary and for determining vesting and eligibility for certain other employees of the subsidiary. The measurement date for these plans is December 31.
In December 2014, the Company announced a plan amendment to one of the Company's defined benefit pension plans. Under the plan amendment, no additional benefits may be earned by participants after January 31, 2015 and participants' accrued benefits will freeze at the levels earned as of January 31, 2015. In addition, the amendment added a lump sum payment option effective February 1, 2015. The Company made a similar plan amendment to another of its defined benefit pension plans in 2012. In conjunction with both of the defined benefit pension plans' amendments, the Company amended, in 2014 and 2012, its defined contribution savings plan to allow participants impacted by the amendments to participate in the Company's annual retirement contribution program.
In connection with the Merger, the Company assumed certain U.S. pension plans and other post-retirement benefit plans covering Axiall employees. The Axiall pension plans were closed to new participants and provide benefits to certain employees and retirees. The Axiall pension plans' assets and obligations merged into the Company's defined benefit pension plan for salaried employees during 2017. The other post-retirement benefit plans are unfunded and provide medical and life insurance benefits for certain employees and their dependents.
Non-U.S. Plans
The Company has defined benefit pension plans covering current and former employees associated with the Company's European operations. These pension plans are closed to new participants and are for employees in Germany who commenced employment before July 1, 2007. Benefits for employees for these plans are based primarily on employees' pay near retirement. These pension plans are unfunded and have no plan assets. In connection with the Merger, the Company assumed certain defined benefit pension plans. These pension plans are for employees outside of the U.S., namely in Canada and Taiwan. The measurement date for the non-U.S. plans is December 31.

74
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

Details of the changes in benefit obligations, plan assets and funded status of the Company's pension plans are as follows:
 
 
2017
 
2016
 
 
U.S. Plans
 
Non-U.S. Plans
 
U.S. Plans
 
Non-U.S. Plans
Change in benefit obligation
 
 
 
 
 
 
 
 
Benefit obligation, beginning of year
 
$
799

 
$
125

 
$
62

 
$
95

Benefit obligation assumed with acquisition
 
—

 
—

 
818

 
21

Service cost
 
3

 
2

 
1

 
1

Interest cost
 
25

 
3

 
9

 
2

Actuarial loss (gain)
 
41

 
—

 
(74
)
 
13

Benefits paid
 
(45
)
 
(3
)
 
(17
)
 
(3
)
Settlements
 
(16
)
 
(1
)
 
—

 
—

Foreign exchange effects
 
—

 
16

 
—

 
(4
)
Benefit obligation, end of year
 
$
807

 
$
142

 
$
799

 
$
125

 
 
 
 
 
 
 
 
 
Change in plan assets
 
 
 
 
 
 
 
 
Fair value of plan assets, beginning of year
 
$
614

 
$
16

 
$
51

 
$
—

Acquisition
 
—

 
—

 
576

 
16

Actual return
 
97

 
1

 
7

 
—

Employer contribution
 
2

 
1

 
—

 
3

Benefits paid
 
(45
)
 
—

 
(17
)
 
(3
)
Administrative expenses paid
 
(2
)
 
—

 
(3
)
 
—

Settlements
 
(16
)
 
(1
)
 
—

 
—

Foreign exchange effects
 
—

 
1

 
—

 
—

Fair value of plan assets, end of year
 
$
650

 
$
18

 
$
614

 
$
16

Funded status, end of year
 
$
(157
)
 
$
(124
)
 
$
(185
)
 
$
(109
)
 
 
2017
 
2016
 
 
U.S. Plans
 
Non-U.S. Plans
 
U.S. Plans
 
Non-U.S. Plans
Amounts recognized in the consolidated
   balance sheet at December 31
 
 
 
 
 
 
 
 
Current liabilities
 
$
(2
)
 
$
(3
)
 
$
(2
)
 
$
(2
)
Noncurrent liabilities
 
(155
)
 
(121
)
 
(183
)
 
(107
)
Net amount recognized
 
$
(157
)
 
$
(124
)
 
$
(185
)
 
$
(109
)
 
 
2017
 
2016
 
 
U.S. Plans
 
Non-U.S. Plans
 
U.S. Plans
 
Non-U.S. Plans
Amounts recognized in accumulated other
   comprehensive income (loss)
 
 
 
 
 
 
 
 
Net loss (gain)
 
$
(71
)
 
$
9

 
$
(53
)
 
$
8

Total before tax (1)
 
$
(71
)
 
$
9

 
$
(53
)
 
$
8


______________________________
(1)
After-tax totals for pension benefits were $43 and $30 for 2017 and 2016 , respectively, and are reflected in stockholders' equity as accumulated other comprehensive income.
In the U.S., the Pension Protection Act of 2006 (the "Pension Protection Act") established a relationship between a qualified pension plan's funded status and the actual benefits that can be provided. Restrictions on plan benefits and additional funding and notice requirements are imposed when a plan's funded status is less than certain threshold levels. For the 2017 plan year, the funded status for the Company's U.S. pension plans are above 80% and, as such, are exempt from the Pension Protection Act's benefit restrictions.

75
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

Pension plans with an accumulated benefit obligation in excess of plan assets at December 31 are as follows:
 
 
2017
 
2016
 
 
U.S. Plans
 
Non-U.S. Plans
 
U.S. Plans
 
Non-U.S. Plans
Information for pension plans with an accumulated
   benefit obligation in excess of plan assets
 
 
 
 
 
 
 
 
Projected benefit obligation
 
$
(807
)
 
$
(128
)
 
$
(799
)
 
$
(113
)
Accumulated benefit obligation
 
(807
)
 
(126
)
 
(799
)
 
(110
)
Fair value of plan assets
 
650

 
5

 
614

 
5

The following table provides the components of net periodic benefit costs, other changes in plan assets and benefit obligation recognized in other comprehensive income.
 
 
Year Ended December 31,
 
 
2017
 
2016
 
2015
 
 
U.S.
Plans
 
Non-U.S.
Plans
 
U.S.
Plans
 
Non-U.S.
Plans
 
U.S.
Plans
 
Non-U.S.
Plans
Components of net periodic benefit cost
 
 
 
 
 
 
 
 
 
 
 
 
Service cost
 
$
3

 
$
2

 
$
1

 
$
2

 
$
—

 
$
2

Administrative expenses
 
2

 
—

 
3

 
—

 
—

 
—

Interest cost
 
25

 
2

 
9

 
2

 
2

 
2

Expected return on plan assets
 
(40
)
 
(1
)
 
(15
)
 
—

 
(3
)
 
—

Net amortization
 
1

 
1

 
1

 
—

 
1

 
1

Settlement benefits
 
—

 
—

 
—

 
—

 
1

 
—

Net periodic benefit cost (gain)
 
$
(9
)
 
$
4

 
$
(1
)
 
$
4

 
$
1

 
$
5

 
 
 
 
 
 
 
 
 
 
 
 
 
Other changes in plan assets and benefit
   obligation recognized in other
   comprehensive income (OCI)
 
 
 
 
 
 
 
 
 
 
 
 
Net loss (gain) emerging
 
$
(18
)
 
$
—

 
$
(67
)
 
$
13

 
$
1

 
$
(17
)
Amortization of net loss
 
(1
)
 
(1
)
 
(1
)
 
—

 
(2
)
 
(1
)
Total recognized in OCI
 
$
(19
)
 
$
(1
)
 
$
(68
)
 
$
13

 
$
(1
)
 
$
(18
)
Total net periodic benefit cost and OCI
 
$
(28
)
 
$
3

 
$
(69
)
 
$
17

 
$
—

 
$
(13
)
The estimated prior service cost and net loss for the defined benefit plans that will be amortized from accumulated other comprehensive income into net periodic benefit cost during 2018 are expected to be $0 and $1 , respectively.

76
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

The weighted-average assumptions used to determine pension plan obligations and net periodic benefit costs for the plans are as follows:
 
 
2017
 
2016
 
2015
 
 
U.S.
Plans
 
Non-U.S.
Plans
 
U.S.
Plans
 
Non-U.S.
Plans
 
U.S.
Plans
 
Non-U.S.
Plans
Weighted average assumptions used to
   determine benefit obligations at
   December 31
 
 
 
 
 
 
 
 
 
 
 
 
Discount rate
 
3.4
%
 
1.8
%
 
3.8
%
 
1.8
%
 
4.0
%
 
2.4
%
Rate of compensation increase
 
—
%
 
2.6
%
 
—
%
 
2.6
%
 
—
%
 
2.5
%
Weighted average assumptions used to
   determine net periodic benefit costs for
   years ended December 31
 
 
 
 
 
 
 
 
 
 
 
 
Discount rate for benefit obligations
 
3.8
%
 
1.8
%
 
3.2
%
 
2.4
%
 
3.5
%
 
1.9
%
Discount rate for service cost
 
4.1
%
 
1.9
%
 
3.4
%
 
2.4
%
 
—
%
 
—
%
Discount rate for interest cost
 
3.2
%
 
2.0
%
 
2.9
%
 
2.4
%
 
—
%
 
—
%
Expected return on plan assets
 
6.8
%
 
3.8
%
 
6.8
%
 
4.6
%
 
7.0
%
 
—
%
Rate of compensation increase
 
N/A

 
2.6
%
 
—
%
 
2.6
%
 
—
%
 
2.5
%
The discount rates for the Company's U.S. and non-U.S. plans are determined using a benchmark pension discount curve and applying spot rates from the curve to each year of expected benefit payments to determine the appropriate discount rate for the Company.
The Company pension plans' investments are held in the Westlake U.S. Salaried Plan and the Westlake U.S. Wage Plan. The Company's overall investment strategy for its pension plan assets is to achieve a balance between moderate income generation and capital appreciation. The investment strategy includes a mix of approximately  60% of investments for long-term growth, and  40% for near-term benefit payments with a diversification of asset types. These pension funds' investment policies target asset allocations from approximately 60% equity securities and 40% fixed income securities in order to pursue a balance between moderate income generation and capital appreciation.
Equity securities primarily include investments in large-cap and small-cap companies located in the U.S. and international developed and emerging markets stocks. Fixed income securities are comprised of investment and non-investment grade bonds, including U.S. Treasuries and U.S. and non-U.S. corporate bonds of companies from diversified industries. Each pension fund investment policy allows a discretionary range in various asset classes within the asset allocation model of up to 10% . The Company does not believe that there are significant concentrations of risk in the pension plan assets due to its strategy of asset diversification. At December 31, 2017 , plan assets did not include direct ownership of the Company's common stock.
Under the accounting guidance for fair value measurements, inputs used to measure fair value are classified in one of three levels:
Level 1: Quoted market prices in active markets for identical assets or liabilities.
Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.
Level 3: Unobservable inputs that are not corroborated by market data.

77
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

The investments in the collective trust and mutual funds are valued using a market approach based on the net asset value of units held. The fair values of the Company's U.S. plan assets at December 31, by asset category, are as follows:
 
 
2017
 
 
U.S. Plans
 
Non U.S. Plans
 
 
Level 1
 
Level 2
 
Total
 
Level 1
 
Level 2
 
Total
Cash and common stock:
 
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
—

 
$
—

 
$
—

 
$
5

 
$
—

 
$
5

Common stock
 
21

 
—

 
21

 
—

 
—

 
—

Collective investment trust and
mutual funds—Equity securities:
 
 
 
 
 
 
 
 
 
 
 
 
Large-cap funds (1)
 
49

 
173

 
222

 
—

 
2

 
2

Small-cap funds (2)
 
9

 
25

 
34

 
—

 
—

 
—

International funds (3)
 
69

 
50

 
119

 
—

 
5

 
5

Collective investment trust and mutual
   funds—Fixed income:
 
 
 
 
 
 
 
 
 
 
 
 
Bond funds (4)
 
116

 
125

 
241

 
—

 
6

 
6

Short-term investment funds
 
—

 
13

 
13

 
—

 
—

 
—

 
 
$
264

 
$
386

 
$
650

 
$
5

 
$
13

 
$
18


 
 
2016
 
 
U.S. Plans
 
Non U.S. Plans
 
 
Level 1
 
Level 2
 
Total
 
Level 1
 
Level 2
 
Total
Cash and common stock:
 
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
—

 
$
—

 
$
—

 
$
5

 
$
—

 
$
5

Common stock
 
17

 
—

 
17

 
—

 
—

 
—

Collective investment trust and
   mutual funds—Equity securities:
 
 
 
 
 
 
 
 
 
 
 
 
Large-cap funds (1)
 
50

 
167

 
217

 
—

 
2

 
2

Small-cap funds (2)
 
8

 
23

 
31

 
—

 
—

 
—

International funds (3)
 
53

 
54

 
107

 
—

 
4

 
4

Collective investment trust and mutual
   funds—Fixed income:
 
 
 
 
 
 
 
 
 
 
 
 
Bond funds (4)
 
62

 
165

 
227

 
—

 
5

 
5

Short-term investment funds
 
—

 
15

 
15

 
—

 
—

 
—

 
 
$
190

 
$
424

 
$
614

 
$
5

 
$
11

 
$
16

______________________________
(1)
Substantially all of the assets of these funds are invested in large-cap U.S. companies. The remainder of the assets of these funds is invested in cash reserves.
(2)
Substantially all of the assets of these funds are invested in small-cap U.S. companies. The remainder of the assets of these funds is invested in cash reserves.
(3)
Substantially all of the assets of these funds are invested in international companies in developed markets (excluding the U.S.). The remainder of the assets of these funds is invested in cash reserves.
(4)
This category represents investment grade bonds of U.S. issuers, including U.S. Treasury notes.
The Company's funding policy for its U.S. plans is consistent with the minimum funding requirements of federal law and regulations, and based on preliminary estimates, the Company expects to make contributions of approximately $3 for the pension plans in 2018 .

78
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

Multi-employer Plans
Non-U.S. Plans
The Company participates in two multi-employer plans, Pensionskasse der Mitarbeiter der Hoechst-Gruppe VVaG and Pensionskasse der Wacker-Chemie GmbH VVaG, which provide benefits to certain of the Company's employees in Germany. These multi-employer plans are closed to new participants. The benefit obligations are covered up to a certain salary threshold by contributions made by the Company and employees to the plans.
Contributions to the Company's multi-employer plans are expensed as incurred and were as follows:
 
 
Year Ended December 31,
 
 
2017
 
2016
 
2015
 
 
Non-U.S.
Plans
 
Non-U.S.
Plans
 
Non-U.S.
Plans
Contributions to multi-employer plans (1)
 
$
8

 
$
5

 
$
4


______________________________
(1)
The plan information for both the Pensionskasse der Mitarbeiter der Hoechst-Gruppe VVaG and Pensionskasse der Wacker-Chemie GmbH VVaG plans is publicly available. The plans provide fixed, monthly retirement payments on the basis of the credits earned by the participating employees. To the extent that the plans are underfunded, future contributions to the plans may increase and may be used to fund retirement benefits for employees related to other employers. The Company does not consider either of its multi-employer plans individually significant.
Other Post-retirement Benefits
In the U.S., the Company provides post-retirement healthcare benefits to the employees of two subsidiaries who meet certain minimum age and service requirements. The Company has the right to modify or terminate some of these benefits.
In conjunction with the Axiall acquisition, the Company assumed post-retirement plans in the U.S. and Canada which are unfunded and provide medical and life insurance benefits for certain employees and their dependents.
The following table provides a reconciliation of the benefit obligations of the Company's unfunded post-retirement healthcare plans.
 
 
2017
 
2016
 
 
U.S. Plans
 
Non-U.S.
Plans
 
U.S. Plans
 
Non-U.S.
Plans
Change in benefit obligation
 
 
 
 
 
 
 
 
Benefit obligation, beginning of year
 
$
80

 
$
3

 
$
18

 
$
—

Benefit obligation assumed with acquisition
 
—

 
—

 
69

 
3

Service cost
 
1

 
—

 
—

 
—

Interest cost
 
2

 
—

 
1

 
—

Actuarial loss (gain)
 
(1
)
 
—

 
(6
)
 
—

Benefits paid
 
(9
)
 
—

 
(2
)
 
—

Benefit obligation, end of year
 
$
73

 
$
3

 
$
80

 
$
3

 
 
 
 
 
 
 
 
 
Change in plan assets
 
 
 
 
 
 
 
 
Fair value of plan assets, beginning of year
 
$
—

 
$
—

 
$
—

 
$
—

Employer contribution
 
9

 
—

 
2

 
—

Plan participants' contributions
 
—

 
—

 
—

 
—

Benefits paid
 
(9
)
 
—

 
(2
)
 
—

Fair value of plan assets, end of year
 
$
—

 
$
—

 
$
—

 
$
—

Funded status, end of year
 
$
(73
)
 
$
(3
)
 
$
(80
)
 
$
(3
)

79
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

 
 
2017
 
2016
 
 
U.S. Plans
 
Non-U.S.
Plans
 
U.S. Plans
 
Non-U.S.
Plans
Amounts recognized in the consolidated balance sheet at December 31
 
 
 
 
 
 
 
 
Current liabilities
 
$
(8
)
 
$
—

 
$
(8
)
 
$
—

Noncurrent liabilities
 
(65
)
 
(3
)
 
(72
)
 
(3
)
Net amount recognized
 
$
(73
)
 
$
(3
)
 
$
(80
)
 
$
(3
)
 
 
2017
 
2016
 
 
U.S. Plans
 
Non-U.S.
Plans
 
U.S. Plans
 
Non-U.S.
Plans
Amounts recognized in accumulated other comprehensive income (loss)
 
 
 
 
 
 
 
 
Net loss
 
$
(5
)
 
$
—

 
$
(4
)
 
$
—

Total before tax (1)
 
$
(5
)
 
$
—

 
$
(4
)
 
$
—


______________________________
(1)
After-tax totals for post-retirement healthcare benefits were a loss of $0 and $1 for 2017 and 2016 , respectively, and are reflected in stockholders' equity as accumulated other comprehensive income (loss).
The following table provides the components of net periodic benefit costs, other changes in plan assets and benefit obligation recognized in other comprehensive income.
 
 
Year Ended December 31,
 
 
2017
 
2016
 
2015
 
 
U.S. Plans
 
Non-U.S.
Plans
 
U.S. Plans
 
Non-U.S.
Plans
 
U.S. Plans
Components of net periodic benefit cost
 
 
 
 
 
 
 
 
 
 
Service cost
 
$
1

 
$
—

 
$
—

 
$
—

 
$
—

Interest cost
 
2

 
—

 
1

 
—

 
1

Net amortization
 
—

 
—

 
—

 
—

 
—

Net periodic benefit cost
 
$
3

 
$
—

 
$
1

 
$
—

 
$
1

 
 
 
 
 
 
 
 
 
 
 
Other changes in plan assets and benefit obligation recognized in OCI
 
 
 
 
 
 
 
 
 
 
Net loss (gain) emerging
 
$
(1
)
 
$
—

 
$
(6
)
 
$
—

 
$
(2
)
Total recognized in OCI
 
$
(1
)
 
$
—

 
$
(6
)
 
$
—

 
$
(2
)
Total net periodic benefit cost and OCI
 
$
2

 
$
—

 
$
(5
)
 
$
—

 
$
(1
)
The estimated prior service cost and net loss for the post-retirement healthcare benefit plans that will be amortized from accumulated other comprehensive income into net periodic benefit cost during 2018 are both expected to be zero .

80
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

The weighted-average assumptions used to determine post-retirement healthcare plan obligations and net periodic benefit costs for the plans are as follows:
 
 
2017
 
2016
 
2015
 
 
U.S. Plans
 
Non-U.S.
Plans
 
U.S. Plans
 
Non-U.S.
Plans
 
U.S. Plans
Weighted average assumptions used to determine benefit obligations at December 31
 
 
 
 
 
 
 
 
 
 
Discount rate
 
3.0
%
 
4.0
%
 
3.3
%
 
4.0
%
 
3.5
%
Health care cost trend rate
 
 
 
 
 
 
 
 
 
 
  - Initial rate
 
7.3
%
 
6.2
%
 
7.3
%
 
6.2
%
 
—
%
  - Ultimate rate
 
4.5
%
 
4.5
%
 
4.5
%
 
4.5
%
 
—
%
  - Years to ultimate
 
11

 
12

 
11

 
12

 
0

Weighted average assumptions used to determine net periodic benefit costs for years ended December 31
 
 
 
 
 
 
 
 
 
 
Discount rate for benefit obligations
 
3.3
%
 
3.3
%
 
2.6
%
 
3.3
%
 
3.3
%
Discount rate for service cost
 
3.8
%
 
3.3
%
 
3.1
%
 
3.3
%
 
—
%
Discount rate for interest cost
 
2.6
%
 
3.3
%
 
2.8
%
 
3.3
%
 
—
%
Health care cost trend rate
 
 
 
 
 
 
 
 
 
 
  - Initial rate
 
6.8
%
 
6.8
%
 
7.0
%
 
6.8
%
 
—
%
  - Ultimate rate
 
4.6
%
 
4.5
%
 
4.5
%
 
4.5
%
 
—
%
  - Years to ultimate
 
11

 
12

 
12

 
13

 
0

The discount rate is determined using a benchmark pension discount curve and applying spot rates from the curve to each year of expected benefit payments to determine the appropriate discount rate for the Company. A one percentage-point increase or decrease in assumed healthcare trend rates would not have a significant effect on the amounts reported for the healthcare plans.
Estimated Future Benefit Payments
The following benefit payments are expected to be paid:
 
 
Pension
Benefits
 
Other Post-
retirement
Benefits
Estimated future benefit payments:
 
 
 
 
Year 1
 
$
51

 
$
8

Year 2
 
53

 
8

Year 3
 
52

 
8

Year 4
 
52

 
8

Year 5
 
53

 
8

Years 6 to 10
 
265

 
30

13. Stock-Based Compensation
Under the Westlake Chemical Corporation 2013 Omnibus Incentive Plan (as amended and restated, the "2013 Plan"), all employees and non-employee directors of the Company, as well as certain individuals who have agreed to become the Company's employees, are eligible for awards. Shares of common stock may be issued as authorized in the 2013 Plan. At the discretion of the administrator of the 2013 Plan, employees and non-employee directors may be granted awards in the form of stock options, stock appreciation rights, stock awards, restricted stock units or cash awards (any of which may be a performance award). Outstanding stock option awards have a 10 -year term and vest either (1) ratably on an annual basis over a one to four -year period or (2) at the end of a five to 9.5 -year period. Outstanding restricted stock units vest either (1) ratably on an annual basis over a three -year period or (2) at the end of a one to six -year period. In accordance with accounting guidance related to share-based payments, stock-based compensation expense for all stock-based compensation awards is based on estimated grant-date fair value. The Company recognizes these stock-based compensation costs net of a forfeiture rate and on a straight-line basis over the requisite service period of the award for only those shares expected to vest. For the years ended December 31, 2017 , 2016 and 2015 , the total recognized stock-based compensation expense related to equity awards issued under the 2013 Plan was $14 , $14 and $10 , respectively.
Option activity and changes during the year ended December 31, 2017 were as follows:
 
 
Options
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Term
(Years)
 
Aggregate
Intrinsic
Value
Outstanding at December 31, 2016
 
1,404,734

 
$
33.76

 
 
 
 
Granted
 
289,553

 
61.87

 
 
 
 
Exercised
 
(401,505
)
 
29.68

 
 
 
 
Cancelled
 
(23,181
)
 
56.92

 
 
 
 
Outstanding at December 31, 2017
 
1,269,601

 
$
41.04

 
5.9
 
$
83

Exercisable at December 31, 2017
 
719,676

 
$
28.89

 
3.9
 
$
56

For options outstanding at December 31, 2017 , the options had the following range of exercise prices:
Range of Prices
 
Options 
Outstanding
 
Weighted
Average
Remaining 
Contractual
Life (Years)
$7.12 - $9.65
 
300,366

 
1.6
$10.26 - $18.05
 
167,582

 
3.6
$22.92 - $30.05
 
316,601

 
7.6
$40.38 - $52.35
 
285,553

 
9.1
$61.87 - $68.18
 
199,499

 
6.8

81
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

The aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between the Company's closing stock price on the last trading day of the year and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on December 31, 2017 . This amount changes based on the fair market value of the Company's common stock. For the years ended December 31, 2017 , 2016 and 2015 , the total intrinsic value of options exercised was $24 , $4 and $1 , respectively.
As of December 31, 2017 , $4 of total unrecognized compensation cost related to stock options is expected to be recognized over a weighted-average period of 1.4 years. Income tax benefits of $8 , $1 and $0 were realized from the exercise of stock options during the years ended December 31, 2017 , 2016 and 2015 , respectively.
The Company used the Black-Scholes option pricing model to value its options. The table below presents the weighted average value and assumptions used in determining each option's fair value. Volatility was calculated using historical trends of the Company's common stock price.
 
 
Stock Option Grants
 
 
Year Ended December 31,
 
 
2017
 
2016
 
2015
Weighted average fair value
 
$
15.84

 
$
11.67

 
$
20.21

Risk-free interest rate
 
2.1
%
 
1.4
%
 
1.7
%
Expected life in years
 
5

 
5

 
5

Expected volatility
 
29.2
%
 
32.9
%
 
34.2
%
Expected dividend yield
 
1.2
%
 
1.6
%
 
0.9
%
The Company had no non-vested restricted stock awards as of December 31, 2017 and 2016. As of December 31, 2017 , there was no unrecognized stock-based compensation expense related to non-vested restricted stock awards. The total fair value of restricted stock awards that vested during the years ended December 31, 2017 , 2016 and 2015 was $0 , $4 and $8 , respectively.
Non-vested restricted stock units as of December 31, 2017 and changes during the year ended December 31, 2017 were as follows:
 
 
Number of
Units
 
Weighted
Average
Grant Date
Fair Value
Non-vested at December 31, 2016
 
597,559

 
$
55.64

Granted
 
198,659

 
62.46

Vested
 
(91,997
)
 
61.39

Forfeited
 
(40,355
)
 
56.08

Non-vested at December 31, 2017
 
663,866

 
$
56.86

As of December 31, 2017 , there was $17 of unrecognized stock-based compensation expense related to non-vested restricted stock units. This cost is expected to be recognized over a weighted-average period of 1.6 years. The total fair value of restricted stock units that vested during the years ended December 31, 2017 , 2016 and 2015 was $6 , $4 and $1 , respectively.

82
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

Axiall Awards Assumed in the Merger
In the Merger, all outstanding Axiall restricted stock units were assumed by the Company and converted into restricted stock units in respect of the Company's common stock, with the same terms and conditions except that upon settlement the award holders will receive the greater of (1) the value of $33.00 per Axiall restricted stock unit that was converted into a restricted stock unit in respect of the Company's common stock and (2) the value of the Company's common stock. The awards are classified as liability awards for accounting purposes and are re-measured at each reporting date until they vest. The portion of the replacement award that is attributable to pre-combination service by the employee was included in the measure of consideration transferred to acquire Axiall. The remaining fair value of the replacement awards will be recognized as stock-based compensation expense over the remaining vesting period. Total stock-based compensation expense recognized related to Axiall restricted stock units that were assumed by the Company and converted into restricted stock units during the years ended December 31, 2017 and 2016 was $9 and $38 , respectively, of which $33 was included in transaction and integration-related costs in the consolidated statement of operations during the year ended December 31, 2016 .
The Company estimates the fair value of these awards using the Company's common stock price and a pricing model to estimate the value attributable to the $33.00 minimum price per Axiall restricted stock unit converted into a restricted stock unit in respect of the Company's common stock. The table below presents the assumptions used in determining each liability classified restricted stock unit's fair value. Volatility was calculated using historical trends of the Company's common stock price.
 
 
Liability Classified Restricted Stock Awards
 
 
Year Ended December 31, 2017
Weighted average vesting period in years
 
0.8
 
Risk-free interest rate
 
1.6
%
Expected volatility
 
23.1
%
Expected dividend yield
 
0.8
%
Non-vested liability classified restricted stock awards as of December 31, 2017 and changes during the year ended December 31, 2017 were as follows:
 
 
Number of
Units
 
Weighted Average Fair Value
Non-vested at December 31, 2016
 
286,147

 
$
60.77

Vested
 
(161,324
)
 
65.29

Cancelled
 
(23,831
)
 
66.97

Non-vested at December 31, 2017
 
100,992

 
$
106.53

As of December 31, 2017 , there was $5 of unrecognized stock-based compensation expense related to non-vested liability classified restricted stock awards. The total fair value of liability classified restricted stock awards that vested during the years ended  December 31, 2017 and 2016 was $11 and $3 , respectively. The total fair value of liability classified restricted stock awards cancelled during the year ended December 31, 2017 was $2 .
Westlake Chemical Partners LP Awards
The Company's wholly-owned subsidiary and the general partner of Westlake Partners, Westlake Chemical Partners GP LLC ("WLKP GP"), maintains a unit-based compensation plan for directors and employees of WLKP GP and Westlake Partners.
The Westlake Partners 2014 Long-term Incentive Plan ("Westlake Partners 2014 Plan") permits various types of equity awards including but not limited to grants of phantom units and restricted units. Awards granted under the Westlake Partners 2014 Plan may be settled with Westlake Partners units or in cash or a combination thereof. Compensation expense for these awards was not material to the Company's consolidated financial statements for the years ended December 31, 2017 , 2016 and 2015 .

83
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

14. Fair Value Measurements
The Company has financial assets and liabilities subject to fair value measures. These financial assets and liabilities include cash and cash equivalents, accounts receivable, net, accounts payable and long-term debt, all of which are recorded at carrying value. The amounts reported in the consolidated balance sheets for cash and cash equivalents, accounts receivable, net and accounts payable approximate their fair value due to the short maturities of these instruments. The carrying and fair values of the Company's long-term debt (including the current portion of long-term debt) at December 31, 2017 and 2016 are summarized in the table below. The Company's long-term debt instruments are publicly-traded. A market approach, based upon quotes from financial reporting services, is used to measure the fair value of the Company's long-term debt. Because the Company's long-term debt instruments may not be actively traded, the inputs used to measure the fair value of the Company's long-term debt are classified as Level 2 inputs within the fair value hierarchy.
 
 
2017
 
2016
 
 
Carrying
Value
 
Fair
Value
 
Carrying
Value
 
Fair
Value
Revolving credit facility
 
$
—

 
$
—

 
$
325

 
$
325

4.625% Westlake 2021 Senior Notes (1)
 
645

 
639

 
652

 
651

4.625% Subsidiary 2021 Senior Notes (1)
 
65

 
65

 
66

 
66

3.60% 2022 Senior Notes
 
249

 
255

 
248

 
252

4.875% Westlake 2023 Senior Notes
 
445

 
449

 
447

 
451

4.875% Subsidiary 2023 Senior Notes
 
16

 
16

 
17

 
17

3.60% 2026 Senior Notes
 
740

 
757

 
739

 
722

Loan related to tax-exempt waste disposal revenue
   bonds due 2027
 
11

 
11

 
11

 
11

6 ½% 2029 GO Zone Senior Notes
 
99

 
111

 
99

 
112

6 ¾% 2032 GO Zone Senior Notes
 
—

 
—

 
248

 
259

6 ½% 2035 GO Zone Senior Notes
 
88

 
99

 
88

 
100

6 ½% 2035 IKE Zone Senior Notes
 
65

 
74

 
65

 
73

5.0% 2046 Senior Notes
 
675

 
787

 
674

 
692

4.375% 2047 Senior Notes
 
491

 
518

 
—

 
—

3.50% 2032 Senior Notes
 
248

 
256

 
—

 
—

___________________________
(1)
The 4.625% Westlake 2021 Senior Notes and 4.625% Subsidiary 2021 Senior Notes were classified as a component of current liabilities in the consolidated balance sheet at December 31, 2017 . For additional information, see Note 9.

84
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

15. Income Taxes
On December 22, 2017, the U.S. Tax Cuts and Jobs Act (the "Tax Act") was signed into law. The Tax Act, among other changes, reduces U.S. corporate income tax rate from 35% to 21%, effective January 1, 2018, and also requires a one-time deemed repatriation of foreign earnings at specified rates. The corporate income tax rate change resulted in a revaluation of the Company's deferred tax assets and liabilities. The accounting guidance on income taxes requires that the effect on deferred tax assets and liabilities of a change in tax rates be recognized in the period the tax rate change was enacted. The SEC staff guidance allows registrants to record provisional amounts during a measurement period when it does not have the necessary information available, prepared or analyzed (including computations) in reasonable detail to complete its accounting for the change in tax law. The measurement period ends when a company has obtained, prepared and analyzed the information necessary to finalize its accounting, but cannot extend beyond one year. Under the above guidance, the Company made a provisional adjustment of $591 of income tax benefit in the 2017 consolidated financial statements for items that the Company could reasonably estimate such as revaluation of deferred tax assets and liabilities and a one-time U.S. tax on the mandatory deemed repatriation of the Company's post-1986 foreign earnings. The Company will continue to assess the income tax effects of the Tax Act based on further standard setting activities, any transition provisions, and changes in the facts and circumstances of the Company's tax position, during the measurement period.
The components of income before income taxes are as follows:
 
 
Year Ended December 31,
 
 
2017
 
2016
 
2015
Domestic
 
$
917

 
$
476

 
$
880

Foreign
 
164

 
82

 
83

 
 
$
1,081

 
$
558

 
$
963

The Company's provision for (benefit from) income taxes consists of the following:
 
 
Year Ended December 31,
 
 
2017
 
2016
 
2015
Current
 
 
 
 
 
 
Federal
 
$
231

 
$
8

 
$
225

State
 
18

 
9

 
24

Foreign
 
27

 
20

 
9

 
 
276

 
37

 
258

Deferred
 
 
 
 
 
 
Federal
 
(557
)
 
136

 
30

State
 
25

 
(33
)
 
3

Foreign
 
(2
)
 
(2
)
 
7

 
 
(534
)
 
101

 
40

Total provision for (benefit from) income taxes
 
$
(258
)
 
$
138

 
$
298


85
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

A reconciliation of taxes computed at the statutory rate to the Company's income tax expense is as follows:
 
 
Year Ended December 31,
 
 
2017
 
2016
 
2015
Provision for federal income tax, at statutory rate
 
$
378

 
$
195

 
$
337

State income tax provision, net of federal income tax effect
 
26

 
1

 
17

Foreign income tax rate differential
 
(33
)
 
(8
)
 
(13
)
Manufacturing deduction
 
(23
)
 
(2
)
 
(24
)
Depletion
 
(7
)
 
(2
)
 
—

Noncontrolling interests
 
(9
)
 
(7
)
 
(7
)
Tax on previously held shares of Axiall Corporation and certain
   other acquisition related items
 
—

 
(13
)
 
—

Tax Act related adjustment
 
(591
)
 
—

 
—

Changes in state apportionment and other state adjustments
 
2

 
(17
)
 
—

Research and development expenditures and adjustments related to prior
   years' tax returns
 
(1
)
 
(8
)
 
—

Other, net
 
—

 
(1
)
 
(12
)
 
 
$
(258
)
 
$
138

 
$
298

The tax effects of the principal temporary differences between financial reporting and income tax reporting at December 31 are as follows:
 
 
2017
 
2016
Net operating loss carryforward
 
$
64

 
$
70

Credit carryforward
 
26

 
24

Accruals
 
53

 
67

Pension
 
79

 
114

Allowance for doubtful accounts
 
5

 
12

Inventories
 
11

 
13

Other
 
15

 
36

Deferred taxes assets—total
 
253

 
336

Property, plant and equipment
 
(906
)
 
(1,374
)
Intangibles
 
(154
)
 
(221
)
Turnaround costs
 
(8
)
 
(1
)
Basis difference—consolidated partnerships
 
(209
)
 
(308
)
Other
 
(18
)
 
(17
)
Deferred tax liabilities—total
 
(1,295
)
 
(1,921
)
Valuation allowance
 
(56
)
 
(53
)
Total net deferred tax liabilities
 
$
(1,098
)
 
$
(1,638
)
 
 
 
 
 
Balance sheet classifications
 
 
 
 
Noncurrent deferred tax asset
 
$
13

 
$
12

Noncurrent deferred tax liability
 
(1,111
)
 
(1,650
)
Total net deferred tax liabilities
 
$
(1,098
)
 
$
(1,638
)
At December 31, 2017 , the Company had foreign and state net operating loss carryforwards of approximately $405 , which will expire in varying amounts between 2018 and 2037 and are subject to certain limitations on an annual basis. Management believes the Company will realize the benefit of a portion of the net operating loss carryforwards before they expire, but to the extent that the full benefit may not be realized, a valuation allowance has been recorded. The valuation allowance increased by $3 in 2017 mostly as a result of the revaluation of the Company's deferred tax assets.

86
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

The Tax Act requires a one-time U.S. tax at a specified rate for a mandatory deemed repatriation of post-1986 foreign earnings. For the quarter ended December 31, 2017 , the Company recorded, on a provisional basis, approximately $5 of U.S. tax expense related to this one-time repatriation tax and elected to pay the tax over eight years as allowed by the Tax Act.
For the year ended December 31, 2017 , the Company accrued $7 of foreign tax as it is no longer permanently reinvested with respect to the outside basis difference for all of its foreign subsidiaries.
The Company files income tax returns in the U.S. federal jurisdiction, various states and foreign jurisdictions. The Company is no longer subject to examinations by tax authorities before the year 2011.
16. Earnings per Share
The Company has unvested restricted stock units outstanding that are considered participating securities and, therefore, computes basic and diluted earnings per share under the two-class method. Basic earnings per share for the periods are based upon the weighted average number of shares of common stock outstanding during the periods. Diluted earnings per share include the effect of certain stock options.
 
 
Year Ended December 31,
 
 
2017
 
2016
 
2015
Net income attributable to Westlake Chemical Corporation
 
$
1,304

 
$
399

 
$
646

Less:
 
 
 
 
 
 
Net income attributable to participating securities
 
(7
)
 
(2
)
 
(3
)
Net income attributable to common shareholders
 
$
1,297

 
$
397

 
$
643

The following table reconciles the denominator for the basic and diluted earnings per share computations shown in the consolidated statements of operations:
 
 
Year Ended December 31,
 
 
2017
 
2016
 
2015
Weighted average common shares—basic
 
129,087,043

 
129,367,712

 
131,823,707

Plus incremental shares from:
 
 
 
 
 
 
Assumed exercise of options
 
452,970

 
607,110

 
478,105

Weighted average common shares—diluted
 
129,540,013

 
129,974,822

 
132,301,812

 
 
 
 
 
 
 
Earnings per common share attributable to
   Westlake Chemical Corporation:
 
 
 
 
 
 
Basic
 
$
10.05

 
$
3.07

 
$
4.88

Diluted
 
$
10.00

 
$
3.06

 
$
4.86


There are no antidilutive options to purchase shares of common stock for the year ended December 31, 2017 . Excluded from the computation of diluted earnings per share for the years ended December 31, 2016 and 2015 are options to purchase 318,259 and 301,969 shares of common stock, respectively. These options were outstanding during the periods reported but were excluded because the effect of including them would have been antidilutive.
17. Supplemental Information
Accrued Liabilities
Accrued liabilities were $657 and $538 at December 31, 2017 and 2016 , respectively. Accrued rebates and accrued income taxes, which are components of accrued liabilities, were $108 and $130 , respectively, at December 31, 2017 and $78 and $11 at December 31, 2016 , respectively. No other component of accrued liabilities was more than five percent of total current liabilities.

87
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

Non-cash Investing Activity
The change in capital expenditure accruals reducing additions to property, plant and equipment was $9 and $7 for the years ended December 31, 2017 and 2015 , respectively. The change in capital expenditure accruals increasing additions to property, plant and equipment was $7 for the year ended December 31, 2016 .
Other Income, Net
Other income, net included a $49 gain realized on previously held shares of Axiall common stock for the year ended December 31, 2016 and a $21 gain on acquisition and related expenses, net on the acquisition of Huasu for the year ended December 31, 2015 . No other components of other income, net were material to the statements of operations for the years ended December 31, 2017 , 2016 and 2015 .
Cash Flow Information
 
 
Year Ended December 31,
 
 
2017
 
2016
 
2015
Cash paid for:
 
 
 
 
 
 
Interest paid, net of interest capitalized
 
$
154

 
$
46

 
$
32

Income taxes paid
 
84

 
3

 
314

18. Related Party and Affiliate Transactions
The Company leases office space for management and administrative services from an affiliate of the Company's principal stockholder. For the years ended December 31, 2017 , 2016 and 2015 , the Company incurred lease payments of approximately $3 , $3 and $2 , respectively.
Cypress Interstate Pipeline L.L.C., a natural gas liquids pipeline joint venture company in which the Company owns a 50% equity stake, transports natural gas liquid feedstocks to the Company's Lake Charles complex through its pipeline. The Company accounts for its investments in Cypress Interstate Pipeline L.L.C. under the equity method of accounting. The investment in Cypress Interstate Pipeline L.L.C. at December 31, 2017 and 2016 was $9 and $9 , respectively. For the years ended December 31, 2017 , 2016 and 2015 , the Company incurred pipeline fees of approximately $15 , $14 and $14 , respectively, payable to this joint venture for usage of the pipeline. The amounts due to this joint venture were $1 and $1 at December 31, 2017 and 2016 , respectively.
EPS Ethylene Pipeline Süd GmbH & Co. KG, an ethylene pipeline company in which the Company owns a 10% equity stake, transports ethylene feedstocks to the Company's Gendorf, Germany production facility through its pipeline. For the years ended December 31, 2017 , 2016 and 2015 , the Company incurred pipeline fees of approximately $0 , $1 and $1 , respectively, for usage of the pipeline. There were no outstanding amounts due to this related party at December 31, 2017 and 2016 .
The Company owns a 15% and an 11% equity stake in InfraServ Knapsack GmbH & Co. KG and InfraServ Gendorf GmbH & Co. KG, respectively. The Company has service agreements with these entities, including contracts to provide electricity and technical services to certain of the Company's production facilities in Germany. The investment in Infraserv was $56 and $50 at December 31, 2017 and 2016 , respectively. For the years ended December 31, 2017 , 2016 and 2015 , the Company incurred charges aggregating approximately $133 , $131 and $116 , respectively, for these services. The amounts accrued for these related parties were approximately $33 and $25 at December 31, 2017 and 2016 , respectively.
The Company owns a 50% interest in Shriram Axiall Private Limited ("SAPL"), which the Company acquired as a result of the Merger. SAPL is a joint venture formed in April 2014 to facilitate the manufacture and sale of certain compound products in India. The Company accounts for its investments in SAPL under the equity method of accounting. The investment in SAPL at December 31, 2017 and 2016 was $0 and $2 , respectively.

88
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

The Company owns a 50% interest in RS Cogen LLC ("RS Cogen"), which the Company acquired as a result of the Merger. RS Cogen operates a process steam, natural gas-fired cogeneration facility adjacent to the Lake Charles South Facility. The Company accounts for its investment in RS Cogen under the equity method of accounting. The investment in RS Cogen at December 31, 2017 and 2016 was $10 and $10 , respectively. For the year ended December 31, 2017 and for the period from August 31, 2016 to December 31, 2016, the Company recorded purchases of approximately $26 and $9 from RS Cogen, respectively. The amount payable to this related party was approximately $2 and $1 at December 31, 2017 and 2016 , respectively.
The Company owns a 50% interest in Vinyl Solutions, LLC ("Vinyl Solutions"), which the Company acquired as a result of the Merger. The Company accounts for its investments in Vinyl Solutions under the equity method of accounting. Vinyl Solutions is a compounding manufacturer of specialty compounds. For the year ended December 31, 2017 and for the period from August 31, 2016 to December 31, 2016, the Company recorded sales of $17 and $6 , respectively, to Vinyl Solutions. The amount receivable from this related party was $7 and $5 at December 31, 2017 and 2016 , respectively.
On June 17, 2015, Eagle US 2 LLC ("Eagle" ) , a wholly-owned subsidiary of Axiall, entered into an amended and restated limited liability company agreement with Lotte Chemical USA Corporation (" Lotte") related to the formation of LACC, LLC ("LACC"), which was formed by Eagle and Lotte to design, build and operate a 1 billion ton per year ethylene plant. Pursuant to a contribution and subscription agreement, dated as of June 17, 2015, between Eagle and LACC, Eagle has agreed to make a maximum capital commitment to LACC of up to $225 to fund the construction costs of the plant, representing a 10% interest in LACC. Eagle and Lotte also entered into a call option agreement, dated as of June 17, 2015, pursuant to which Eagle has the right, but not the obligation, until the third anniversary of the substantial completion of the plant, to acquire up to a 50% ownership interest in LACC from Lotte. The construction of the plant commenced in January 2016. The plant is being built adjacent to the Company's largest chlor-alkali chemical facility, located in Lake Charles, to take advantage of the Company's existing infrastructure, access to competitive feedstock resources and ethylene distribution infrastructure. The anticipated start-up for the plant is expected to be in the first quarter of 2019 . The Company acquired this investment as a result of the Merger. As of December 31, 2017 and 2016 , the Company's investment in LACC was $125 and $59 , respectively. Total funding by the Company in LACC for the year ended December 31, 2017 and for the period from August 31, 2016 to December 31, 2016 amounted to $66 and $17 , respectively. The amount receivable from LACC at December 31, 2017 and 2016 was approximately $0 and $1 , respectively. The Company's investment in LACC is accounted for under the cost method.
Dividends received from equity method investments were $6 , $5 and $6 for the years ended December 31, 2017 , 2016 and 2015 , respectively.
One of the Company's directors serves as Chairman and Chief Executive Officer of American Air Liquide Holdings, Inc. and as a Senior Vice President of the Air Liquide Group ("Air Liquide"). The Company purchased oxygen, nitrogen and utilities and leased cylinders from various affiliates of American Air Liquide Holdings, Inc. including Airgas and subsidiaries that were acquired in 2016 by Air Liquide aggregating approximately $30 , $22 and $10 for the years ended December 31, 2017 , 2016 and 2015 , respectively. The Company also sold certain utilities to Air Liquide aggregating approximately $7 and $4 during the years ended December 31, 2017 and 2016 , respectively. The amount payable to Air Liquide was $2 and $4 at December 31, 2017 and 2016 , respectively, and the amount receivable from Air Liquide was $1 and $1 at December 31, 2017 and 2016 , respectively.
19. Westlake Chemical Partners LP
On August 4, 2014, Westlake Partners completed its initial public offering (the "IPO") of 12,937,500 common units at a price of $24.00 per unit. Net proceeds to Westlake Partners from the sale of the units was approximately $286 , net of underwriting discounts, structuring fees and offering expenses of approximately $24 . At the consummation of the IPO, Westlake Partners' assets consisted of a 10.6% limited partner interest in OpCo, as well as the general partner interest in OpCo. Immediately after the IPO, the Company retained an 89.4% limited partner interest in OpCo and a significant interest in Westlake Partners. The IPO represented the sale of 47.8% of the common units in Westlake Partners.
Westlake Partners purchased additional 2.7% and 5.0% newly-issued limited partner interests in OpCo on April 29, 2015 and on September 29, 2017, respectively.
On September 29, 2017, Westlake Partners completed a secondary offering of 5,175,000 common units at a price of $22.00 per unit. Net proceeds to Westlake Partners from the sale of the units were $111 , net of underwriting discounts, structuring fees and estimated offering expenses of approximately $3 . At December 31, 2017 , Westlake Partners had a 18.3% limited partner interest in OpCo, and the Company retained an 81.7% limited partner interest in OpCo and a significant interest in Westlake Partners.

89
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)


20. Commitments and Contingencies
The Company is involved in a number of legal and regulatory matters, principally environmental in nature, that are incidental to the normal conduct of its business, including lawsuits, investigations and claims. The outcome of these matters are inherently unpredictable. The Company believes that, in the aggregate, the outcome of all known legal and regulatory matters will not have a material adverse effect on its consolidated financial statements; however, specific outcomes with respect to such matters may be material to the Company's consolidated statements of operations in any particular period in which costs, if any, are recognized. The Company's assessment of the potential impact of environmental matters, in particular, is subject to uncertainty due to the complex, ongoing and evolving process of investigation and remediation of such environmental matters, and the potential for technological and regulatory developments. In addition, the impact of evolving claims and programs, such as natural resource damage claims, industrial site reuse initiatives and state remediation programs creates further uncertainty of the ultimate resolution of these matters. The Company anticipates that the resolution of many legal and regulatory matters, and in particular environmental matters, will occur over an extended period of time.
Environmental. As of December 31, 2017 and 2016 , the Company had reserves for environmental contingencies totaling approximately $49 and $49 , respectively, most of which was classified as noncurrent liabilities. The Company's assessment of the potential impact of these environmental contingencies is subject to considerable uncertainty due to the complex, ongoing and evolving process of investigation and remediation, if necessary, of such environmental contingencies, and the potential for technological and regulatory developments.
Calvert City Proceedings. For several years, the Environmental Protection Agency (the "EPA") has been conducting remedial investigation and feasibility studies at the Company's Calvert City, Kentucky facility pursuant to the Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (CERCLA). As the current owner of the Calvert City facility, the Company was named by the EPA as a potentially responsible party ("PRP") along with Goodrich Corporation ("Goodrich") and its successor-in-interest, PolyOne Corporation ("PolyOne"). On November 30, 2017, the EPA published a draft Proposed Plan, incorporating by reference an August 2015 draft Remedial Investigation (RI) report, an October 2017 draft Feasibility Study (FS) report and a new Technical Impracticability Waiver document dated December 19, 2017. The draft Proposed Plan describes a preferred remedy that includes a containment wall with targeted treatment and supplemental hydraulic containment, as well as active treatment of historical groundwater contamination under the Tennessee River. The EPA has estimated that the total remedy will cost $200 to $250 with an estimated $1 to $3 in annual operation and maintenance (O&M) costs. The Company's allocation of liability for remedial or O&M costs, if any, will be determined by the outcome of the contractual dispute with Goodrich/PolyOne, which is the subject of a pending arbitration proceeding as described below.
In connection with the 1990 and 1997 acquisitions of the Goodrich chemical manufacturing complex in Calvert City, Goodrich agreed to indemnify the Company for any liabilities related to preexisting contamination at the complex. For its part, the Company agreed to indemnify Goodrich for post-closing contamination caused by the Company's operations. The soil and groundwater at the complex, which does not include the Company's nearby PVC facility, had been extensively contaminated by Goodrich's operations. In 1993, Goodrich spun off the predecessor of PolyOne, and that predecessor assumed Goodrich's indemnification obligations relating to preexisting contamination. In 2003, litigation arose among the Company, Goodrich and PolyOne with respect to the allocation of the cost of remediating contamination at the site. The parties settled this litigation in December 2007 and the case was dismissed. In the settlement, the parties agreed that, among other things: (1) PolyOne would pay 100% of the costs (with specified exceptions), net of recoveries or credits from third parties, incurred with respect to environmental issues at the Calvert City site from August 1, 2007 forward; and (2) either the Company or PolyOne might, from time to time in the future (but not more than once every five years), institute an arbitration proceeding to adjust that percentage. In May 2017, PolyOne filed a demand for arbitration. In this proceeding, PolyOne seeks to readjust the percentage allocation of costs and to recover approximately $17 from the Company in reimbursement of previously paid remediation costs. The Company filed a cross demand for arbitration seeking $6 in unreimbursed remediation costs incurred during the relevant period.
On October 6, 2017, PolyOne filed suit against the Company in the U.S. District Court for the Western District of Kentucky seeking for the court — instead of the arbitration panel — to resolve claims asserted by the Company in the arbitration proceedings related to reimbursement of costs incurred by the Company at the Calvert City complex. PolyOne is seeking a declaratory judgment from the court that costs claimed by the Company in the arbitration are not covered under the 2007 settlement agreement and thus are not within the jurisdiction of the arbitration panel. In response, the Company has filed a motion to dismiss asserting that PolyOne's jurisdictional claims are unfounded and that the arbitration panel has jurisdiction over Westlake's claims for cost reimbursement under the arbitration agreement contained within the 2007 settlement agreement.

90
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

At this time, since the proceedings are in an early stage, the Company is not able to estimate the impact, if any, that the arbitration proceeding could have on the Company's consolidated financial statements in 2017 and later years. Any cash expenditures that the Company might incur in the future with respect to the remediation of contamination at the Calvert City complex would likely be spread out over an extended period. As a result, the Company believes it is unlikely that any remediation costs allocable to it will be material in terms of expenditures made in any individual reporting period.
Environmental Remediation: Reasonably Possible Matters. The Company's assessment of the potential impact of environmental contingencies is subject to considerable uncertainty due to the complex, ongoing and evolving process of investigation and remediation, if necessary, of such environmental contingencies, and the potential for technological and regulatory developments. As such, in addition to the amounts currently reserved, the Company may be subject to reasonably possible loss contingencies related to environmental matters in the range of $55 to $110 .
Other Commitments
The Company is obligated under various long-term and short-term noncancelable operating leases, primarily related to rail car leases and land. Several of the leases provide for renewal terms and, in certain leases, purchase options. At December 31, 2017 , future minimum lease commitments for operating lease obligations and capital lease obligations were as follows:
 
 
Operating
Leases
 
Capital
Leases
2018
 
$
108

 
$
3

2019
 
97

 
3

2020
 
73

 
3

2021
 
56

 
2

2022
 
44

 
2

Thereafter
 
651

 
9

Total minimum lease payments
 
$
1,029

 
$
22

Less: Imputed interest costs
 
 
 
(12
)
Present value of net minimum lease payments
 
 
 
$
10

Operating lease rental expense was approximately $147 , $87 and $69 for the years ended December 31, 2017 , 2016 and 2015 , respectively.
The Company has various unconditional purchase obligations, primarily to purchase goods and services, including commitments to purchase various utilities, feedstock, nitrogen, oxygen, product storage and pipeline usage. Unrecorded unconditional purchase obligations for the next five years are as follows: $430 , $412 , $376 , $330 and $95 in 2018 , 2019 , 2020 , 2021 and 2022 , respectively.
21. Segment and Geographic Information
Segment Information
The Company operates in two principal operating segments: Olefins and Vinyls. These segments are strategic business units that offer a variety of different products. The Company manages each segment separately as each business requires different technology and marketing strategies.
The Company's Olefins segment manufactures and markets polyethylene, styrene monomer and various ethylene co-products. The Company's ethylene production is used in the Company's polyethylene, styrene and VCM operations. In addition, the Company sells ethylene and ethylene co-products, primarily propylene, crude butadiene, pyrolysis gasoline and hydrogen, to external customers.
No single customer accounted for more than 10% of sales in the Olefins segment for the years ended December 31, 2017 , 2016 or 2015 .
The Company's Vinyl segment manufactures and markets PVC, VCM, ethylene dichloride ("EDC"), chlor-alkali (chlorine and caustic soda), chlorinated derivative products and ethylene. The Company also manufactures and sells building products fabricated from PVC, including siding, pipe, fittings, profiles, trim, mouldings, fence and decking products, window and door

91
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

components and film and sheet products. The Company's primary North American chemical manufacturing facilities are located in its Calvert City, Kentucky and Lake Charles, Plaquemine and Geismar, Louisiana sites. The Company also produces chlorine, caustic soda, hydrogen and chlorinated derivative products at its facilities in Natrium, Longview, Washington and Beauharnois, Quebec and PVC resin and PVC compounds at several facilities in Mississippi. In addition, the Company has manufacturing facilities in Germany, the United Kingdom, Taiwan and the People's Republic of China.
As of December 31, 2017 , the Company owned 24 building products facilities. The Company uses its chlorine, VCM and PVC production to manufacture its building products. No single customer accounted for more than 10% of sales in the Vinyls segment for the years ended December 31, 2017 , 2016 or 2015 .
The accounting policies of the individual segments are the same as those described in Note 1.

92
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

 
 
Year Ended December 31,
 
 
2017
 
2016
 
2015
Net external sales
 
 
 
 
 
 
Olefins
 
 
 
 
 
 
Polyethylene
 
$
1,518

 
$
1,463

 
$
1,651

Styrene, feedstock and other
 
533

 
431

 
609

Total olefins
 
2,051

 
1,894

 
2,260

Vinyls
 
 
 
 
 
 
PVC, caustic soda and other
 
4,769

 
2,493

 
1,718

Building products
 
1,221

 
689

 
485

Total vinyls
 
5,990

 
3,182

 
2,203

 
 
$
8,041

 
$
5,076

 
$
4,463

 
 
 
 
 
 
 
Intersegment sales
 
 
 
 
 
 
Olefins
 
$
393

 
$
165

 
$
107

Vinyls
 
1

 
26

 
1

 
 
$
394

 
$
191

 
$
108

 
 
 
 
 
 
 
Income (loss) from operations
 
 
 
 
 
 
Olefins
 
$
655

 
$
558

 
$
747

Vinyls
 
647

 
174

 
255

Corporate and other
 
(69
)
 
(151
)
 
(42
)
 
 
$
1,233

 
$
581

 
$
960

 
 
 
 
 
 
 
Depreciation and amortization
 
 
 
 
 
 
Olefins
 
$
145

 
$
136

 
$
111

Vinyls
 
449

 
238

 
134

Corporate and other
 
7

 
4

 
1

 
 
$
601

 
$
378

 
$
246

 
 
 
 
 
 
 
Other income (expense), net
 
 
 
 
 
 
Olefins
 
$
3

 
$
5

 
$
5

Vinyls
 
(1
)
 
3

 
8

Corporate and other
 
5

 
48

 
25

 
 
$
7

 
$
56

 
$
38

 
 
 
 
 
 
 
Provision for (benefit from) income taxes
 
 
 
 
 
 
Olefins
 
$
63

 
$
175

 
$
243

Vinyls
 
(302
)
 
25

 
64

Corporate and other
 
(19
)
 
(62
)
 
(9
)
 
 
$
(258
)
 
$
138

 
$
298

 
 
 
 
 
 
 
Capital expenditures
 
 
 
 
 
 
Olefins
 
$
97

 
$
324

 
$
305

Vinyls
 
459

 
302

 
176

Corporate and other
 
21

 
3

 
10

 
 
$
577

 
$
629

 
$
491


93
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

 
 
December 31, 2017
 
December 31, 2016
Total assets
 
 
 
 
Olefins
 
$
2,006

 
$
2,093

Vinyls
 
8,853

 
8,287

Corporate and other
 
1,217

 
510

 
 
$
12,076

 
$
10,890

A reconciliation of total segment income from operations to consolidated income before income taxes is as follows:
 
 
Year Ended December 31,
 
 
2017
 
2016
 
2015
Income from operations for reportable segments
 
$
1,233

 
$
581

 
$
960

Interest expense
 
(159
)
 
(79
)
 
(35
)
Other income, net
 
7

 
56

 
38

Income before income taxes
 
$
1,081

 
$
558

 
$
963

Geographic Information
 
 
Year Ended December 31,
 
 
2017
 
2016
 
2015
Sales to external customers (1)
 
 
 
 
 
 
United States
 
$
5,739

 
$
3,526

 
$
3,133

Foreign
 
 
 
 
 
 
Canada
 
653

 
317

 
196

Germany
 
432

 
402

 
394

Switzerland
 
142

 
101

 
107

Brazil
 
108

 
41

 
16

China
 
104

 
87

 
46

Italy
 
96

 
84

 
90

Taiwan
 
96

 
25

 
—

Other
 
671

 
493

 
481

 
 
$
8,041

 
$
5,076

 
$
4,463

 
 
December 31, 2017
 
December 31, 2016
Long-lived assets
 
 
 
 
United States
 
$
5,668

 
$
5,783

Foreign
 
 
 
 
Germany
 
504

 
401

Other
 
240

 
236

 
 
$
6,412

 
$
6,420


______________________________
(1)
Revenues are attributed to countries based on location of customer.

94
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

22. Guarantor Disclosures
The Company's payment obligations under the Senior Notes, 4.375% 2047 Senior Notes, 3.60% 2022 Senior Notes, the 3.60% 2026 Senior Notes, the 5.0% 2046 Senior Notes and the 4.875% Westlake 2023 Senior Notes are fully and unconditionally guaranteed by each of its current and future domestic subsidiaries that guarantee other debt of the Company or of another guarantor of those notes in excess of $5 (the "Guarantor Subsidiaries"). Each Guarantor Subsidiary is 100% owned by Westlake Chemical Corporation (the " 100% Owned Guarantor Subsidiaries"). During 2016 and 2017, the Company executed a Joinder Agreement with the Administrative Agent of the Credit Agreement, whereby certain subsidiaries of the Company were added as Guarantor Subsidiaries. These guarantees are the joint and several obligations of the Guarantor Subsidiaries. The following condensed consolidating financial information presents the financial condition, results of operations and cash flows of Westlake Chemical Corporation, the 100% owned Guarantor Subsidiaries, and the remaining subsidiaries that do not guarantee the Senior Notes, the 4.375% 2047 Senior Notes, the 3.60% 2022 Senior Notes, the 3.60% 2026 Senior Notes, the 5.0% 2046 Senior Notes and the 4.875% Westlake 2023 Senior Notes (the "Non-Guarantor Subsidiaries"), together with consolidating eliminations necessary to present the Company's results on a consolidated basis.
In 2016, certain of the Company's subsidiary guarantors were released from their guarantees of the Company's 3.60% 2022 Senior Notes in connection with the replacement of the Company's revolving credit facility. Westlake Chemical OpCo LP, which was previously separately presented as a less than 100% owned guarantor, and certain of the Company's other 100% owned subsidiaries that were previously presented as guarantors, are now reflected as Non-Guarantor Subsidiaries in the condensed consolidating guarantor financial information. Prior periods were retrospectively adjusted to conform to the current presentation of Guarantor Subsidiaries and Non-Guarantor Subsidiaries.

95
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

Condensed Consolidating Financial Information as of December 31, 2017
 
 
Westlake
Chemical
Corporation
 
100% Owned
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Balance Sheet
 
 
 
 
 
 
 
 
 
 
Current assets
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
1,089

 
$
57

 
$
385

 
$
—

 
$
1,531

Accounts receivable, net
 
3,331

 
4,128

 
580

 
(7,038
)
 
1,001

Inventories
 
—

 
654

 
246

 
—

 
900

Prepaid expenses and other current assets
 
52

 
26

 
31

 
(79
)
 
30

Restricted cash
 
—

 
1

 
—

 
—

 
1

Total current assets
 
4,472

 
4,866

 
1,242

 
(7,117
)
 
3,463

Property, plant and equipment, net
 
—

 
4,374

 
2,038

 
—

 
6,412

Goodwill
 
—

 
855

 
157

 
—

 
1,012

Customer relationships, net
 
—

 
479

 
137

 
—

 
616

Other intangible assets, net
 
—

 
88

 
73

 
—

 
161

Other assets, net
 
10,706

 
798

 
1,271

 
(12,363
)
 
412

Total assets
 
$
15,178

 
$
11,460

 
$
4,918

 
$
(19,480
)
 
$
12,076

Current liabilities
 
 
 
 
 

 
 
 
 
Accounts payable
 
$
6,367

 
$
864

 
$
224

 
$
(6,855
)
 
$
600

Accrued liabilities
 
189

 
484

 
246

 
(262
)
 
657

Current portion of long-term debt, net
 
710

 
—

 
—

 
—

 
710

Total current liabilities
 
7,266

 
1,348

 
470

 
(7,117
)
 
1,967

Long-term debt, net
 
3,034

 
4,242

 
220

 
(4,369
)
 
3,127

Deferred income taxes
 
—

 
1,026

 
92

 
(7
)
 
1,111

Pension and other liabilities
 
4

 
347

 
151

 
—

 
502

Total liabilities
 
10,304

 
6,963

 
933

 
(11,493
)
 
6,707

Total Westlake Chemical Corporation stockholders' equity
 
4,874

 
4,497

 
3,490

 
(7,987
)
 
4,874

Noncontrolling interests
 
—

 
—

 
495

 
—

 
495

Total equity
 
4,874

 
4,497

 
3,985

 
(7,987
)
 
5,369

Total liabilities and equity
 
$
15,178

 
$
11,460

 
$
4,918

 
$
(19,480
)
 
$
12,076


96
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

Condensed Consolidating Financial Information as of December 31, 2016
 
 
Westlake
Chemical
Corporation
 
100% Owned
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Balance Sheet
 
 
 
 
 
 
 
 
 
 
Current assets
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
147

 
$
53

 
$
259

 
$
—

 
$
459

Accounts receivable, net
 
2,118

 
3,330

 
324

 
(4,833
)
 
939

Inventories
 
—

 
598

 
203

 
—

 
801

Prepaid expenses and other current assets
 
31

 
42

 
12

 
(37
)
 
48

Restricted cash
 
—

 
—

 
161

 
—

 
161

Total current assets
 
2,296

 
4,023

 
959

 
(4,870
)
 
2,408

Property, plant and equipment, net
 
—

 
4,476

 
1,944

 
—

 
6,420

Goodwill
 
—

 
792

 
155

 
—

 
947

Customer relationships, net
 
—

 
468

 
143

 
—

 
611

Other intangible assets, net
 
—

 
131

 
70

 
(25
)
 
176

Other assets, net
 
9,170

 
874

 
1,116

 
(10,832
)
 
328

Total assets
 
$
11,466

 
$
10,764

 
$
4,387

 
$
(15,727
)
 
$
10,890

Current liabilities
 
 
 
 
 
 
 
 
 
 
Accounts payable
 
$
4,331

 
$
748

 
$
225

 
$
(4,808
)
 
$
496

Accrued liabilities
 
26

 
390

 
183

 
(61
)
 
538

Term loan
 
—

 
—

 
149

 
—

 
149

Total current liabilities
 
4,357

 
1,138

 
557

 
(4,869
)
 
1,183

Long-term debt, net
 
3,585

 
4,091

 
—

 
(3,997
)
 
3,679

Deferred income taxes
 
—

 
1,581

 
92

 
(23
)
 
1,650

Pension and other liabilities
 
—

 
361

 
125

 
—

 
486

Total liabilities
 
7,942

 
7,171

 
774

 
(8,889
)
 
6,998

Total Westlake Chemical Corporation stockholders' equity
 
3,524

 
3,593

 
3,245

 
(6,838
)
 
3,524

Noncontrolling interests
 
—

 
—

 
368

 
—

 
368

Total equity
 
3,524

 
3,593

 
3,613

 
(6,838
)
 
3,892

Total liabilities and equity
 
$
11,466

 
$
10,764

 
$
4,387

 
$
(15,727
)
 
$
10,890



97
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

Condensed Consolidating Financial Information for the Year Ended December 31, 2017
 
 
Westlake
Chemical
Corporation
 
100% Owned
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Statement of Operations
 
 
 
 
 
 
 
 
 
 
Net sales
 
$
—

 
$
6,650

 
$
3,143

 
$
(1,752
)
 
$
8,041

Cost of sales
 
—

 
5,559

 
2,438

 
(1,725
)
 
6,272

Gross profit
 
—

 
1,091

 
705

 
(27
)
 
1,769

Selling, general and administrative expenses
 
3

 
292

 
131

 
(27
)
 
399

Amortization of intangibles
 
1

 
81

 
26

 
—

 
108

Transaction and integration-related costs
 
—

 
27

 
2

 
—

 
29

Income (loss) from operations
 
(4
)
 
691

 
546

 
—

 
1,233

Other income (expense)
 
 
 
 
 
 
 
 
 
 
Interest expense
 
(154
)
 
(178
)
 
(6
)
 
179

 
(159
)
Other income (expense), net
 
154

 
(3
)
 
35

 
(179
)
 
7

Income (loss) before income taxes
 
(4
)
 
510

 
575

 
—

 
1,081

Provision for (benefit from) income taxes
 
10

 
(312
)
 
44

 
—

 
(258
)
Equity in net income of subsidiaries
 
1,318

 
—

 
—

 
(1,318
)
 
—

Net income (loss)
 
1,304

 
822

 
531

 
(1,318
)
 
1,339

Net income attributable to noncontrolling interests
 
—

 
—

 
35

 
—

 
35

Net income (loss) attributable to Westlake Chemical Corporation
 
$
1,304

 
$
822

 
$
496

 
$
(1,318
)
 
$
1,304

Comprehensive income attributable to Westlake Chemical Corporation
 
$
1,432

 
$
833

 
$
493

 
$
(1,326
)
 
$
1,432



98
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

Condensed Consolidating Financial Information for the Year Ended December 31, 2016
 
 
Westlake
Chemical
Corporation
 
100% Owned
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Statement of Operations
 
 
 
 
 
 
 
 
 
 
Net sales
 
$
—

 
$
4,010

 
$
2,445

 
$
(1,379
)
 
$
5,076

Cost of sales
 
—

 
3,533

 
1,919

 
(1,357
)
 
4,095

Gross profit
 
—

 
477

 
526

 
(22
)
 
981

Selling, general and administrative expenses
 
2

 
178

 
100

 
(22
)
 
258

Amortization of intangibles
 
1

 
27

 
10

 
—

 
38

Transaction and integration-related costs
 
—

 
103

 
1

 
—

 
104

Income (loss) from operations
 
(3
)
 
169

 
415

 
—

 
581

Other income (expense)
 
 
 
 
 
 
 
 
 
 
Interest expense
 
(83
)
 
(76
)
 
(2
)
 
82

 
(79
)
Other income (expense), net
 
77

 
(14
)
 
75

 
(82
)
 
56

Income (loss) before income taxes
 
(9
)
 
79

 
488

 
—

 
558

Provision for (benefit from) income taxes
 
(8
)
 
115

 
31

 
—

 
138

Equity in net income of subsidiaries
 
400

 
—

 
—

 
(400
)
 
—

Net income (loss)
 
399

 
(36
)
 
457

 
(400
)
 
420

Net income attributable to noncontrolling interests
 
—

 
—

 
21

 
—

 
21

Net income (loss) attributable to Westlake Chemical Corporation
 
$
399

 
$
(36
)
 
$
436

 
$
(400
)
 
$
399

Comprehensive income attributable to Westlake Chemical Corporation
 
$
407

 
$
11

 
$
396

 
$
(407
)
 
$
407



99
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

Condensed Consolidating Financial Information for the Year Ended December 31, 2015
 
 
Westlake
Chemical
Corporation
 
100% Owned
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Statement of Operations
 
 
 
 
 
 
 
 
 
 
Net sales
 
$
—

 
$
3,558

 
$
2,286

 
$
(1,381
)
 
$
4,463

Cost of sales
 
—

 
2,842

 
1,797

 
(1,361
)
 
3,278

Gross profit
 
—

 
716

 
489

 
(20
)
 
1,185

Selling, general and administrative expenses
 
3

 
146

 
89

 
(20
)
 
218

Amortization of intangibles
 
—

 
5

 
2

 
—

 
7

Income (loss) from operations
 
(3
)
 
565

 
398

 
—

 
960

Other income (expense)
 
 
 
 
 
 
 
 
 
 
Interest expense
 
(42
)
 
(35
)
 
—

 
42

 
(35
)
Other income (expense), net
 
20

 
5

 
55

 
(42
)
 
38

Income (loss) before income taxes
 
(25
)
 
535

 
453

 
—

 
963

Provision for (benefit from) income taxes
 
(7
)
 
275

 
30

 
—

 
298

Equity in net income of subsidiaries
 
664

 
—

 
—

 
(664
)
 
—

Net income (loss)
 
646

 
260

 
423

 
(664
)
 
665

Net income attributable to noncontrolling interests
 
—

 
—

 
19

 
—

 
19

Net income (loss) attributable to Westlake Chemical Corporation
 
$
646

 
$
260

 
$
404

 
$
(664
)
 
$
646

Comprehensive income attributable to Westlake Chemical Corporation
 
$
596

 
$
261

 
$
335

 
$
(596
)
 
$
596



100
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

Condensed Consolidating Financial Information for the Year Ended December 31, 2017
 
 
Westlake
Chemical
Corporation
 
100% Owned
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Statement of Cash Flows
 
 
 
 
 
 
 
 
 
 
Cash flows from operating activities
 
 
 
 
 
 
 
 
 
 
Net income (loss)
 
$
1,304

 
$
822

 
$
531

 
$
(1,318
)
 
$
1,339

Adjustments to reconcile net income to net cash provided by (used for) operating
   activities
 
 
 
 
 
 
 
 
 
 
Depreciation and amortization
 
—

 
395

 
206

 
—

 
601

Deferred income taxes
 
12

 
(535
)
 
(11
)
 
—

 
(534
)
Net changes in working capital and other
 
(1,327
)
 
41

 
100

 
1,318

 
132

Net cash provided by (used for) operating activities
 
(11
)
 
723

 
826

 
—

 
1,538

Cash flows from investing activities
 
 
 
 
 
 
 
 
 
 
Acquisition of business, net of cash acquired
 
—

 
(13
)
 
—

 
—

 
(13
)
Additions to property, plant and equipment
 
—

 
(407
)
 
(170
)
 
—

 
(577
)
Additions to cost method investment
 
—

 
(66
)
 
—

 
—

 
(66
)
Other
 
—

 
2

 
(134
)
 
136

 
4

Net cash provided by (used for) investing activities
 
—

 
(484
)
 
(304
)
 
136

 
(652
)
Cash flows from financing activities
 
 
 
 
 
 
 
 
 
 
Intercompany financing
 
746

 
(611
)
 
(135
)
 
—

 
—

Receivable under the investment management agreement
 
136

 
—

 
—

 
(136
)
 
—

Debt issuance costs
 
(6
)
 
—

 
—

 
—

 
(6
)
Dividends paid
 
(103
)
 
—

 
—

 
—

 
(103
)
Distributions to noncontrolling interests
 
—

 
376

 
(404
)
 
—

 
(28
)
Proceeds from debt issuance and drawdown of revolver
 
225

 
—

 
8

 
—

 
233

Net proceeds from issuance of Westlake Chemical Partners LP common units
 
—

 
—

 
111

 
—

 
111

Proceeds from senior notes issuance
 
745

 
—

 
—

 
—

 
745

Repayment of term loan
 
—

 
—

 
(150
)
 
—

 
(150
)
Restricted cash associated with term loan
 
—

 
—

 
154

 
—

 
154

Repayment of revolver
 
(550
)
 
—

 
—

 
—

 
(550
)
Repayment of notes payable
 
(251
)
 
—

 
(6
)
 
—

 
(257
)
Other
 
11

 
—

 
—

 
—

 
11

Net cash provided by (used for) financing activities
 
953

 
(235
)
 
(422
)
 
(136
)
 
160


101
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

 
 
Westlake
Chemical
Corporation
 
100% Owned
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Effect of exchange rate changes on cash and cash equivalents
 
—

 
—

 
26

 
—

 
26

Net increase (decrease) in cash and cash equivalents
 
942

 
4

 
126

 
—

 
1,072

Cash and cash equivalents at beginning of the year
 
147

 
53

 
259

 
—

 
459

Cash and cash equivalents at end of the year
 
$
1,089

 
$
57

 
$
385

 
$
—

 
$
1,531



102
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

Condensed Consolidating Financial Information for the Year Ended December 31, 2016
 
 
Westlake
Chemical
Corporation
 
100% Owned
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Statement of Cash Flows
 
 
 
 
 
 
 
 
 
 
Cash flows from operating activities
 
 
 
 
 
 
 
 
 
 
Net income (loss)
 
$
399

 
$
(36
)
 
$
457

 
$
(400
)
 
$
420

Adjustments to reconcile net income to net cash provided by (used for) operating
   activities
 
 
 
 
 
 
 
 
 
 
Depreciation and amortization
 
—

 
217

 
161

 
—

 
378

Deferred income taxes
 
1

 
103

 
(3
)
 
—

 
101

Net changes in working capital and other
 
(437
)
 
90

 
(118
)
 
400

 
(65
)
Net cash provided by (used for) operating activities
 
(37
)
 
374

 
497

 
—

 
834

Cash flows from investing activities
 
 
 
 
 
 
 
 
 
 
Acquisition of business, net of cash acquired
 
—

 
(2,502
)
 
64

 
—

 
(2,438
)
Additions to property, plant and equipment
 
—

 
(275
)
 
(354
)
 
—

 
(629
)
Additions to cost method investments
 
—

 
(17
)
 
—

 
—

 
(17
)
Proceeds from sales and maturities of securities
 
658

 
—

 
5

 
—

 
663

Purchase of securities
 
(138
)
 
—

 
—

 
—

 
(138
)
Other
 
—

 
(4
)
 
—

 
—

 
(4
)
Net cash provided by (used for) investing activities
 
520

 
(2,798
)
 
(285
)
 
—

 
(2,563
)
Cash flows from financing activities
 
 
 
 
 
 
 
 
 
 
Intercompany financing
 
(2,199
)
 
2,207

 
(8
)
 
—

 
—

Debt issuance costs
 
(35
)
 
—

 
(1
)
 
—

 
(36
)
Dividends paid
 
(97
)
 
—

 
—

 
—

 
(97
)
Distributions paid
 
—

 
263

 
(280
)
 
—

 
(17
)
Proceeds from debt issuance and drawdown of revolver
 
450

 
—

 
158

 
—

 
608

Proceeds from senior notes issuance
 
1,429

 
—

 
—

 
—

 
1,429

Restricted cash associated with term loan
 
—

 
—

 
(154
)
 
—

 
(154
)
Repayment of revolver
 
(125
)
 
—

 
—

 
—

 
(125
)
Repayment of notes payable
 
—

 
—

 
(13
)
 
—

 
(13
)
Repurchase of common stock for treasury
 
(67
)
 
—

 
—

 
—

 
(67
)
Other
 
5

 
—

 
—

 
—

 
5

Net cash provided by (used for) financing activities
 
(639
)
 
2,470

 
(298
)
 
—

 
1,533


103
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

 
 
Westlake
Chemical
Corporation
 
100% Owned
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Effect of exchange rate changes on cash and cash equivalents
 
—

 
—

 
(8
)
 
—

 
(8
)
Net increase (decrease) in cash and cash equivalents
 
(156
)
 
46

 
(94
)
 
—

 
(204
)
Cash and cash equivalents at beginning of the year
 
303

 
7

 
353

 
—

 
663

Cash and cash equivalents at end of the year
 
$
147

 
$
53

 
$
259

 
$
—

 
$
459



104
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

Condensed Consolidating Financial Information for the Year Ended December 31, 2015
 
 
Westlake
Chemical
Corporation
 
100% Owned
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Statement of Cash Flows
 
 
 
 
 
 
 
 
 
 
Cash flows from operating activities
 
 
 
 
 
 
 
 
 
 
Net income (loss)
 
$
646

 
$
260

 
$
423

 
$
(664
)
 
$
665

Adjustments to reconcile net income to net cash provided by (used for) operating
   activities
 
 
 
 
 
 
 
 
 
 
Depreciation and amortization
 
—

 
114

 
132

 
—

 
246

Deferred income taxes
 
—

 
39

 
1

 
—

 
40

Net changes in working capital and other
 
(659
)
 
93

 
30

 
664

 
128

Net cash provided by (used for) operating activities
 
(13
)
 
506

 
586

 
—

 
1,079

Cash flows from investing activities
 
 
 
 
 
 
 
 
 
 
Acquisition of business, net of cash acquired
 
—

 
—

 
16

 
—

 
16

Additions to property, plant and equipment
 
—

 
(215
)
 
(276
)
 
—

 
(491
)
Proceeds from disposition of equity method investments
 
—

 
28

 
—

 
—

 
28

Proceeds from sales and maturities of securities
 
49

 
—

 
—

 
—

 
49

Purchase of securities
 
(556
)
 
(49
)
 
—

 
—

 
(605
)
Other
 
—

 
(3
)
 
—

 
—

 
(3
)
Net cash used for investing activities
 
(507
)
 
(239
)
 
(260
)
 
—

 
(1,006
)
Cash flows from financing activities
 
 
 
 
 
 
 
 
 
 
Intercompany financing
 
418

 
(590
)
 
172

 
—

 
—

Dividends paid
 
(92
)
 
—

 
—

 
—

 
(92
)
Distributions paid
 
—

 
327

 
(342
)
 
—

 
(15
)
Proceeds from debt issuance
 
—

 
—

 
53

 
—

 
53

Repayment of notes payable
 
—

 
—

 
(74
)
 
—

 
(74
)
Repurchase of common stock for treasury
 
(163
)
 
—

 
—

 
—

 
(163
)
Other
 
4

 
—

 
—

 
—

 
4

Net cash provided by (used for) financing activities
 
167

 
(263
)
 
(191
)
 
—

 
(287
)
Effect of exchange rate changes on cash and cash equivalents
 
—

 
—

 
(4
)
 
—

 
(4
)
Net increase (decrease) in cash and cash equivalents
 
(353
)
 
4

 
131

 
—

 
(218
)
Cash and cash equivalents at beginning of the year
 
656

 
3

 
222

 
—

 
881

Cash and cash equivalents at end of the year
 
$
303

 
$
7

 
$
353

 
$
—

 
$
663

 

105
WESTLAKE CHEMICAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(in millions of dollars, except share amounts and per share data)

23. Quarterly Financial Information (Unaudited)
 
 
Three Months Ended
 
 
March 31,
2017
 
June 30,
2017
 
September 30,
2017
 
December 31,
2017
Net sales
 
$
1,943

 
$
1,979

 
$
2,109

 
$
2,010

Gross profit
 
368

 
405

 
498

 
498

Income from operations
 
236

 
266

 
366

 
365

Net income
 
145

 
159

 
219

 
816

Net income attributable to
   Westlake Chemical Corporation
 
138

 
153

 
211

 
802

Earnings per common share attributable to
Westlake Chemical Corporation: (1)
 
 
 
 
 
 
 
 
Basic
 
$
1.07

 
$
1.18

 
$
1.62

 
$
6.18

Diluted
 
$
1.06

 
$
1.17

 
$
1.61

 
$
6.15

 
 
 
 
 
 
 
 
 
 
 
Three Months Ended
 
 
March 31,
2016
 
June 30,
2016
 
September 30,
2016
 
December 31,
2016
Net sales
 
$
975

 
$
1,086

 
$
1,280

 
$
1,735

Gross profit
 
255

 
241

 
203

 
282

Income from operations
 
202

 
180

 
46

 
153

Net income
 
129

 
116

 
70

 
105

Net income attributable to
   Westlake Chemical Corporation
 
123

 
111

 
66

 
99

Earnings per common share attributable to
Westlake Chemical Corporation: (1)
 
 
 
 
 
 
 
 
Basic
 
$
0.94

 
$
0.85

 
$
0.51

 
$
0.76

Diluted
 
$
0.94

 
$
0.85

 
$
0.51

 
$
0.76


______________________________
(1)
Basic and diluted earnings per common share ("EPS") for each quarter is computed using the weighted average shares outstanding during that quarter, while EPS for the year is computed using the weighted average shares outstanding for the year. As a result, the sum of the EPS for each of the four quarters may not equal the EPS for the year.

106

 
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
None.

Item 9A. Controls and Procedures
Disclosure, Controls and Procedures
We carried out an evaluation, under the supervision and with the participation of our management, including our President and Chief Executive Officer (our principal executive officer) and our Executive Vice President and Chief Financial Officer (our principal financial officer), of the effectiveness of our disclosure controls and procedures pursuant to Rules 13a-15 and 15d-15 under the Securities Exchange Act of 1934 as of the end of the period covered by this Form 10-K. Based upon that evaluation, our President and Chief Executive Officer and our Executive Vice President and Chief Financial Officer concluded that our disclosure controls and procedures are effective as of December 31, 2017 to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and is accumulated and communicated to management as appropriate to allow timely decisions regarding required disclosure.
Internal Control Over Financial Reporting
Westlake's management's report on internal control over financial reporting appears on page 47 of this Annual Report on Form 10-K. In addition, PricewaterhouseCoopers LLP, the independent registered public accounting firm that audited the financial statements included in this Annual Report on Form 10-K, has also audited the effectiveness of internal control over financial reporting as of December 31, 2017 , as stated in their report that appears on page 48 of this Annual Report on Form 10-K.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting that occurred during the year ended December 31, 2017 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Item 9B. Other Information
None.


107
Table of Contents

PART III

Item 10. Directors, Executive Officers and Corporate Governance.
Pursuant to Item 401(b) of Regulation S-K, the information required by this item with respect to our executive officers is set forth in Part I of this Form 10-K.

Item 11. Executive Compensation.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

Item 13. Certain Relationships and Related Transactions, and Director Independence.

Item 14. Principal Accountant Fees and Services.
The information required by Items 10, 11, 12, 13 and 14 is incorporated by reference to the Proxy Statement, which will be filed with the SEC pursuant to Regulation 14A under the Exchange Act within 120 days of December 31, 2017 .



108
Table of Contents

PART IV

Item 15. Exhibits and Financial Statement Schedules
(a)(1)
The financial statements listed in the Index to Consolidated Financial Statements in Item 8 of this Form 10-K are filed as part of this Form 10-K.
 
 
(a)(2)
All schedules are omitted because the information is not applicable, not required, or has been furnished in the Consolidated Financial Statements or Notes thereto in Item 8 of this Form 10-K.

(a)(3)
Exhibits
Exhibit No.
 
Exhibit Index
 
 
 
2.1
 
 
 
 
2.2

 
 
 
3.1
 
 
 
 
3.2
 
 
 
 
3.3
 
 
 
 
4.1
 
 
 
 
4.2
 
 
 
 
4.3
 
 
 
 
4.4
 
 
 
 
4.5
 
 
 
 
4.6
 
 
 
 
4.7
 
 
 
 

109
Table of Contents

Exhibit No.
 
Exhibit Index
 
 
 
4.8
 
 
 
 
4.9
 
 
 
 
4.10
 
 
 
 
4.11
 
 
 
 
4.12




4.13




4.14




4.15




4.16

 
 
 
4.17
 

 
 
 
4.18
 
 
 
 
4.19†
 
 
 
 
 
 
Westlake and its subsidiaries are party to other long-term debt instruments not filed herewith under which the total amount of securities authorized does not exceed 10% of the total assets of Westlake and its subsidiaries on a consolidated basis. Pursuant to paragraph 4(iii)(A) of Item 601(b) of Regulation S-K, Westlake agrees to furnish a copy of such instruments to the SEC upon request.
 
 
 

110
Table of Contents

Exhibit No.
 
Exhibit Index
 
 
 
10.1

 
 
 
10.2

 
 
 
10.3

 
 
 
10.4†
 
 
 
 
10.5
 
 
 
 
10.6
 
 
 
 
10.7
 
 
 
 
10.8
 
 
 
 
10.9
 
 
 
 
10.1
 
 
 
 
10.11
 
 
 
 
10.12†
 
 
 
 
10.13




10.14+
 
 
 
 
10.15+
 
 
 
 

111
Table of Contents

Exhibit No.
 
Exhibit Index
 
 
 
10.16+
 
 
 
 
10.17+
 
 
 
 
10.18+
 
 
 
 
10.19+
 
 
 
 
10.20
 
 
 
 
10.21†
 
 
 
 
10.22†
 
 
 
 
10.23†
 
 
 
 
10.24†
 
 
 
 
12.1†

 
 
 
21†
 
 
 
 
23.1†
 
 
 
 
31.1†
 
 
 
 
31.2†
 
 
 
 
32.1†
 
 
 
 
101.INS†
 
XBRL Instance Document.
 
 
 
101.SCH†
 
XBRL Taxonomy Extension Schema Document.
 
 
 
101.CAL†
 
XBRL Taxonomy Extension Calculation Linkbase Document.
 
 
 
101.DEF†
 
XBRL Taxonomy Extension Definition Linkbase Document.
 
 
 
101.LAB†
 
XBRL Taxonomy Extension Label Linkbase Document.
 
 
 
101.PRE†
 
XBRL Taxonomy Extension Presentation Linkbase Document.

______________________________
†
Filed herewith.
+
Management contract, compensatory plan or arrangement.

112
Table of Contents

SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
 
 
WESTLAKE CHEMICAL CORPORATION
 
 
 
 
Date:
February 21, 2018
 
/ S /    A LBERT  C HAO
 
 
 
Albert Chao, President and Chief Executive Officer
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Signature
 
Title
 
Date
 
 
 
/S/     A LBERT C HAO
 
President and Chief Executive Officer
   (Principal Executive Officer)
 
February 21, 2018
Albert Chao
 
 
 
 
/S/     M . S TEVEN B ENDER
 
Executive Vice President and Chief Financial
   Officer (Principal Financial Officer)
 
February 21, 2018
M. Steven Bender
 
 
 
 
/S/     G EORGE J . M ANGIERI
 
Senior Vice President and Chief Accounting
   Officer (Principal Accounting Officer)
 
February 21, 2018
George J. Mangieri
 
 
 
 
/S/     J AMES C HAO
 
Chairman of the Board of Directors
 
February 21, 2018
James Chao
 
 
 
 
/S/     A LBERT C HAO
 
Director
 
February 21, 2018
Albert Chao
 
 
 
 
/S/     R OBERT T . B LAKELY
 
Director
 
February 21, 2018
Robert T. Blakely
 
 
 
 
/S/     D AVID C HAO
 
Director
 
February 21, 2018
David Chao
 
 
 
 
 
 
 
/S/     M ICHAEL J . G RAFF
 
Director
 
February 21, 2018
Michael J. Graff
 
 
 
 
/S/     M ARIUS H AAS
 
Director
 
February 21, 2018
Marius Haas
 
 
 
 
 
 
 
/S/     D OROTHY C . J ENKINS
 
Director
 
February 21, 2018
Dorothy C. Jenkins
 
 
 
 
/S/     M AX L.   L UKENS
 
Director
 
February 21, 2018
Max L. Lukens
 
 
 
 
/S/     R . B RUCE N ORTHCUTT
 
Director
 
February 21, 2018
R. Bruce Northcutt
 
 
 
 
 
 
/S/     H . J OHN R ILEY, JR.
 
Director
 
February 21, 2018
H. John Riley, Jr.
 
 
 
 
 
 
/S/     J EFFREY S HEETS
 
Director
 
February 21, 2018
Jeffrey Sheets
 
 



113
EXHIBIT 4.19


SUPPLEMENTAL INDENTURE
SUPPLEMENTAL INDENTURE (this “ Supplemental Indenture ”), dated as of February 1, 2018, among Westlake Compounds LLC, a Delaware limited liability company (the “ Guaranteeing Subsidiary” ), Westlake Chemical Corporation, a Delaware corporation (the “ Company ”), the other Subsidiary Guarantors (as defined in the Indenture referred to below and listed on the signature pages hereto) and The Bank of New York Mellon Trust Company, N.A. (as successor to JPMorgan Chase Bank, National Association), as trustee under the Indenture referred to below (the “ Trustee ”).
W I T N E S S E T H
WHEREAS, the Company and the Subsidiary Guarantors have heretofore executed and delivered to the Trustee an indenture dated as of January 1, 2006, as supplemented by that certain Third Supplemental Indenture dated as of July 2, 2010 (the “ Third Supplemental Indenture ”) providing for the issuance of the Company’s 6.50% Senior Notes due 2029 (the “ 6.50% Senior Notes ”), that certain Fourth Supplemental Indenture dated as of December 2, 2010 (the “ Fourth Supplemental Indenture ”) providing for the issuance of the Company’s 6.50% Senior Notes due 2035 (the “ 6.50% Senior (GO Zone) Notes ”), that certain Fifth Supplemental Indenture dated as of December 2, 2010 (the “ Fifth Supplemental Indenture ”) providing for the issuance of the Company’s 6.50% Senior Notes due 2035 (the “ 6.50% Senior (IKE Zone) Notes ”), that certain Sixth Supplemental Indenture dated as of July 17, 2012 (the “ Sixth Supplemental Indenture ”) providing for the issuance of the Company’s 3.600% Senior Notes due 2022 (the “ 3.600% Senior Notes ”), that certain Seventh Supplemental Indenture dated as of February 12, 2013, that certain Supplemental Indenture dated as of May 1, 2013, that certain Supplemental Indenture, dated as of June 1, 2013, related to the 6.50% Senior Notes, that certain Supplemental Indenture dated July 17, 2014, that certain Eighth Supplemental Indenture dated as of August 10, 2016 (the “ Eighth Supplemental Indenture ”) providing for the issuance of the Company’s 3.600% Senior Notes due 2026 (the “ 3.600% Senior Notes due 2026 ”) and 5.000% Senior Notes due 2046 (the “ 5.000% Senior Notes ”), that certain Ninth Supplemental Indenture dated as of September 7, 2016 (the “ Ninth Supplemental Indenture ”) providing for the issuance of the Company’s 4.625% Senior Notes due 2021 (the “ 4.625% Senior Notes ”) and 4.875% Senior Notes due 2023 (the “ 4.875% Senior Notes ”), that certain Supplemental Indenture dated as of October 25, 2016, that certain Tenth Supplemental Indenture dated as of November 29, 2017 (the “ Tenth Supplemental Indenture ”) providing for the issuance of the Company’s 3.50% Senior Notes due 2032 (the “ 3.50% Senior Notes ”), that certain Eleventh Supplemental Indenture dated as of November 28, 2017 (the “ Eleventh Supplemental Indenture ”) providing for the issuance of the Company’s 4.375% Senior Notes due 2047 (the “ 4.375% Senior Notes and together with the other notes defined above, the “ Notes ”) (as so supplemented, the “ Indenture ”);
WHEREAS, Section 4.16 of the Third Supplemental Indenture, the Fourth Supplemental Indenture and the Fifth Supplemental Indenture and Section 4.11 of the Sixth Supplemental Indenture, the Eighth Supplemental Indenture, the Ninth Supplemental Indenture, the Tenth Supplemental Indenture and the Eleventh Supplemental Indenture provide that under certain circumstances a Domestic Subsidiary of the Company shall execute and deliver to the Trustee a supplemental indenture pursuant to which such Domestic Subsidiary shall fully and unconditionally

     1
EXHIBIT 4.19


guarantee all of the Company’s payment obligations under the Indenture and the Notes issued thereunder on the terms and conditions set forth therein (the “ Note Guarantee ”);
WHEREAS, Section 9.01(4) of the Indenture provides that, without the consent of any Holder (as defined therein), the Company, the Subsidiary Guarantors and the Trustee may amend or supplement the Indenture to add guarantees of or additional obligors on each series of the Notes;
WHEREAS, the Guaranteeing Subsidiary desires to become a Subsidiary Guarantor under the Indenture with respect to the Notes and to have the Note Guarantee be treated as a Guarantee under the Indenture; and
WHEREAS, the Company and the Subsidiary Guarantors, pursuant to the foregoing authority, propose to amend and supplement the Indenture in certain respects to provide for the Note Guarantee.
NOW THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Company, the Guaranteeing Subsidiary, the other Subsidiary Guarantors and the Trustee mutually covenant and agree for the equal and ratable benefit of the Holders of the Notes as follows:
1.    CAPITALIZED TERMS. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.
2.    AGREEMENT TO GUARANTEE. The Guaranteeing Subsidiary hereby agrees that (i) it shall be a Subsidiary Guarantor under the Indenture with respect to the Notes, (ii) the Note Guarantee is a “Guarantee” (as defined in Section 10.01(b) of the Indenture) as such term is used in the Indenture, including, without limitation, Article X thereof, and (iii) the terms and provisions of Article X apply to the Note Guarantee.
3.    NEW YORK LAW TO GOVERN. THE INTERNAL LAW OF THE STATE OF NEW YORK SHALL GOVERN AND BE USED TO CONSTRUE THIS SUPPLEMENTAL INDENTURE BUT WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED THEREBY.
4.    COUNTERPARTS. The parties may sign any number of copies of this Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement.
5.    EFFECT OF HEADINGS. The Section headings herein are for convenience only and shall not affect the construction hereof.
6.    THE TRUSTEE. The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Guaranteeing Subsidiary, the other Subsidiary Guarantors and the Company.

     2
EXHIBIT 4.19


7.      TRUST INDENTURE ACT CONTROLS. If any provision of this Supplemental Indenture limits, qualifies or conflicts with the duties imposed by TIA §318(c), the imposed duties will control.
8.    SUPPLEMENTAL INDENTURE INCORPORATED INTO INDENTURE. The terms and conditions of this Supplemental Indenture shall be deemed to be part of the Indenture for all purposes with respect to the Notes and the Note Guarantee. The Indenture is hereby incorporated by reference herein and, as supplemented by this Supplemental Indenture, is in all respects adopted, ratified and confirmed.
9.    NOTES DEEMED CONFORMED. As of the date hereof, the provisions of the Notes shall be deemed to be conformed, without the necessity for any reissuance or exchange of any such Note or any other action on the part of the Holders of the Notes, the Company, any Subsidiary Guarantor or the Trustee, so as to reflect this Supplemental Indenture.
10.    SUCCESSORS. All agreements of the Guaranteeing Subsidiary in the Indenture will bind its successors, except as otherwise expressly provided in the Indenture.
11.    SEVERABILITY. In case any provision in this Supplemental Indenture is invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions will not in any way be affected or impaired thereby.


     3

IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed and attested, all as of the date first above written.

COMPANY :

WESTLAKE CHEMICAL CORPORATION


By: /s/ ALBERT CHAO    
Name: Albert Chao
Title: President and Chief Executive Officer


GUARANTEEING SUBSIDIARY :

WESTLAKE COMPOUNDS LLC

By:     Axiall Holdco, Inc.
    its Manager
By: /s/ ALBERT CHAO    
Name:     Albert Chao
Title:    President


EXISTING SUBSIDIARY GUARANTORS :

Axiall, LLC
Axiall Corporation
Axiall Holdco, Inc.
Axiall Noteco, Inc.
Eagle Natrium LLC
Eagle Spinco Inc.
Eagle US 2 LLC
GVGP, Inc.
Lagoon LLC
By: Westlake Chemical Corporation, its Managing Member
Plastic Trends, Inc.
Rome Delaware Corporation
Royal Building Products (USA) Inc.
Westlake Chemical Investments, Inc.
Westlake Chemical Vinyls LLC
By: Westlake NG I Corporation, its Manager
Westlake Longview Corporation

36792983     [Signature Page to Westlake Compounds LLC Supplemental Indenture]

Westlake Management Services, Inc.
Westlake NG I Corporation
Westlake Olefins Corporation
Westlake Petrochemicals LLC,
By: Westlake Chemical Investments, Inc., its Manager
Westlake Polymers LLC,
By: Westlake Chemical Investments, Inc., its Manager
Westlake Chemical Energy LLC
By: Westlake NG I Corporation, its Manager
Westlake Styrene LLC,
By: Westlake Chemical Investments, Inc., its Manager
Westlake Vinyl Corporation
Westlake Vinyls Company LP,
By: GVGP, Inc., its General Partner
Westlake Vinyls, Inc.
WPT LLC,
By: Westlake Chemical Investments, Inc., its Manager



By: /s/ ALBERT CHAO    
Name: Albert Chao
Title: President

[Signature Page to Westlake Compounds LLC Supplemental Indenture]

North American Specialty Products LLC
By: North American Pipe Corporation, its Manager
Westech Building Products (Evansville) LLC
By: Westech Building Products, Inc., its Manager



By: /s/ ROBERT F. BUESINGER    
Name: Robert F. Buesinger
Title: President

[Signature Page to Westlake Compounds LLC Supplemental Indenture]

Trustee :

THE BANK OF NEW YORK MELLON TRUST     COMPANY, N.A.


By:     /s/ Authorized Signatory            
    Authorized Signatory





[Signature Page to Westlake Compounds LLC Supplemental Indenture]
EXHIBIT 10.4



JOINDER AGREEMENT
Reference is made to the Credit Agreement, dated as of August 23, 2016 (as amended, amended and restated, supplemented, waived or otherwise modified from time to time, the “ Credit Agreement ”) among Westlake Chemical Corporation, the other Borrowers referred to therein, the Guarantors referred to therein, the Lenders party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent. Terms defined in the Credit Agreement are used herein with the same meanings.
NOW, THEREFORE, the Administrative Agent and Westlake Compounds LLC, a Delaware limited liability company (the “ New Guarantor ”), in its capacity as a Guarantor, hereby agree as follows:
1. Joinder as Guarantor . In accordance with Section 5.10(a) of the Credit Agreement, the New Guarantor by its signature below becomes a Guarantor under the Credit Agreement with the same force and effect as if originally named therein as a Guarantor, but in any event subject to the same terms, provisions and limitations set forth in Article XI of the Credit Agreement. The New Guarantor hereby agrees to all the terms and provisions of the Credit Agreement applicable to it as a Guarantor. Each reference to a Guarantor in the Credit Agreement shall be deemed to include the New Guarantor.
2. Representations and Warranties . The New Guarantor represents and warrants that each of the representations and warranties set forth in the Credit Agreement and applicable to the undersigned is true in all material respects on and as of the date hereof, except to the extent any such representation and warranty (i) expressly relates to an earlier date in which case such representation and warranty shall be true and correct in all material respects as of such earlier date or (ii) is qualified by materiality, in which case such representation and warranty shall be true and correct in all respects.
3. Severability . Any provision of this Joinder Agreement which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.
4. Counterparts . This Joinder Agreement may be executed in counterparts, each of which shall constitute an original. Delivery of an executed signature page to this Joinder Agreement by facsimile or electronic transmission shall be as effective as delivery of an original executed counterpart of this Joinder Agreement.
5. No Waiver . Except as expressly supplemented hereby, the Credit Agreement shall remain in full force and effect.
6. Notices . All notices, requests and demands to or upon the New Guarantor, the Administrative Agent or any Lender shall be governed by the terms of Section 9.01 of the Credit Agreement.

1
EXHIBIT 10.4


7. Governing Law . THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.
[Signature Pages Follow]

2
EXHIBIT 10.4


IN WITNESS WHEREOF, the undersigned have caused this Joinder Agreement to be duly executed and delivered by their duly authorized officers as of the day and year first above written.
Guarantor:

WESTLAKE COMPOUNDS LLC


By:      Axiall Holdco, Inc.
     its Manager
By: /s/ ALBERT CHAO
Name:      Albert Chao
Title:      President

Administrative Agent:

JPMORGAN CHASE BANK, N.A.

By:      /s/ LAURIE C. TUZO
Authorized Signatory
Laurie C. Tuzo
Managing Director


3
EXHIBIT 10.12


SECOND AMENDMENT
TO
SENIOR UNSECURED REVOLVING CREDIT AGREEMENT

This SECOND AMENDMENT TO SENIOR UNSECURED REVOLVING CREDIT AGREEMENT (this “ Amendment ”) is made and entered into as of November 28, 2017, by and among WESTLAKE CHEMICAL PARTNERS LP, a Delaware limited partnership (“ Borrower ”), as borrower and WESTLAKE CHEMICAL FINANCE CORPORATION, a Delaware corporation (“ Lender ”), as lender.
W I T N E S S E T H
WHEREAS , the parties hereto entered into that certain Senior Unsecured Revolving Credit Agreement, dated as of April 29, 2015, as further amended on August 1, 2017 (the “ Credit Agreement ”), pursuant to which the Lender has made certain financial accommodations available to the Borrower; and
WHEREAS , the Lender desires to make certain modifications to the Credit Agreement to extend the maturity date thereof as more fully set forth herein;
NOW , THEREFORE , in consideration of the mutual covenants and the payment contained herein, and subject to the terms and conditions herein set forth, the parties hereby agree as follows:
SECTION 1. DEFINITIONS
1.1      Unless otherwise defined herein, including in the text of the preamble and recitals hereto, all capitalized terms used herein shall have the respective meanings given to such terms in Section 1.1 of the Credit Agreement, as amended hereby.
1.2      The rules of interpretation set forth in Sections 1.2 and 1.3 of the Credit Agreement shall apply to this Amendment in all respects.
SECTION 2.      AMENDMENT
2.1      The defined term “Loan Commitment” is hereby deleted in its entirety and replaced with the following:



“‘ Loan Commitment ’ shall mean the obligation of the Lender to make Loans hereunder in an aggregate principal amount at any time outstanding not exceeding $600,000,000.”.
SECTION 3.      EFFECTIVENESS
3.1      This Amendment shall become effective upon the execution and delivery of this Amendment by the Borrower and the Lender.
SECTION 4.      MISCELLANEOUS
4.1      Full Force and Effect . Except as specifically amended hereby, all of the terms and conditions of the Credit Agreement are unaffected and shall continue to be in full force and effect and shall be binding on the parties hereto in accordance with their respective terms. Each reference to the Credit Agreement therein or in any other agreement, document or instrument executed and delivered pursuant to the Credit Agreement shall mean and constitute a reference to the Credit Agreement as amended hereby. Except as specifically set forth in this Amendment, nothing in this Amendment shall be construed as modifying any other term or condition of the Credit Agreement or operate as a waiver of, or in prejudice to, any right, power or remedy of the Lender under the Credit Agreement, any applicable law or any existing or future Default or Event of Default.
4.2      Headings . Section headings used herein are for convenience of reference only, are not part of this Amendment and shall not affect the construction of, or be taken into consideration in interpreting, this Amendment.
4.3      Counterparts . This Amendment may be executed in any number of counterparts, each of which shall be enforceable against the party executing such counterpart, and all of which together shall constitute one instrument. Each counterpart may be delivered in original, facsimile or electronic (e.g., “.pdf”) form.
4.4      Governing Law . This Amendment shall be construed in accordance with and governed by the law of the State of New York.
[ The remainder of this page is intentionally left blank. ]





IN WITNESS WHEREOF , the parties hereto have caused this Amendment to be duly executed as of the day and year first above written.

 
WESTLAKE CHEMICAL PARTNERS LP
By: Westlake Chemical Partners GP LLC, its general partner
as Borrower

 
By:
                /S/ M. STEVEN BENDER
 
 
Name: M. Steven Bender
 


Title: Senior Vice President and Chief Financial Officer
 

WESTLAKE CHEMICAL FINANCE CORPORATION
as Lender

 
By:
                    /S/ JEFF HOLY
 
 
Name: Jeff Holy
 


Title: Vice President and Treasurer



Exhibit 10.21

    



[_______________], 2018


[ Name]
[Title ]


Re:    WESTLAKE CHEMICAL CORPORATION                
NONQUALIFIED STOCK OPTION AWARD

Dear [ Name] :

Westlake Chemical Corporation (the “Company”) is pleased to notify you that you have been granted a nonqualified stock option (“Option”), effective [_______________], 2018 (the “Award Date”), to purchase XXXX shares of common stock of the Company (“Common Stock”) in accordance with the Westlake Chemical Corporation 2013 Omnibus Incentive Plan (the “Plan”). Your Award is more fully described in the attached Appendix A, Terms and Conditions of Nonqualified Stock Option Award.
The price at which you may purchase the shares of Common Stock covered by the Option is [$_____] (the “Grant Price”). Unless otherwise provided in the attached Appendix A, your Option will expire on the tenth anniversary of the Award Date (the “Expiration Date”), and will become exercisable in installments as follows (the “Schedule”):
Period Beginning
Percent of Shares Purchasable
[_______________], 2019
[_______________], 2020
[_______________], 2021
33%
33%
34%

You must be in continuous employment with the Company or one of its Subsidiaries (as defined in the Plan) from the Award Date through each date on which your Option becomes exercisable in order for your Option to become exercisable on such date. Fractional shares will be rounded for purposes of vesting in accordance with Plan policy.
Your Award is subject to the terms and conditions set forth in the Plan. Both the Plan and the Prospectus for the Plan have been previously provided to you. Your Award is also subject to any additional terms and conditions set forth in the attached Appendix A and any rules and regulations adopted by the Plan’s Administrator (as defined in the Plan). In conjunction with this Award we are also required to provide you with the most current relevant SEC filings by the Company; therefore, we refer you to the SEC Filings section of our web page, www.westlake.com .
This Award letter and the attachment contain the formal terms and conditions of your Award and accordingly should be retained in your files for future reference. If you have any questions regarding this Award, you may contact me at 713-960-9111.
Very truly yours,


2018 NQSO Award
Page 2


Joel Gray
Vice President, Human Resources



    


Appendix A
to Award Letter dated
[_______________], 2018
Terms and Conditions of
Employee Nonqualified Stock Option Award
The nonqualified stock option (the “Option”) granted to you by Westlake Chemical Corporation (the “Company”) to purchase common stock of the Company (“Common Stock”) is subject to the terms and conditions set forth in the Westlake Chemical Corporation 2013 Omnibus Incentive Plan (the “Plan”), any rules and regulations adopted by the Administrator (as defined in the Plan), and any additional terms and conditions set forth in this Appendix A which forms a part of the attached award letter to you (the “Award Letter”). Any terms used in this Appendix A and not defined in the Award Letter or this Appendix A have the meanings set forth in the Plan. In the event there is an inconsistency between the terms of the Plan and this Appendix A, the terms of the Plan will control.
1.
Grant Price
You may purchase the shares of Common Stock covered by the Option for the Grant Price stated in your Award Letter.
2.
Term of Option
Your Option expires on the Expiration Date stated in your Award Letter. However, your Option will terminate prior to the Expiration Date as provided in Paragraph 6 of this Appendix A upon the occurrence of one of the events described in that paragraph. Regardless of the provisions of Paragraph 6, in no event can your Option be exercised after the Expiration Date.
3.
Earn-out of Option
(a)
Unless it becomes vested and exercisable on an earlier date as provided in Paragraph 6 below, your Option will become vested and exercisable in cumulative installments as set forth in the Schedule in your Award Letter.
(b)
To the extent your Option has become vested and exercisable, you may exercise the Option as to all or any part of the shares covered by the Option, at any time on or before the date the Option expires or terminates, subject to any limitations imposed by law or by Company policy regarding transactions in Common Stock.
4.
Exercise of Option
Subject to the limitations and the terms set forth in this Appendix A and the Plan, your Option may be exercised from time to time in accordance with the administrative procedures established by the Company in effect at the time of your exercise. In addition, if you have been notified by the Company that you may be subject to certain exercise restrictions, your Option may only be exercised by written notice signed and delivered by you or another person entitled to exercise the Option to the General Counsel of the Company at its principal executive office in Houston, Texas, or as it may hereafter be located, as set forth below. Such written notice shall (a) state the number of shares of Common Stock with respect to which your Option is being exercised and (b) subject to approval of your

A-1



request to exercise, be accompanied by a wire transfer, cashier’s check, cash, money order or other form of payment deemed acceptable by the Administrator or its designee and made payable to Westlake Chemical Corporation in the full amount of the Grant Price for any shares of Common Stock being acquired and any appropriate withholding taxes (as provided in Paragraph 7 of this Appendix A), or by other consideration in the form and manner approved by the Administrator or its designee pursuant to Paragraphs 5 and 7 of this Appendix A. In the alternative, the Administrator or its designee may prescribe other procedures for exercise of your Option. If any law or regulation requires the Company to take any action with respect to the shares specified in such notice, the time for delivery thereof, which would otherwise be as promptly as possible, shall be postponed for the period of time necessary to take such action. You shall have no rights of a shareholder with respect to shares of Common Stock subject to your Option unless and until such time as your Option has been exercised and ownership of such shares of Common Stock has been transferred to you.
5.
Satisfaction of Grant Price
Your Option must be exercised through a “cashless exercise” arrangement with a brokerage firm under which such brokerage firm, on behalf of you or such other person exercising the Option, shall pay to the Company or its designee the Grant Price of the Option or of the portion being exercised, and the Company or its designee, pursuant to an irrevocable notice from you or such other person exercising the Option, shall promptly deliver the shares being purchased to such firm.
6.
Termination of Employment
(a)
General . The following rules apply to your Option in the event of your death, disability or other termination of employment.
(i)
Involuntary Termination Without Cause . If your employment with the Company or a Subsidiary is terminated by the Company or any such Subsidiary without Cause, your Option shall be exercisable to the extent vested on the date of your termination and shall become exercisable with respect to a portion of the previously unexercisable shares that were scheduled to become exercisable on the next vesting date, prorated for the number of full months you were employed from the most recent vesting date until the date of your termination. To the extent vested, regardless whether vested as a result of your termination of employment or vested prior thereto, your Option shall remain exercisable for the longer of (i) 30 days following your termination date or (ii) the period during which you receive salary continuation under any separation agreement, policy, plan or other arrangement with the Company or any of its Subsidiaries, but not to exceed 180 days following your termination date; provided, however, that in no event shall the Option be exercisable after the Expiration Date. Upon expiration of the foregoing period, your Option shall terminate in all respects.
(ii)
Voluntary Termination . Except as provided in Paragraph 6(a)(vi), if you voluntarily terminate employment with the Company or a Subsidiary, your Option shall be exercisable to the extent vested on the date of your termination. To the extent vested, your Option shall remain exercisable until the first to occur of (i) 30 days following your termination date, or (ii) the Expiration Date. Upon expiration of the foregoing period, your Option shall terminate in all respects.

A-2



(iii)
Termination with Cause . If your employment with the Company or a Subsidiary is terminated for Cause, your Option shall immediately terminate and shall no longer be exercisable. You forfeit any previously vested and unexercised portion of your Option.
(iv)
Termination by Reason of Death . If your employment terminates by reason of death, your Option will become fully vested and exercisable and will remain exercisable until the first to occur of (i) one year after the date of your termination, or (ii) the Expiration Date.
(v)
Termination by Reason of Disability . If your employment terminates by reason of total and permanent disability (as determined by the Administrator), your Option will be exercisable to the extent vested on the date of your termination, and will remain exercisable until the first to occur of (i) 180 days after the date of your termination, or (ii) the Expiration Date. Upon expiration of the foregoing period, your Option shall terminate in all respects.
(vi)
Termination by Reason of Normal Retirement . If you voluntarily terminate employment due to Normal Retirement, your Option shall be exercisable to the extent vested on the date of your termination and shall become exercisable with respect to a portion of the previously unexercisable shares, prorated for the number of days you were employed from the Award Date until the date of your termination. With respect to all vested shares, regardless whether vested as a result of your Normal Retirement or vested prior thereto, your Option shall remain exercisable for 30 days following your termination date; provided, however, that in no event shall the Option be exercisable after the Expiration Date. Upon expiration of the foregoing period, your Option shall terminate in all respects.
(vii)
Adjustments by the Administrator . The Administrator may, in its sole discretion, exercised before or after your termination of employment, declare all or any portion of your Option immediately vested and exercisable and/or permit all or any part of your Option to remain exercisable for such period designated by it after the time when the Option would have otherwise terminated as provided in the applicable portion of this Paragraph 6(a), but not beyond the Expiration Date of your Option.
(b)
Administrator Determinations . The Administrator shall have absolute discretion to determine the date and circumstances of termination of your employment, and its determination shall be final, conclusive and binding upon you.
(c)
Cause . For purposes of this Appendix A, Cause shall mean any of the following:
(i)
your conviction by a court of competent jurisdiction of any felony or a crime involving moral turpitude;
(ii)
your knowing failure or refusal to follow reasonable instructions given to you on behalf of the Company or reasonable policies, standards and regulations of the Company or any Subsidiary;

A-3



(iii)
your continued failure or refusal to faithfully and diligently perform the usual, customary duties of your employment with the Company or any Subsidiary;
(iv)
continuously conducting yourself in an unprofessional, unethical or immoral manner; or
(v)
any fraudulent conduct or conduct which discredits the Company or any Subsidiary or is detrimental to the reputation, character and standing of the Company or any Subsidiary.
(d)
Normal Retirement . For purposes of this Appendix A, “Normal Retirement” shall mean your termination from employment with the Company and its Subsidiaries for any reason after you have (a) attained at least 65 years of age, and (b) been employed by the Company or a Subsidiary for a continuous period of 10 years or more ending on the date of your termination.
7.
Tax Consequences and Withholding
(a)
You are urged to consult your own tax advisor regarding the application of the tax laws to your particular situation.
(b)
The Option is not intended to be an “incentive stock option,” as defined in Section 422 of the Code.
(c)
Upon the settlement of your Options, you are authorized to surrender to the Company, or have withheld by the Company from the Common Stock that otherwise would have been delivered to you, an appropriate number of shares of Common Stock, having a Fair Market Value determined in accordance with the Plan, equal to the amount necessary to satisfy any tax withholding obligation arising with respect to your Options.  The Company has no discretion to refuse to accept or withhold the shares of Common Stock.  The authorization provided pursuant to this Section is intended to make the transaction exempt under Rule 16b-3 under the Exchange Act.
8.
Restrictions on Resale
There are no restrictions imposed by the Plan on the resale of shares of Common Stock acquired under the Plan. However, under the provisions of the Securities Act of 1933 (the “Securities Act”) and the rules and regulations of the Securities and Exchange Commission (the “SEC”), resales of shares acquired under the Plan by certain officers and directors of the Company who may be deemed to be “affiliates” of the Company must be made pursuant to an appropriate effective registration statement filed with the SEC, pursuant to the provisions of Rule 144 issued under the Securities Act, or pursuant to another exemption from registration provided in the Securities Act. At the present time, the Company does not have a currently effective registration statement pursuant to which such resales may be made by affiliates. There are no restrictions imposed by the SEC on the resale of shares acquired under the Plan by persons who are not affiliates of the Company. However, the timing of sales of shares may be restricted by applicable law, and the Company may, from time to time, adopt policies regarding timing of sales of shares by employees.
9.
Effect on Other Benefits

A-4



Income recognized by you as a result of exercise of the Option will not be included in the formula for calculating benefits under any of the Company’s retirement and disability plans or any other benefit plans.
10.
Clawback or Recoupment
Your Option, any shares of Common Stock issued hereunder, and any profits realized on the sale of such shares are subject to clawback or recoupment as required by applicable law or Company policy.
If you have any questions regarding your Option or would like to obtain additional information about the Plan or the Administrator, please contact the Vice President, Human Resources at 713-960-9111. Your Award Letter and this Appendix A contain the formal terms and conditions of your award and accordingly should be retained in your files for future reference.


A-5
Exhibit 10.22






[_______________], 2018


[Name]
[Title]


Re:    WESTLAKE CHEMICAL CORPORATION                
RESTRICTED STOCK UNIT AWARD

Dear [Name] :

Westlake Chemical Corporation (the “Company”) is pleased to notify you that you have been granted an award (“Award”) of XXXX units (“Restricted Stock Units”), each such unit representing one share of Common Stock of the Company. Upon the vesting of this Award pursuant to Paragraph 2 below, this Award of Restricted Stock Units will be settled by the issuance to you of one share of Common Stock for each Restricted Stock Unit awarded hereunder. This Award is granted effective [_______________], 2018 (the “Grant Date”), subject to the following terms and conditions:

1.
Relationship to Plan . This Award is subject to all of the terms, conditions and provisions of the Westlake Chemical Corporation 2013 Omnibus Incentive Plan (the “Plan”) and administrative interpretations thereunder, if any, which have been adopted by the Administrator and are in effect on the date hereof. Except as defined herein, capitalized terms shall have the same meanings ascribed to them under the Plan.
2.
Vesting Schedule .
(a)
This Award shall vest in accordance with the following schedule:
Vesting Date
Percentage of Shares Vested
[_______________], 2021
100%

You must be in continuous regular, full-time employment with the Company or any of its Subsidiaries from the Grant Date through the date this Award is scheduled to vest in order for the Award to vest. During the period of time between the Grant Date and the earlier of the date the Restricted Stock Units vest or are forfeited, the Restricted Stock Units will be evidenced by a book entry account in the Company’s records. Fractional shares will be rounded for purposes of vesting in accordance with Plan policy.



2018 RSU Award
Page 2

(b)
All Restricted Stock Units subject to this Award shall vest, irrespective of the limitations set forth in subparagraph(a) above, in the event of your termination of employment with the Company or any of its Subsidiaries due to death.
(c)
Irrespective of the limitations set forth in subparagraph(a) above, in the event of your termination of employment with the Company or any of its Subsidiaries due to Normal Retirement, the Restricted Stock Units subject to this Award shall immediately vest, with such amount multiplied by a fraction, the numerator of which is the number of days of employment with the Company or any of its Subsidiaries you completed after the Grant Date and prior to your Normal Retirement, and the denominator of which is the total number of days in the period from the Grant Date to the date this Award is scheduled to vest. For purposes of this Award, (i) “Normal Retirement” shall mean your termination from employment with the Company and its Subsidiaries for any reason after you have (a) attained at least 65 years of age, and (b) been employed by the Company or a Subsidiary for a continuous period of 10 years or more ending on the date of your termination.
3.
Forfeiture of Award . If your employment terminates other than by reason of death or Normal Retirement, all unvested Restricted Stock Units as of the termination date shall be forfeited.
4.
Distribution Following Termination of Restrictions . Subject to the other provisions of this Award and the Plan, the Restricted Stock Units shall vest as set forth in Paragraph 2, and shares of Common Stock shall be distributed to you (or your beneficiary) as soon as practicable after the Restricted Stock Units vest, but in no event later than March 15th of the year following the year in which the Restricted Stock Units vest. Distribution of Common Stock will be subject to withholding taxes as described in Paragraph 5, and may be in a form selected by the Company, in its discretion, including deposit into a custodial account or delivery of a stock certificate.
Effective January 1, 2009, the Company adopted a “Stock Ownership Policy,” as amended from time to time, that may require you to retain a portion of any shares of Common Stock distributed to you in settlement of the Restricted Stock Units. Please refer to the Stock Ownership Policy for more details.


2018 RSU Award
Page 3

5.
Withholding . Upon the settlement of the Restricted Stock Units, you are authorized to surrender to the Company, or have withheld by the Company from the Common Stock that otherwise would have been delivered to you, an appropriate number of shares of Common Stock, having a Fair Market Value determined in accordance with the Plan, equal to the amount necessary to satisfy any tax withholding obligation arising with respect to your Restricted Stock Units.  The Company has no discretion to refuse to accept or withhold the shares of Common Stock.  The authorization provided pursuant to this Section is intended to make the transaction exempt under Rule 16b-3 under the Exchange Act.
6.
Assignment of Award. Your rights under the Plan and this Restricted Stock Unit Award are personal; no assignment or transfer of your rights under and interest in this Award may be made by you other than by will or by the laws of descent and distribution.
7.
Dividend Equivalents. You are entitled to receive Dividend Equivalents paid in cash with respect to the Restricted Stock Units from the Grant Date until the earlier of the date that Common Stock is delivered to you in satisfaction of this Award or the date this Award is forfeited.
8.
Voting Rights. You do not have voting rights with respect to the Restricted Stock Units. You will be entitled to vote shares of Common Stock you retain that are issued to you in settlement of this Award.
9.
No Employment Guaranteed . No provision of this Restricted Stock Unit Award shall give you any right to continued employment with the Company or any Subsidiary.
10.
Requirements of Law and Stock Exchanges . Your rights to the Restricted Stock Units and the issuance and delivery of the Common Stock to which such Restricted Stock Units relate are subject to compliance with all applicable requirements of law. In addition, the Company shall not be obligated to deliver any shares of Common Stock if counsel to the Company determines that such delivery would violate any applicable law or any rule or regulations of any governmental authority or any rule or regulation of, or agreement of the Company with, any securities exchange or association upon which the Common Stock is listed or quoted.
11.
Governing Law . This Restricted Stock Unit Award shall be governed by, construed, and enforced in accordance with the laws of the State of Texas.
12.
Clawback or Recoupment . This Restricted Stock Unit Award, any shares of Common Stock distributed hereunder and any profits realized on the sale of such shares are subject to clawback or recoupment as required by applicable law or Company policy.
13.
Section 409A of the Code . This Award is intended to be exempt from or to comply with the provisions of Section 409A of the Code (“Section 409A”) and the provisions of this Award shall be administered, interpreted and construed accordingly. Specifically, (i) if you are not Normal Retirement Eligible, the distribution of the Common Stock upon the time of payment specified in Paragraph 4 is exempt from Section 409A as a short-term deferral in compliance with Treasury Regulation Section 1.409A-1(b)(4), and (ii) if you are Normal Retirement Eligible, the time of payment specified with respect to Paragraph 4 is compliant with Treasury Regulation Section 1.409A-3(c)(2) and is compliant with Section 409A as

2018 RSU Award
Page 4

being paid pursuant to a specified time or fixed schedule under Treasury Regulation Section 1.409A-3(i). You will not be considered to have a termination from employment unless such termination meets the requirements for a “separation from service” within the meaning of U.S. Treasury Regulation Section 1.409A-1(h), if applicable. If you are Normal Retirement Eligible and the issuance and delivery of the Common Stock hereunder would be subject to additional taxes and interest under Section 409A because the timing of such payment is not delayed as provided in Section 409A(a)(2)(B) of the Code, then the issuance and delivery of the Common Stock hereunder shall be made on the date that is six months and one day after the date of your Normal Retirement (or if such date does not fall on a business day of the Company, the next following business day of the Company), or such earlier date upon which such amount can be paid or provided under Section 409A without being subject to such additional taxes and interest. For purposes of this Award, “Normal Retirement Eligible” shall mean that you meet the age and service requirements for eligibility for Normal Retirement prior to the calendar year in which any part of this Award is scheduled to vest pursuant to Paragraph 2(a).
In conjunction with this Award we are required to provide you with the latest relevant SEC filings by the Company; therefore, we refer you to the SEC Filings section of our web page, www.westlake.com . If you have any questions regarding this Award, you may contact me at 713-960-9111.

Yours very truly,

Joel Gray
Vice President, Human Resources


Exhibit 10.23




[_______________], 2018


[Name]
[Title]


Re:    WESTLAKE CHEMICAL CORPORATION                
LONG-TERM CASH PERFORMANCE AWARD

Dear [Name] :

Westlake Chemical Corporation (the “Company”) is pleased to notify you that you have been granted an award for the 2018-2020 performance cycle with a target value of $[ XXXX] (“Performance Award”). This Performance Award is granted effective [_______________], 2018 (the “Grant Date”), subject to the following terms and conditions:
1.
Relationship to Plan . This Performance Award is subject to all of the terms, conditions and provisions of the Westlake Chemical Corporation 2013 Omnibus Incentive Plan (the “Plan”) and administrative interpretations thereunder, if any, which have been adopted by the Administrator and are in effect on the date hereof. Except as defined herein, capitalized terms shall have the same meanings ascribed to them under the Plan.
2.
Payment Schedule .
(a)
The amount of the Performance Award shall be calculated based on the Company’s achievement of certain performance conditions, as set forth on Exhibit A (the “Performance Condition”) during the 2018-2020 performance cycle, which is the period from January 1, 2018 through December 31, 2020 (the “Performance Cycle”). The Performance Award shall be paid to you in cash as soon as practicable following the date the Administrator determines to what extent the Performance Conditions were satisfied, provided , however , that you are employed by the Company or any of its Subsidiaries on such payment date.
For the avoidance of doubt, you must be in continuous regular, full-time employment with the Company or any of its Subsidiaries from the Grant Date through the date this Performance Award is paid in order to be eligible to receive this Performance Award.
(b)
The Performance Award shall be paid to you at the target level, irrespective of the limitations set forth in subparagraph (a) above, in the event of your termination of employment with the Company or any of its Subsidiaries due to death, with such amount multiplied by a fraction, the numerator of which is the number of days of employment with the Company or any of its Subsidiaries you completed during the Performance Cycle and prior to your death, and the denominator of which is the


2018 LTCPA
Page 2

total number of days in the Performance Cycle. Such Performance Award shall be paid to your beneficiary within 70 days following your death.
(c)
The Performance Award shall be paid to you, irrespective of the limitations set forth in subparagraph (a) above, in the event of your termination of employment with the Company or any of its Subsidiaries due to Normal Retirement, with such amount multiplied by a fraction, the numerator of which is the number of days of employment with the Company or any of its Subsidiaries you completed during the Performance Cycle and prior to your Normal Retirement, and the denominator of which is the total number of days in the Performance Cycle. To the extent earned based on the Performance Condition, such Performance Award shall be paid to you on March 15 th of the year immediately following the end of the Performance Cycle. For purposes of this Performance Award, “Normal Retirement” shall mean your termination from employment with the Company and its Subsidiaries for any reason after you have (a) attained at least 65 years of age, and (b) been employed by the Company or a Subsidiary for a continuous period of 10 years or more ending on the date of your termination.
3.
Forfeiture of Performance Award . If your employment with the Company or any of its Subsidiaries terminates other than by reason of death or your Normal Retirement, your Performance Award shall be forfeited.
4.
Withholding . At the time of the payment of the Performance Award, the Company shall withhold an amount of cash equal to the amount necessary to satisfy the minimum federal, state and local tax withholding obligation with respect to this Performance Award.
5.
Assignment of Performance Award . Your rights under the Plan and this Performance Award are personal; no assignment or transfer of your rights under and interest in this Performance Award may be made by you other than by will or by the laws of descent and distribution.
6.
No Employment Guaranteed . No provision of this Performance Award shall give you any right to continued employment with the Company or any Subsidiary.
7.
Governing Law . This Performance Award shall be governed by, construed, and enforced in accordance with the laws of the State of Texas.
8.
Clawback or Recoupment . This Performance Award and any cash delivered hereunder are subject to clawback or recoupment as required by applicable law or Company policy.
9.
Section 409A . Any payments under Paragraph 2(a) or 2(b) of this Performance Award are intended to be exempt from Section 409A of the Code, by compliance with the short-term deferral exemption as specified in Treas. Reg. § 1.409A-1(b)(4). Any payment under Paragraph 2(c) of this Performance Award is intended to be compliant with Code Section 409A as being paid pursuant to a specified time or fixed schedule under Treas. Reg. § 1.409A-3(i). The provisions of this Performance Award shall be administered, interpreted and construed accordingly.
If you have any questions regarding this award, you may contact me at 713-960-9111.


2018 LTCPA
Page 3

Very truly yours,

Joel Gray
Vice President, Human Resources






EXHIBIT A
Performance Condition
1.
Definition of Performance Condition . The Performance Condition for the 2018-2020 performance cycle shall be based on the greater of the average annual economic value added (“EVA”) results for Westlake Chemical Corporation and relative total shareholder return (“TSR”) as compared to a peer group of companies. EVA is equal to net operating profit after tax (“NOPAT”) less a capital charge based upon the weighted average cost of capital. TSR means stock price growth for a defined measurement period, with any dividends paid.
Average annual EVA results will be determined by averaging the annual EVA results for Westlake Chemical Corporation over the 2018-2020 three-year period. For purposes of determining TSR, the stock price shall be calculated based on the daily average stock price for the fourth calendar quarter 2017 and the fourth calendar quarter 2020. TSR shall be measured against the peer companies determined by the Administrator and shall be based on a measurement period starting on January 1, 2018 and ending on December 31, 2020 (the “Determination Date”).
2.
Calculation of Performance Award . The amount of the Performance Award shall be determined as set forth on the following chart:
 
Threshold Performance
Target Performance
Maximum Performance
Payment Rate
25% of target value
100% of target value
200% of target value
Performance Rate
(relative TSR)
33.3% ile
50% ile
75% ile
Performance Rate
(Westlake EVA)

* “1X” equals returns equivalent to the cost of capital
.5X
1X*
>2X
As soon as practicable after the Determination Date, the Administrator shall evaluate the level of achievement of the Performance Condition and if at least a threshold level of the Performance Condition was achieved, the Administrator shall certify the level of achievement of the Performance Condition in writing and shall pay the amount of the Performance Award no later than April 1 after the Determination Date.
The Performance Award for performance between Threshold Performance and Target Performance, or between Target Performance and Maximum Performance, shall be determined by linear interpolation between the values listed in the chart above. However, in no event shall the amount potentially payable to you under this Performance Award exceed the payment rate for Maximum Performance. For the avoidance of doubt, if the Threshold Performance condition is not satisfied, no amount shall be payable to you pursuant to this Performance Award.

A-1
2018 LTCPA


3.
Adjustments . If a change in control of the Company occurs, and as a result the Administrator determines that the relative TSR calculation would no longer be fairly representative of the Company's performance, the Administrator may make such adjustments to the Performance Condition as it deems necessary in the calculation of the Company’s TSR.

A-2
2018 LTCPA
Exhibit 10.24



[_______________], 2018


[Name]
[Title]


Re:    WESTLAKE CHEMICAL CORPORATION                
SPECIAL INCENTIVE AWARD


Dear [Name] :

Westlake Chemical Corporation (the “Company”) is pleased to notify you that you have been granted a special incentive award (“Award”) of XXXX units (“Restricted Stock Units”), each such unit representing one share of Common Stock of the Company. Upon the vesting of this Award pursuant to Paragraph 2 below, this Award of Restricted Stock Units will be settled by the issuance to you of one share of Common Stock for each Restricted Stock Unit awarded hereunder. This Award is granted effective [_______________], 2018 (the “Grant Date”), subject to the following terms and conditions:

1.
Relationship to Plan . This Award is subject to all of the terms, conditions and provisions of the Westlake Chemical Corporation 2013 Omnibus Incentive Plan (the “Plan”) and administrative interpretations thereunder, if any, which have been adopted by the Administrator and are in effect on the date hereof. Except as defined herein, capitalized terms shall have the same meanings ascribed to them under the Plan.
2.
Vesting Schedule .
(a)
This Award shall vest in accordance with the following schedule:
Vesting Date
Percentage of Shares Vested
[_______________], 2021
100%

You must be in continuous regular, full-time employment with the Company or any of its Subsidiaries from the Grant Date through the date this Award is scheduled to vest in order for the Award to vest. During the period of time between the Grant Date and the earlier of the date the Restricted Stock Units vest or are forfeited, the Restricted Stock Units will be evidenced by a book entry account in the Company’s records. Fractional shares will be rounded for purposes of vesting in accordance with Plan policy.

(b)
All Restricted Stock Units subject to this Award shall vest, irrespective of the limitations set forth in subparagraph(a) above, in the event of your termination of employment with the Company or any of its Subsidiaries due to death.
(c)
Irrespective of the limitations set forth in subparagraph(a) above, in the event of your termination of employment with the Company or any of its Subsidiaries due


2018 RSU Award
Page 2

to Normal Retirement, the Restricted Stock Units subject to this Award shall immediately vest, with such amount multiplied by a fraction, the numerator of which is the number of days of employment with the Company or any of its Subsidiaries you completed after the Grant Date and prior to your Normal Retirement, and the denominator of which is the total number of days in the period from the Grant Date to the date this Award is scheduled to vest. For purposes of this Award, (i) “Normal Retirement” shall mean your termination from employment with the Company and its Subsidiaries for any reason after you have (a) attained at least 65 years of age, and (b) been employed by the Company or a Subsidiary for a continuous period of 10 years or more ending on the date of your termination.
3.
Forfeiture of Award . If your employment terminates other than by reason of death or Normal Retirement, all unvested Restricted Stock Units as of the termination date shall be forfeited.
4.
Distribution Following Termination of Restrictions . Subject to the other provisions of this Award and the Plan, the Restricted Stock Units shall vest as set forth in Paragraph 2, and shares of Common Stock shall be distributed to you (or your beneficiary) as soon as practicable after the Restricted Stock Units vest, but in no event later than March 15th of the year following the year in which the Restricted Stock Units vest. Distribution of Common Stock will be subject to withholding taxes as described in Paragraph 5, and may be in a form selected by the Company, in its discretion, including deposit into a custodial account or delivery of a stock certificate.
Effective January 1, 2009, the Company adopted a “Stock Ownership Policy,” as amended from time to time, that may require you to retain a portion of any shares of Common Stock distributed to you in settlement of the Restricted Stock Units. Please refer to the Stock Ownership Policy for more details.



2018 RSU Award
Page 3

5.
Withholding . Upon the settlement of the Restricted Stock Units, you are authorized to surrender to the Company, or have withheld by the Company from the Common Stock that otherwise would have been delivered to you, an appropriate number of shares of Common Stock, having a Fair Market Value determined in accordance with the Plan, equal to the amount necessary to satisfy any tax withholding obligation arising with respect to your Restricted Stock Units.  The Company has no discretion to refuse to accept or withhold the shares of Common Stock.  The authorization provided pursuant to this Section is intended to make the transaction exempt under Rule 16b-3 under the Exchange Act.
6.
Assignment of Award. Your rights under the Plan and this Restricted Stock Unit Award are personal; no assignment or transfer of your rights under and interest in this Award may be made by you other than by will or by the laws of descent and distribution.
7.
No Dividend Equivalents . You are not entitled to receive Dividend Equivalents with respect to the Restricted Stock Units under this Award.
8.
Voting Rights. You do not have voting rights with respect to the Restricted Stock Units. You will be entitled to vote shares of Common Stock you retain that are issued to you in settlement of this Award.
9.
No Employment Guaranteed . No provision of this Restricted Stock Unit Award shall give you any right to continued employment with the Company or any Subsidiary.
10.
Requirements of Law and Stock Exchanges . Your rights to the Restricted Stock Units and the issuance and delivery of the Common Stock to which such Restricted Stock Units relate are subject to compliance with all applicable requirements of law. In addition, the Company shall not be obligated to deliver any shares of Common Stock if counsel to the Company determines that such delivery would violate any applicable law or any rule or regulations of any governmental authority or any rule or regulation of, or agreement of the Company with, any securities exchange or association upon which the Common Stock is listed or quoted.
11.
Governing Law . This Restricted Stock Unit Award shall be governed by, construed, and enforced in accordance with the laws of the State of Texas.
12.
Clawback or Recoupment . This Restricted Stock Unit Award, any shares of Common Stock distributed hereunder and any profits realized on the sale of such shares are subject to clawback or recoupment as required by applicable law or Company policy.
13.
Section 409A of the Code . This Award is intended to be exempt from or to comply with the provisions of Section 409A of the Code (“Section 409A”) and the provisions of this Award shall be administered, interpreted and construed accordingly. Specifically, (i) if you are not Normal Retirement Eligible, the distribution of the Common Stock upon the time of payment specified in Paragraph 4 is exempt from Section 409A as a short-term deferral in compliance with Treasury Regulation Section 1.409A-1(b)(4), and (ii) if you are Normal Retirement Eligible, the time of payment specified with respect to Paragraph 4 is compliant with Treasury Regulation Section 1.409A-3(c)(2) and is compliant with Section 409A as being paid pursuant to a specified time or fixed schedule under Treasury Regulation Section 1.409A-3(i). You will not be considered to have a termination from employment unless


2018 RSU Award
Page 4

such termination meets the requirements for a “separation from service” within the meaning of U.S. Treasury Regulation Section 1.409A-1(h), if applicable. If you are Normal Retirement Eligible and the issuance and delivery of the Common Stock hereunder would be subject to additional taxes and interest under Section 409A because the timing of such payment is not delayed as provided in Section 409A(a)(2)(B) of the Code, then the issuance and delivery of the Common Stock hereunder shall be made on the date that is six months and one day after the date of your Normal Retirement (or if such date does not fall on a business day of the Company, the next following business day of the Company), or such earlier date upon which such amount can be paid or provided under Section 409A without being subject to such additional taxes and interest. For purposes of this Award, “Normal Retirement Eligible” shall mean that you meet the age and service requirements for eligibility for Normal Retirement prior to the calendar year in which any part of this Award is scheduled to vest pursuant to Paragraph 2(a).
In conjunction with this Award we are required to provide you with the latest relevant SEC filings by the Company; therefore, we refer you to the SEC Filings section of our web page, www.westlake.com . If you have any questions regarding this Award, you may contact me at 713-960-9111.
Yours very truly,

Joel Gray
Vice President, Human Resources



EXHIBIT 12.1


WESTLAKE CHEMICAL CORPORATION
RATIO OF EARNINGS TO FIXED CHARGES
(millions of dollars)
 
 
Year Ended December 31,
 
 
2017
 
2016
 
2015
 
2014
 
2013
Earnings
 
 
 
 
 
 
 
 
 
 
Income before Income Taxes
 
$
1,081

 
$
558

 
$
963

 
$
1,084

 
$
942

Fixed Charges
 
207

 
119

 
68

 
63

 
59

Equity Investee Distributions
 
6

 
5

 
6

 
5

 
5

Capitalized Interest
 
(4
)
 
(10
)
 
(10
)
 
(7
)
 
(26
)
Noncontrolling interest
 
(10
)
 
(1
)
 
—

 
—

 
—

Equity Investment (Income) Loss
 
(6
)
 
(4
)
 
(22
)
 
1

 
(5
)
Total Earnings Available for Fixed Charges
 
$
1,274

 
$
667

 
$
1,005

 
$
1,146

 
$
975

 
 
 
 
 
 
 
 
 
 
 
Fixed Charges
 
 
 
 
 
 
 
 
 
 
Interest Expense
 
$
159

 
$
79

 
$
35

 
$
37

 
$
18

Capitalized Interest
 
4

 
10

 
10

 
7

 
26

Portion of Rentals
 
44

 
30

 
23

 
19

 
15

Total Fixed Charges
 
$
207

 
$
119

 
$
68

 
$
63

 
$
59

 
 
 
 
 
 
 
 
 
 
 
Ratio of Earnings to Fixed Charges
 
6.2

 
5.6

 
14.8

 
18.2

 
16.5





EXHIBIT 21
SUBSIDIARIES OF WESTLAKE *
   Name of Subsidiary
 
State or Other Jurisdiction
of Incorporation or
Organization
 
   Names Doing Business
 
 
 
 
 
Axiall Canada, Inc.
 
Canada
 
Axiall Canada, Inc.
 
 
 
 
 
Axiall Corporation
 
Delaware
 
Axiall Corporation
 
 
 
 
 
Axiall Holdco, Inc.
 
Delaware
 
Axiall Holdco, Inc.
 
 
 
 
 
Axiall Noteco, Inc.
 
Delaware
 
Axiall Noteco, Inc.
 
 
 
 
 
Axiall Taiwan Ltd.
 
Taiwan
 
Axiall Taiwan Ltd.
 
 
 
 
 
Axiall, LLC
 
Delaware
 
Axiall, LLC
 
 
 
 
 
Eagle Natrium LLC
 
Delaware
 
Eagle Natrium LLC
 
 
 
 
 
Eagle Spinco Inc.
 
Delaware
 
Eagle Spinco Inc.
 
 
 
 
 
Eagle US 2 LLC
 
Delaware
 
Eagle US 2 LLC
 
 
 
 
 
Lagoon LLC
 
Delaware
 
Lagoon LLC
 
 
 
 
 
North American Pipe Corporation
 
Delaware
 
North American Pipe Corporation
   and NAPCO
 
 
 
 
 
North American Specialty Products LLC
 
Delaware
 
North American Specialty Products LLC
 
 
 
 
 
Plastic Trends, Inc.
 
Michigan
 
Plastic Trends, Inc.
 
 
 
 
 
Rome Acquisition Holding Corp.
 
Nova Scotia
 
Rome Acquisition Holding Corp.
 
 
 
 
 
Rome Delaware Corp.
 
Delaware
 
Rome Delaware Corp.
 
 
 
 
 
Royal Building Products (USA) Inc.
 
Delaware
 
Royal Building Products (USA) Inc.
 
 
 
 
 
Royal Group, Inc.
 
Canada
 
Royal Group, Inc.
 
 
 
 
 
Taiwan Chlorine Industries Ltd.
 
Taiwan
 
Taiwan Chlorine Industries Ltd.

 
 
 
 
 
Vinnolit Benelux-France B.V.B.A.

 
Dendermonde, Belgium
 
Vinnolit Benelux-France B.V.B.A.

 
 
 
 
 
Vinnolit GmbH & Co. KG

 
Ismaning, Germany
 
Vinnolit GmbH & Co. KG

 
 
 
 
 
Vinnolit Hillhouse Ltd.

 
Lancashire, England
 
Vinnolit Hillhouse Ltd.

 
 
 
 
 
Vinnolit Italia S.r.L.

 
Milan, Italy
 
Vinnolit Italia S.r.L.

 
 
 
 
 
Vinnolit Limited

 
United Kingdom
 
Vinnolit Limited
 
 
 
 
 
Vinnolit Schkopau GmbH

 
Ismaning, Germany
 
Vinnolit Schkopau GmbH

 
 
 
 
 
Westlake Building Products, Inc.
 
Delaware
 
Westlake Building Products, Inc.

 
 
 
 
 
Westlake Chemical Finance Corporation
 
Delaware
 
Westlake Chemical Finance Corporation
 
 
 
 
 
Westlake Chemical Investments, Inc.
 
Delaware
 
Westlake Chemical Investments, Inc.

 
 
 
 
 
Westlake Chemical OpCo LP
 
Delaware
 
Westlake Chemical OpCo LP
 
 
 
 
 
Westlake Chemical Partners GP LLC
 
Delaware
 
Westlake Chemical Partners GP LLC

 
 
 
 
 
Westlake Chemical Partners LP
 
Delaware
 
Westlake Chemical Partners LP
 
 
 
 
 
Westlake Development Corporation
 
Delaware
 
Westlake Development Corporation

 
 
 
 
 
Westlake International Holdings Cooperatief U.A.
 
The Netherlands
 
Westlake International Holdings Cooperatief U.A.

 
 
 
 
 
Westlake International Holdings C.V.
 
The Netherlands
 
Westlake International Holdings C.V.
 
 
 
 
 
Westlake International Holdings II C.V.

 
The Netherlands

 
Westlake International Holdings II C.V.





 
 
 
 
 
Westlake Longview Corporation
 
Delaware
 
Westlake Longview Corporation
 
 
 
 
 
Westlake Management Services, Inc.
 
Delaware
 
Westlake Management Services, Inc.
 
 
 
 
 
Westlake Olefins Corporation
 
Delaware
 
Westlake Olefins Corporation

 
 
 
 
 
Westlake Petrochemicals LLC
 
Delaware
 
Westlake Petrochemicals LLC,
   Westlake Petrochemicals LP and WPE
 
 
 
 
 
Westlake Polymers LLC
 
Delaware
 
Westlake Polymers LLC,
   Westlake Polymers LP and WPE
 
 
 
 
 
Westlake Styrene LLC
 
Delaware
 
Westlake Styrene LLC

 
 
 
 
 
Westlake Vinyls Company LP
 
Delaware
 
Westlake Vinyls Company LP

 
 
 
 
 
Westlake Vinyl Corporation
 
Delaware
 
Westlake Vinyl Corporation
 
 
 
 
 
Westlake Vinyls, Inc.
 
Delaware
 
Westlake Vinyls, Inc.

 
 
 
 
 
WPT LLC
 
Delaware
 
WPT LLC and WPT LP
 
 
 
 
 

______________________________
*
Westlake has elected to omit the names of certain subsidiaries. None of the omitted subsidiaries, considered either alone or together with the other omitted subsidiaries of its immediate parent, constitutes a “Significant Subsidiary” as set forth in Section 601(b)(21) of Regulation S-K.





EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-213548) and Form S‑8 (No. 333-118205) of Westlake Chemical Corporation of our report dated February 21, 2018 relating to the consolidated financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.  
/s/ PricewaterhouseCoopers LLP
Houston, Texas
February 21, 2018




EXHIBIT 31.1
CERTIFICATIONS
I, Albert Chao, certify that:
1.
I have reviewed this annual report on Form 10-K of Westlake Chemical Corporation;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)
evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)
disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a)
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Date:
February 21, 2018
 
/s/ A LBERT  C HAO
 
 
 
Albert Chao
President and Chief Executive Officer
(Principal Executive Officer)




EXHIBIT 31.2
CERTIFICATIONS
I, M. Steven Bender, certify that:
1.
I have reviewed this annual report on Form 10-K of Westlake Chemical Corporation;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)
evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)
disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a)
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Date:
February 21, 2018
 
/s/ M. S TEVEN  B ENDER
 
 
 
M. Steven Bender
Executive Vice President and Chief Financial Officer
(Principal Financial Officer)




EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Westlake Chemical Corporation (the "Company") on Form 10-K for the fiscal year ended December 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Albert Chao, President and Chief Executive Officer of the Company, and I, M. Steven Bender, Senior Vice President, Chief Financial Officer and Treasurer of the Company, certify, to the best of our knowledge, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:
(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date:
February 21, 2018
 
/s/ A LBERT  C HAO
 
 
 
Albert Chao
President and Chief Executive Officer
(Principal Executive Officer)
 
 
 
 
Date:
February 21, 2018
 
/s/ M. S TEVEN  B ENDER
 
 
 
M. Steven Bender
Executive Vice President and Chief Financial Officer
(Principal Financial Officer)